AOP,AOP name,Event,Event Process,Event Action,Level of Organisation,Process_merged,Ontology_ID,Object,Ontology_ID,Action,Ontology_ID,Cell Context,  ,Organ Context,Ontology_ID
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:861,Ketogenesis (production of ketone bodies),Decreased,Molecular,ketosis,D007662,,,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:38,Protein Alkylation leading to Liver Fibrosis,Event:244,Protein,Alkylation,Molecular,protein alkylation,GO:0008213,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:81,Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure,Event:574,Appetite and hunger,Increased,Individual,Appetite,D001066,,,increased process quality,PATO:0002304,,,,
Aop:104,Altered ion channel activity leading impaired heart function,Event:699,cardiac arrthymia,Increased,Organ,"Arrhythmias, Cardiac",D001145,,,increased object quality,PATO:0002305,,,Heart,UBERON:0000948
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:868,"Tissue Degeneration, Necrosis & Atrophy",Increase,Tissue,atrophy,D001284,olfactory epithelium,UBERON:0001997,increased process quality,PATO:0002304,,,olfactory organ,UBERON:0002268
Aop:116,Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:713,Adenomas/carcinomas (renal tubular),Increase,Tissue,"Carcinoma, Renal Cell",D002292,adenoma,D000236,increased object quality,PATO:0002305,,,renal tubule,UBERON:0009773
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:823,Cystic dilatation (renal tubule),Occurrence,Organ,Dilatation,D004106,renal tubule,UBERON:0009773,occurrence,PATO:0000057,,,kidney,UBERON:0002113
Aop:14,Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility,Event:323,Disease susceptibility,Increased,Individual,Disease Susceptibility,D004198,,,increased process quality,PATO:0002304,,,,
Aop:7,Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female,Event:406,Fertility,impaired,Individual,fertility,D005298,,,decreased process quality,PATO:0002302,,,,
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:406,Fertility,impaired,Individual,fertility,D005298,,,decreased process quality,PATO:0002302,,,,
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:406,Fertility,impaired,Individual,fertility,D005298,,,decreased process quality,PATO:0002302,,,,
Aop:1,Uncharacterized liver damage leading to hepatocellular carcinoma,Event:334,Hepatocelluar carcinoma,Promotion,Individual,hepatocellular carcinoma,D006528,,,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:117,Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,"Carcinoma, Hepatocellular",D006528,adenoma,D000236,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:118,Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,"Carcinoma, Hepatocellular",D006528,adenoma,D000236,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:1,Uncharacterized liver damage leading to hepatocellular carcinoma,Event:142,Hyperplasia,Hyperplasia,Tissue,hyperplasia,D006965,,,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:854,Cellular proliferation / hyperplasia,Alterations,Tissue,hyperplasia,D006965,hepatic oval stem cell,CL:0002196,increased process quality,PATO:0002304,,,liver,UBERON:0002107
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:854,Cellular proliferation / hyperplasia,Alterations,Tissue,hyperplasia,D006965,intrahepatic bile duct epithelial cell,CL:0002538,increased process quality,PATO:0002304,,,liver,UBERON:0002107
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:415,Leydig cell,Hyperplasia,Cellular,hyperplasia,D006965,,,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:105,Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:767,Hyperplasia (renal tubular cells),Increase,Cellular,Hyperplasia,D006965,kidney tubule cell,CL:1000507,increased process quality,PATO:0002304,kidney tubule cell,CL:1000507,,
Aop:109,Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse),Event:735,Hyperplasia (terminal bronchiolar cells),Increase,Cellular,hyperplasia,D006965,bronchial epithelial cell,CL:0002328,increased process quality,PATO:0002304,bronchial epithelial cell,CL:0002328,terminal bronchiole epithelium,UBERON:0001958 
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:740,Hyperplasia (follicular cells),Increase,Cellular,hyperplasia,D006965,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:740,Hyperplasia (follicular cells),Increase,Cellular,hyperplasia,D006965,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:121,Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat),Event:796,Hyperplasia (urothelial),Increase,Cellular,hyperplasia,D006965,urothelial cell,CL:0000731,increased process quality,PATO:0002304,urothelial cell,CL:0000731,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:921,Hyperplasia of goblet cells,Increase,Tissue,hyperplasia,D006965,goblet cell ,CL:0000160,occurrence,PATO:0000057,,,lung,UBERON:0002048
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1025,Hyperplasia (follicular cells),Increased,Tissue,hyperplasia,D006965,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,,,thyroid gland,UBERON:0002046 
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1051,ovarian stromal cells,Hyperplasia,Cellular,hyperplasia,D006965,stromal cell of ovary,CL:0002132,increased process quality,PATO:0002304,stromal cell of ovary,CL:0002132,,
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1052,ovarian epithelium,Hyperplasia,Tissue,hyperplasia,D006965,epithelium of female gonad,UBERON:0004911,increased process quality,PATO:0002304,,,epithelium of female gonad,UBERON:0004911
Aop:167,Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,Event:1069,Hyperplasia (glandular epithelial cells of endometrium),Increased,Cellular,hyperplasia,D006965,glandular epithelial cell,CL:0000150,increased process quality,PATO:0002304,glandular epithelial cell,CL:0000150,,
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1081,lactotroph hyperplasia and hypertrophy,Increased,Cellular,hyperplasia,D006965,prolactin secreting cell,CL:0000439,increased process quality,PATO:0002304,prolactin secreting cell ,CL:0000439,,
Aop:170,Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat,Event:1085,hyperplasia (mammary gland),Increased,Tissue,hyperplasia,D006965,mammary gland,UBERON:0001911,increased process quality,PATO:0002304,,,mammary gland,UBERON:0001911
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1192,Ductal Hyperplasia,Increased,Tissue,hyperplasia,D006965,,,increased process quality        ,PATO:0002304,,,mammary duct,UBERON:0001765
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:739,Hypertrophy and proliferation (follicular cell),Increase,Cellular,hypertrophy,D006984,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:739,Hypertrophy and proliferation (follicular cell),Increase,Cellular,hypertrophy,D006984,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1024,Hypertrophy and proliferation (follicular cell),Increased,Cellular,hypertrophy,D006984,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:164,Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse,Event:1043,smooth muscle,Hypertrophy/hyperplasia,Cellular,hypertrophy,D006984,smooth muscle tissue,UBERON:0001135,increased process quality,PATO:0002304,,,,
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1081,lactotroph hyperplasia and hypertrophy,Increased,Cellular,hypertrophy,D006984,prolactin secreting cell,CL:0000439,increased process quality,PATO:0002304,prolactin secreting cell ,CL:0000439,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:984,Suppression of transplant rejection,Suppression,Individual,Immunosuppression,D007165,,,increased process quality,PATO:0002304,,,,
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1105,renal ischemia,Occurrence,Tissue,ischemia,D007511,kidney,UBERON:0002113,occurrence,PATO:0000057,,,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:477,Ketogenesis,Decreased,Cellular,Ketosis,D007662,,,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:252,Renal pathology due to VTG deposition,Increase,Organ,Kidney Diseases,D007674,,,increased process quality,PATO:0002304,,,kidney,UBERON:0002113
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:920,Metaplasia of goblet cells,Increase,Tissue,Metaplasia,D008679,goblet cell ,CL:0000160,occurrence,PATO:0000057,,,lung,UBERON:0002048
Aop:4,Ecdysone receptor agonism leading to mortality,Event:351,Mortality,Increase,Individual,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:351,Mortality,Increased,Population,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:21,Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality,Event:350,"Increase, Mortality","Increase, Mortality",Individual,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:351,Mortality,Increased,Population,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:104,Altered ion channel activity leading impaired heart function,Event:351,Mortality,Increased,Population,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:351,Mortality,Increased,Population,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:351,"Increased, Mortality","Increased, Mortality",Population,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:160,Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,Event:351,Mortality,Increased,Population,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:161,Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,Event:351,Mortality,Increased,Individual,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:351,Mortality,Increased,Individual,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:186,unknown MIE leading to renal failure and mortality,Event:351,Mortality,Increased,Individual,mortality,D009026,,,increased process quality,PATO:0002304,,,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1135,"Acidosis, hypovolemic shock and organ dysfunction",Reduced fitness or even mortality,Tissue,mortality,D009026,,,increased object quality,PATO:0002305,,,,
Aop:15,Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations,Event:185,Mutations,Increase,Molecular,mutation,D009154,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:15,Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations,Event:336,Heritable mutations in offspring,Increase,Individual,mutation,D009154,DNA,CHEBI:16991,increased process quality,PATO:0002304,,,,
Aop:46,AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC),Event:376,Induced Mutations in Critical Genes,Increased,Cellular,mutation,D009154,cellular tumor antigen p53,PR:000003035,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:876,Mutations in Critical Genes,Increase,Molecular,mutation,D009154,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:139,Alkylation of DNA leading to cancer 2,Event:185,Mutations,Increase,Molecular,mutation,D009154,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:141,Alkylation of DNA leading to cancer 3,Event:185,Mutations,Increase,Molecular,mutation,D009154,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:39,Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins,Event:313,Allergic Respiratory Hypersensitivity Response,Increase,Organ,Respiratory Hypersensitivity,D012130,,,increased process quality,PATO:0002304,,,lung,UBERON:0002048
Aop:184,Nosema infection causes abnormal role change that leads to colony loss/failure,Event:1108,Role change within caste,Abnormal,Population,role,D012380,,,abnormal,PATO:0000460,,,,
Aop:52,ER agonism leading to skewed sex ratios due to altered sexual differentiation in males,Event:417,sex ratio,skewed,Population,sex ratio,D012744,,,deviation(from_normal),PATO:0000069,,,,
Aop:81,Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure,Event:573,Energetic demands and therefore metabolic stress,Increase,Individual,"Stress, Physiological",D013312,,,increased process quality,PATO:0002304,,,,
Aop:183,Nosema infection increases energetic demands leading to colony loss/failure,Event:1110,Energetic demands and therefore metabolic stress,Increased,Individual,"Stress, Physiological",D013312,,,increased process quality,PATO:0002304,,,,
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1006,Young of year survival,Reduced,Individual,survival,D013534,,,decreased object quality,PATO:0002303,,,,
Aop:156,Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1006,Young of year survival,Reduced,Individual,survival,D013534,,,decreased object quality,PATO:0002303,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1006,Young of year survival,Reduced,Individual,survival,D013534,,,decreased object quality,PATO:0002303,,,,
Aop:158,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1006,Young of year survival,Reduced,Individual,survival,D013534,,,decreased object quality,PATO:0002303,,,,
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1006,Young of year survival,Reduced,Individual,survival,D013534,,,decreased object quality,PATO:0002303,,,,
Aop:202,In-utero DNA topoisomerase II poisons leading to infant leukaemia,Event:1253,In utero MLL chromosomal translocation,,Cellular,"Translocation, Genetic",D014178,,,occurrence,PATO:0000057,embryonic cell,CL:0002321,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 1,Event:1107,"Weakened, Colony","Weakened, Colony",Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:79,Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:79,Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,Colony Collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:81,Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:82,Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:84,Suppression of immune system contributes to impaired development and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:85,Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:86,Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2,Event:1107,"Weakened, Colony","Weakened, Colony",Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:1107,"Weakened, Colony","Weakened, Colony",Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:1107,"Weakened, Colony","Weakened, Colony",Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:178,Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:178,Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:179,Varroa mite infestation increases virus levels leading to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:179,Varroa mite infestation increases virus levels leading to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:180,Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:180,Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:181,Weather event contributes to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:181,Weather event contributes to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:182,Weather event contributes abnormal foraging leading to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:182,Weather event contributes abnormal foraging leading to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:183,Nosema infection increases energetic demands leading to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:183,Nosema infection increases energetic demands leading to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:184,Nosema infection causes abnormal role change that leads to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:184,Nosema infection causes abnormal role change that leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:185,Queen egg-laying decrease leads to colony loss/failure,Event:1107,Colony,Weakened,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:185,Queen egg-laying decrease leads to colony loss/failure,Event:563,Colony,Loss/Failure,Population,colony collapse,D056631,,,increased process quality,PATO:0002304,,,,
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:889,Proteostasis,impaired,Cellular,Proteostasis deficiencies,D057165,protein,CHEBI:36080,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1151,Bone deterioration,Osteoporosis and vascular calcification,Individual,vascular calcification,D061205,vasculature ,UBERON:0002049,increased process quality,PATO:0002304,,,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:675,Reproductive Success,Reduced,Individual,reproductive process,GO:0000003,,,decreased process quality,PATO:0002302,,,,
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:675,Reproductive Success,Reduced,Individual,reproductive process,GO:0000003,,,decreased process quality,PATO:0002302,,,,
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:675,Reproductive Success,Reduced,Individual,reproductive process,GO:0000003,,,decreased process quality,PATO:0002302,,,,
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:675,Reproductive Success,Reduced,Individual,reproductive process,GO:0000003,,,decreased process quality,PATO:0002302,,,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1277,Reproductive failure,,Individual,reproduction,GO:0000003,,,decreased process quality,PATO:0002302,,,,
Aop:208,Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure,Event:1277,Reproductive failure,,Individual,reproduction,GO:0000003,,,decreased process quality,PATO:0002302,,,,
Aop:210,Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building ,Event:1277,Reproductive failure,,Individual,reproduction,GO:0000003,,,decreased process quality,PATO:0002302,,,,
Aop:91,Sodium channel inhibition leading to reduced survival,Event:585,Action Potential,Inhibition,Cellular,action potential,GO:0001508,,,decreased process quality,PATO:0002302,,,,
Aop:93,sodium channel inhibition leading to increased predation,Event:585,Action Potential,Inhibition,Cellular,action potential,GO:0001508,,,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:94,Sodium channel inhibition leading to congenital malformations,Event:585,Action Potential,Inhibition,Cellular,action potential,GO:0001508,,,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:95,Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival,Event:585,Action Potential,Inhibition,Cellular,action potential,GO:0001508,,,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:104,Altered ion channel activity leading impaired heart function,Event:698,Action Potential,Altered,Cellular,action potential,GO:0001508,,,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:672,"Prostaglandin F2alpha synthesis, ovary",Reduced,Organ,prostaglandin biosynthetic process,GO:0001516,prostaglandin F2alpha,CHEBI:15553,decreased process quality,PATO:0002302,,,female gonad,UBERON:0000992
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:681,"Prostaglandin F2alpha synthesis, ovary",Decreased,Organ,prostaglandin biosynthetic process,GO:0001516,prostaglandin F2alpha,CHEBI:15553,decreased process quality,PATO:0002302,,,female gonad,UBERON:0000992
Aop:43,Disruption of VEGFR Signaling Leading to Developmental Defects,Event:28,Angiogenesis,Reduction,Cellular,angiogenesis,GO:0001525,,,decreased process quality,PATO:0002302,stromal cell,CL:0000499,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1213,Angiogenesis,Increased,Cellular,angiogenesis,GO:0001525,,,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte growth,GO:0001555,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte growth,GO:0001555,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte growth,GO:0001555,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte growth,GO:0001555,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte growth,GO:0001555,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:398,Dendritic Cells,Activation,Cellular,cell activation,GO:0001775,,,increased process quality,PATO:0002304,dendritic cell,CL:0000451,,
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:650,Increased Glucocorticoid,Stimulation of adult Leydig cells via the Adrenal Corticosterone,Molecular,cell activation,GO:0001775,,,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:981,Suppression of cytokine production in the presence of T-cell activation,Suppression,Cellular,cell activation,GO:0001775,,,increased process quality,PATO:0002304,T-cell,CL:0000084,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1197,Fibroblasts,Activation,Cellular,fibroblast activation,GO:0001775,,,decreased process quality,PATO:0002302,fibroblast,CL:0000057,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1224,Epithelial irritation,Non-neuronal production of TNF,Individual,cytokine production,GO:0001816,tumor necrosis factor alpha,PR:000000134,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1234,Epithelial irritation,Production of nerve growth factor,Tissue,cytokine production,GO:0001816,beta-nerve growth factor,PR:000011194,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1235,Epithelial irritation,Non-neuronal production of IL-8/CXCL1,Tissue,cytokine production,GO:0001816,interleukin-8 ,PR:000001395,increased process quality,PATO:0002304,,,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,Event:1143,"Depletion, energy reserves","Depletion, energy reserves",Individual,serotonin secretion,GO:0001820,,,,,,,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,Event:626,"Increased, serotonin (5-HT)","Increased, serotonin (5-HT)",Cellular,serotonin secretion,GO:0001820,sodium-dependent serotonin transporter,PR:000015189,decreased process quality,PATO:0002302,motor neuron,CL:0000100,,
Aop:98,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation,Event:626,serotonin (5-HT),Increased,Cellular,serotonin secretion,GO:0001820,sodium-dependent serotonin transporter,PR:000015189,decreased process quality,PATO:0002302,motor neuron,CL:0000100,,
Aop:195,5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,Event:626,serotonin (5-HT),Increased,Cellular,serotonin secretion,GO:0001820,sodium-dependent serotonin transporter,PR:000015189,decreased process quality,PATO:0002302,motor neuron,CL:0000100,,
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:768,Cytotoxicity,Increase,Cellular,leukocyte mediated cytotoxicity,GO:0001909,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1189,Proliferation (Endothelial cells),Increased,Cellular,endothelial cell proliferation,GO:0001935,,,increased process quality        ,PATO:0002304,endothelial cell,CL:0000115,,
Aop:112,Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat),Event:746,Dopaminergic activity,Increase,Cellular,"synaptic transmission, dopaminergic",GO:0001963,,,increased process quality,PATO:0002304,dopaminergic neuron,CL:0000700,,
Aop:170,Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat,Event:1083,Dopaminergic activity,Decreased,Cellular,"synaptic transmission, dopaminergic",GO:0001963,dopaminergic neuron,CL:0000700,increased process quality,PATO:0002304,,,,
Aop:91,Sodium channel inhibition leading to reduced survival,Event:588,predation,Increased,Population,predatory behavior,GO:0002120,,,increased process quality,PATO:0002304,,,,
Aop:93,sodium channel inhibition leading to increased predation,Event:588,predation,Increased,Population,predatory behavior,GO:0002120,,,increased process quality,PATO:0002304,,,,
Aop:95,Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival,Event:588,predation,Increased,Population,predatory behavior,GO:0002120,,,increased process quality,PATO:0002304,,,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation,Event:623,predation,Increase,Population,predatory behavior,GO:0002120,,,increased behavioral activity,PATO:0000760,,,,
Aop:98,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation,Event:588,predation,Increased,Population,predatory behavior,GO:0002120,,,increased behavioral activity,PATO:0000760,,,,
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:588,predation,Increased,Population,predatory behavior,GO:0002120,,,increased behavioral activity,PATO:0000760,,,,
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:339,Larval development,Altered,Individual,larval development,GO:0002164,,,deviation(from_normal),PATO:0000069,,,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:566,Larval development,impaired,Population,larval development,GO:0002164,,,deviation(from_normal),PATO:0000069,,,,
Aop:82,Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure,Event:566,Larval development,impaired,Population,larval development,GO:0002164,,,deviation(from_normal),PATO:0000069,,,,
Aop:86,Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,Event:566,Larval development,impaired,Population,larval development,GO:0002164,,,deviation(from_normal),PATO:0000069,,,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:566,Larval development,impaired,Population,larval development,GO:0002164,,,deviation(from_normal),PATO:0000069,,,,
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:398,Dendritic Cells,Activation,Cellular,MHC protein complex assembly,GO:0002396,,,increased process quality,PATO:0002304,dendritic cell,CL:0000451,,
Aop:14,Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility,Event:152,Inflammatory cytokines,Suppression,Individual,cytokine production involved in inflammatory response,GO:0002534,,,decreased process quality,PATO:0002302,,,,
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:826,Keratinocytes,Activation,Cellular,cytokine production involved in inflammatory response,GO:0002534,,,increased process quality,PATO:0002304,keratinocyte,CL:0000312,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:981,Suppression of cytokine production in the presence of T-cell activation,Suppression,Cellular,cytokine production involved in inflammatory response,GO:0002534,NFAT activation molecule 1,PR:000011161,decreased process quality,PATO:0002302,memory T cell,CL:0000813,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:1266,Release of circulating crustacean cardioactive peptide,Reduction,Tissue,peptide secretion,GO:0002790,cardioactive peptide (fruit fly),PR:Q9VCW0,decreased process quality,PATO:0002302,,,blood,UBERON:0000178
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:819,Glomerular filtration,Decreased,Tissue,glomerular filtration,GO:0003094,,,decreased process quality,PATO:0002302,,,kidney,UBERON:0002113
Aop:43,Disruption of VEGFR Signaling Leading to Developmental Defects,Event:110,Endothelial network,Impairment,Tissue,endothelium development,GO:0003158,,,deviation(from_normal),PATO:0000069,,,embryo,UBERON:0000922
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:110,Endothelial network,Impairment,Tissue,endothelium development,GO:0003158,,,deviation(from_normal),PATO:0000069,,,endothelium,UBERON:0001986
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:692,"Maturation inducing steroid receptor signalling, oocyte",Reduced,Tissue,steroid hormone receptor activity,GO:0003707,steroid hormone  ,CHEBI:26764,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:1000,PPAR alpha co-repressor,stabilization,Molecular,transcription corepressor activity,GO:0003714,nuclear receptor corepressor 2,PR:000011048,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:1000,PPAR alpha co-repressor,stabilization,Molecular,transcription corepressor activity,GO:0003714,nuclear receptor corepressor 1,PR:000011047,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:482,DHB4/HSD17B4,Decreased,Molecular,catalytic activity,GO:0003824,17-beta-hydroxysteroid dehydrogenase 14,PR:000008778,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:788,Incorporation of active iodide into iodotyrosines,Decrease,Cellular,catalytic activity,GO:0003824,iodotyrosine deiodinase 1 (mouse),PR:Q9DCX8,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:120,Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat),Event:790,5alpha-reductase activity,Inhibition,Cellular,catalytic activity,GO:0003824,3-oxo-5-alpha-steroid 4-dehydrogenase 2 (rat),PR:P31214,decreased process quality,PATO:0002302,,,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:798,Prolyl hydroxylases,Inhibition,Cellular,catalytic activity,GO:0003824,Prolyl hydroxylases,D064828,decreased process quality,PATO:0002302,,,,
Aop:131,AhR activation leading to uroporphyria,Event:845,UROD,Inhibition,Molecular,catalytic activity,GO:0003824,uroporphyrinogen decarboxylase,PR:000017134,decreased process quality,PATO:0002302,,,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:973,Akt/eNOS activity,Decrease,Cellular,catalytic activity,GO:0003824,"nitric oxide synthase, endothelial",PR:000011328,decreased process quality,PATO:0002302,vascular endothelial cell,CL:0002139,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:973,Akt/eNOS activity,Decrease,Cellular,catalytic activity,GO:0003824,AKT kinase,PR:000029189,decreased process quality,PATO:0002302,vascular endothelial cell,CL:0002139,,
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1002,Deiodinase 2,Inhibition,Cellular,catalytic activity,GO:0003824,type II iodothyronine deiodinase,PR:000006481,decreased process quality,PATO:0002302,,,,
Aop:156,Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1002,Deiodinase 2,Inhibition,Cellular,catalytic activity,GO:0003824,type II iodothyronine deiodinase,PR:000006481,decreased process quality,PATO:0002302,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1009,Deiodinase 1,Inhibition,Cellular,catalytic activity,GO:0003824,type I iodothyronine deiodinase,PR:000006480,decreased process quality,PATO:0002302,,,,
Aop:158,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1009,Deiodinase 1,Inhibition,Cellular,catalytic activity,GO:0003824,type I iodothyronine deiodinase,PR:000006480,decreased process quality,PATO:0002302,,,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1134,Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone,Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139,Molecular,catalytic activity,GO:0003824,Vitamin K Epoxide Reductases,D064417,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:188,Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,Event:1152,Iodotyrosine deiodinase (IYD),Inhibition,Molecular,catalytic activity,GO:0003824,iodotyrosine deiodinase 1 (human),PR:Q6PHW0,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:189,Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,Event:1009,Deiodinase 1,Inhibition,Molecular,catalytic activity,GO:0003824,type I iodothyronine deiodinase,PR:000006480,decreased process quality,PATO:0002302,,,,
Aop:190,Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,Event:1002,Deiodinase 2,Inhibition,Molecular,catalytic activity,GO:0003824,type II iodothyronine deiodinase,PR:000006481,decreased process quality,PATO:0002302,,,,
Aop:191,Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,Event:1153,Deiodinase 3,Inhibition,Molecular,catalytic activity,GO:0003824,type III iodothyronine deiodinase  ,PR:000006482,decreased process quality,PATO:0002302,,,,
Aop:193,Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis,Event:1156,Dual oxidase,Inhibition,Molecular,catalytic activity,GO:0003824,dual oxidase 1,PR:000006727,decreased process quality,PATO:0002302,,,,
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:295,Upregulation of glucuronyltransferase activity,Induction,Molecular,catalytic activity,GO:0003824,"beta-1,3-glucuronyltransferase",PR:000001325,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:8,3-hydroxyacyl-CoA dehydrogenase type-2 activity,Decreased,Cellular,3-hydroxyacyl-CoA dehydrogenase activity,GO:0003857,3-hydroxyacyl-CoA dehydrogenase type-2,PR:000008774,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1288,3-hydroxy-3-methylglutaryl-CoA reductase gene,Activation,Cellular,3-hydroxyacyl-CoA dehydrogenase activity,GO:0003857,3-hydroxyacyl-CoA dehydrogenase type-2,PR:000008774,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:114,HPPD inhibition leading to corneal papillomas and carcinomas (in rat),Event:766,4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme,Inhibition,Molecular,4-hydroxyphenylpyruvate dioxygenase activity,GO:0003868,4-hydroxyphenylpyruvate dioxygenase (rat),PR:P32755,decreased process quality,PATO:0002302,,,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:470,Acetyl-CoA carboxylase-1 (ACC-1),Up Regulation,Molecular,acetyl-CoA carboxylase activity,GO:0003989,acetyl-CoA carboxylase 1,PR:000003596,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:12,Acetylcholinesterase (AchE),Inhibition,Cellular,acetylcholinesterase activity,GO:0003990,acetylcholinesterase,PR:000003626,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:34,LXR activation leading to hepatic steatosis,Event:116,FAS,Activation,Molecular,fatty acid synthase activity,GO:0004312,fatty acid synthase,PR:000007348,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1286,GSS and GSTs gene,Down Regulation,Cellular,glutathione synthase activity,GO:0004363,glutathione synthetase,PR:000008293,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1286,GSS and GSTs gene,Down Regulation,Cellular,glutathione transferase activity,GO:0004364,glutathione S-transferase,PR:000029945,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:279,Thyroperoxidase,Inhibition,Molecular,iodide peroxidase activity,GO:0004447,thyroid peroxidase,PR:000016584,decreased process quality,PATO:0002302,,,thyroid follicle,UBERON:0005305
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:279,Thyroperoxidase,Inhibition,Molecular,iodide peroxidase activity,GO:0004447,thyroid peroxidase,PR:000016584,decreased process quality,PATO:0002302,,,thyroid follicle,UBERON:0005305
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:279,Thyroperoxidase,Inhibition,Molecular,iodide peroxidase activity,GO:0004447,thyroid peroxidase,PR:000016584,decreased process quality,PATO:0002302,,,thyroid follicle,UBERON:0005305
Aop:175,Thyroperoxidase inhibition leading to altered amphibian metamorphosis,Event:279,Thyroperoxidase,Inhibition,Molecular,iodide peroxidase activity,GO:0004447,thyroid peroxidase,PR:000016584,decreased process quality,PATO:0002302,,,thyroid follicle,UBERON:0005305
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:526,Inhibition of Dopamine-beta-hydroxylase,Inhibition,Molecular,dopamine beta-monooxygenase activity,GO:0004500,dopamine beta-hydroxylase,PR:000006294,decreased process quality,PATO:0002302,noradrenergic cell,CL:0000459,,
Aop:32,"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",Event:147,Inducible Nitric Oxide Synthase by Metabolite CGA 265307,Inhibition,Cellular,nitric-oxide synthase activity,GO:0004517,"nitric oxide synthase, brain",PR:000011326,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:828,Phospholipase A,Inhibition,Molecular,phospholipase activity,GO:0004620,phospholipase A1 member A (human),PR:Q53H76,decreased process quality,PATO:0002302,,,,
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 1,PR:000013427,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 2,PR:000013428,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:63,Cyclooxygenase inhibition leading to reproductive dysfunction,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 1,PR:000013427,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:63,Cyclooxygenase inhibition leading to reproductive dysfunction,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 2,PR:000013428,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 2,PR:000013428,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 1,PR:000013427,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 2,PR:000013428,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 1,PR:000013427,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 2,PR:000013428,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 1,PR:000013427,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 2,PR:000013428,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:79,Cyclooxygenase activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 1,PR:000013427,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1103,Cyclooxygenase 1 activity,Inhibition,Molecular,prostaglandin-endoperoxide synthase activity,GO:0004666,prostaglandin G/H synthase 1,PR:000013427,decreased process quality,PATO:0002302,,,,
Aop:108,Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:726,Induction of pyruvate dehydrogenase (PDH),Increased,Molecular,pyruvate dehydrogenase activity,GO:0004738,pyruvate dehydrogenase [ubiquinone],PR:000023575,increased process quality,PATO:0002304,,,,
Aop:108,Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:724,Pyruvate dehydrogenase kinase (PDK) enzyme,Inhibition,Cellular,pyruvate dehydrogenase activity,GO:0004738,"Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (rat)",PR:Q63065,decreased process quality,PATO:0002302,,,,
Aop:11,Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol,Event:245,PXR/SXR,Activation,Molecular,receptor activity,GO:0004872,nuclear receptor subfamily 1 group I member 2,PR:000011397,,,eukaryotic cell,CL:0000255,,
Aop:21,Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality,Event:18,AHR,Activation,Molecular,aryl hydrocarbon receptor activity,GO:0004874,aryl hydrocarbon receptor,PR:000003858,increased process quality,PATO:0002304,,,,
Aop:57,AhR activation leading to hepatic steatosis,Event:18,AHR,Activation,Molecular,aryl hydrocarbon receptor activity,GO:0004874,aryl hydrocarbon receptor,PR:000003858,increased process quality,PATO:0002304,,,,
Aop:131,AhR activation leading to uroporphyria,Event:18,AHR,Activation,Molecular,aryl hydrocarbon receptor activity,GO:0004874,aryl hydrocarbon receptor,PR:000003858,increased process quality,PATO:0002304,,,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:18,AHR,Activation,Molecular,aryl hydrocarbon receptor activity,GO:0004874,aryl hydrocarbon receptor,PR:000003858,increased process quality,PATO:0002304,,,,
Aop:19,Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),Event:27,"Androgen receptor, Antagonism",N/A,Molecular,androgen receptor activity,GO:0004882,androgen receptor,PR:000004191,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:25,Androgen receptor,Agonism,Molecular,androgen receptor activity,GO:0004882,androgen receptor,PR:000004191,increased process quality,PATO:0002304,,,,
Aop:111,Decrease in androgen receptor activity leading to Leydig cell tumors (in rat),Event:742,Androgen receptor activity,Decreased,Molecular,androgen receptor activity,GO:0004882,androgen receptor,PR:000004191,decreased process quality,PATO:0002302,,,,
Aop:117,Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:785,Androgen receptor,Activation,Molecular,androgen receptor activity,GO:0004882,androgen receptor,PR:000004191,increased process quality,PATO:0002304,,,,
Aop:14,Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility,Event:122,Glucocorticoid Receptor,Activation,Molecular,glucocorticoid receptor activity,GO:0004883,glucocorticoid receptor,PR:000011406,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:494,Glucocorticoid Receptor Agonist,Activation,Molecular,glucocorticoid receptor activity,GO:0004883,glucocorticoid receptor,PR:000011406,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:654,Activation by other glucocorticoid receptor agonists,Decreased testosterone by the fetal Leydig cells,Cellular,glucocorticoid receptor activity,GO:0004883,glucocorticoid receptor,PR:000011406,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:651,Decreased testosterone by adult Leydig cells,Glucocorticoid Receptor mediated alterations in steriodogenic enzymes,Cellular,glucocorticoid receptor activity,GO:0004883,glucocorticoid receptor,PR:000011406,deviation(from_normal),PATO:0000069,Leydig cell,CL:0000178,,
Aop:164,Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse,Event:1039,beta-2 adrenergic receptor,Increased activity,Molecular,beta2-adrenergic receptor activity,GO:0004941,beta-2 adrenergic receptor,PR:000001193,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:638,Histamine Receptor (H2),Antagonism,Molecular,histamine receptor activity,GO:0004969,histamine H2 receptor,PR:000001423,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:875,Ionotropic glutamate receptors,Binding of agonist,Molecular,ionotropic glutamate receptor activity,GO:0004970,ionotropic glutamate receptor complex,GO:0008328,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:201,NMDA receptors,Binding of antagonist,Molecular,NMDA glutamate receptor activity,GO:0004972,NMDA selective glutamate receptor complex,GO:0017146 ??,arrested,PATO:0000297,neuron,CL:0000540,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:201,NMDA receptors,Binding of antagonist,Molecular,NMDA glutamate receptor activity,GO:0004972,NMDA selective glutamate receptor complex,GO:0017146 ??,arrested,PATO:0000297,neuron,CL:0000540,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:941,EGFR,Activation,Molecular,epidermal growth factor-activated receptor activity,GO:0005006,epidermal growth factor receptor,PR:000006933,occurrence,PATO:0000057,epithelial cell of lung,CL:0000082,,
Aop:111,Decrease in androgen receptor activity leading to Leydig cell tumors (in rat),Event:743,Testosterone binding to androgen receptor (hypothalamus),Decreased,Molecular,receptor binding,GO:0005102,testosterone,CHEBI:17347,decreased process quality,PATO:0002302,hypothalamus native cell,CL:2000030,,
Aop:39,Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins,Event:151,"Inflammatory cytokines, chemokines, cytoprotective gene pathways",Activation,Molecular,cytokine activity,GO:0005125,Cytokine,84050,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1222,Local increase of SP,SP (Substance P) release,Cellular,neuropeptide hormone activity,GO:0005184,Substance P,CHEBI:80308,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1433,Increased CGRP,neuronal release of CGRP,Cellular,neuropeptide hormone activity,GO:0005184,Calcitonin gene-related peptide 1,CHEBI:80337,,,neuron,CL:0000540,respiratory tract,UBERON:0000065
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1435,Increased neurokinin A (NKA) by neuronal cells,,Cellular,neuropeptide hormone activity,GO:0005184,Neurokinin A,CHEBI:80311,,,neuron,CL:0000540,respiratory tract,UBERON:0000065
Aop:104,Altered ion channel activity leading impaired heart function,Event:697,ion channels,impaired,Cellular,ion channel activity,GO:0005216,potassium voltage-gated channel subfamily H member 2 (human),PR:Q12809,decreased process quality,PATO:0002302,,,,
Aop:104,Altered ion channel activity leading impaired heart function,Event:697,ion channels,impaired,Cellular,ion channel activity,GO:0005216,ATP-sensitive inward rectifier potassium channel 1,PR:000001978,decreased process quality,PATO:0002302,,,,
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:760,Glutamate-gated chloride channel,Activation,Molecular,chloride channel activity,GO:0005254,glutamate-gated chloride channel (fruit fly),PR:Q94900,increased process quality,PATO:0002304,,,,
Aop:161,Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,Event:1018,Glutamate-gated chloride channels,Activation,Molecular,chloride channel activity,GO:0005254,glutamate-gated chloride channel (fruit fly),PR:Q94900,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:51,Ca++ ATPase,Inhibition,Molecular,calcium-transporting ATPase activity,GO:0005388,calcium ion-transporting ATPase complex,GO:0090534,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 1,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,binding,GO:0005488,calcium ion,CHEBI:39124,deviation(from_normal),PATO:0000069,,,,
Aop:105,Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:714,Binding of chemicals to 2u (serum),Increased,Molecular,binding,GO:0005488,major urinary protein (rat),PR:P02761,increased process quality,PATO:0002304,,,serum,UBERON:0001977
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:957,Transthyretin in serum,Binding,Molecular,binding,GO:0005488,transthyretin,PR:000016801,increased process quality,PATO:0002304,,,serum,UBERON:0001977
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:980,Binding of calcineurin with FK506-FKBP complexes,"Binding, Formation",Molecular,binding,GO:0005488,FK506-binding protein 15,PR:000007535,increased process quality,PATO:0002304,,,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:980,Binding of calcineurin with FK506-FKBP complexes,"Binding, Formation",Molecular,binding,GO:0005488,FKBP12 (Arabidopsis thaliana),TAIR:AT5G64350,increased process quality,PATO:0002304,,,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:1201,Binding,Immunophilins,Molecular,binding,GO:0005488,Immunophilins,D020104,increased process quality,PATO:0002304,,,,
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:261,SH-/selen-proteins,Binding,Molecular,protein binding,GO:0005515,Selenium-Binding Proteins, D051137,occurrence,PATO:0000057,eukaryotic cell,CL:0000255,,
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:396,Protein,Covalent Binding,Molecular,protein binding,GO:0005515,electrophilic reagant,CHEBI:59739,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,calmodulin binding,GO:0005516,calcium ion,CHEBI:39124,deviation(from_normal),PATO:0000069,,,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,calmodulin binding,GO:0005516,calcium ion,CHEBI:39124,deviation(from_normal),PATO:0000069,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,calmodulin binding,GO:0005516,calcium ion,CHEBI:39124,deviation(from_normal),PATO:0000069,,,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:990,Incomplete ecdysis,Increased,Organ,chitin biosynthetic process,GO:0006031,chitin,CHEBI:17029,increased process quality,PATO:0002304,,,dermal skeleton,UBERON:0010364
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:888,NADH-ubiquinone oxidoreductase (complex I),Binding of inhibitor,Molecular,"mitochondrial electron transport, NADH to ubiquinone",GO:0006120,NADH-ubiquinone oxidoreductase chain 1,PR:000031316,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:15,Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations,Event:155,Insufficient or incorrect DNA repair,N/A,Cellular,dna repair,GO:0006281,DNA,CHEBI:16991,insufficient,PATO:0001628,eukaryotic cell,CL:0000255,,
Aop:46,AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC),Event:493,Insufficient repair or mis-repair of pro-mutagenic DNA adducts,Increased,Molecular,dna repair,GO:0006281,nuclear DNA,67194,insufficient ,PATO:0001628,hepatocyte,CL:0000182,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:664,Mitochondrial DNA repair mechanisms,Overwhelmed,Cellular,DNA repair,GO:0006281,Mitochondrial deoxyribonucleic acid,67199,abnormal,PATO:0000460,eukaryotic cell,CL:0000255,,
Aop:139,Alkylation of DNA leading to cancer 4,Event:155,Insufficient or incorrect DNA repair,N/A,Cellular,dna repair,GO:0006281,DNA,CHEBI:16991,insufficient,PATO:0001628,eukaryotic cell,CL:0000255,,
Aop:141,Alkylation of DNA leading to cancer 5,Event:155,Insufficient or incorrect DNA repair,N/A,Cellular,dna repair,GO:0006281,DNA,CHEBI:16991,insufficient,PATO:0001628,eukaryotic cell,CL:0000255,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1281,DNA Damage-Repair,Increased,Cellular,dna repair,GO:0006281,DNA,CHEBI:16991,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:15,Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations,Event:97,DNA,Alkylation,Molecular,DNA alkylation,GO:0006305,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:46,AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC),Event:373,Pro-mutagenic DNA Adducts,Formation,Molecular,DNA alkylation,GO:0006305,nuclear DNA,67194,deviation(from_normal),PATO:0000069,hepatocyte,CL:0000182,,
Aop:139,Alkylation of DNA leading to cancer 1,Event:97,DNA,Alkylation,Molecular,DNA alkylation,GO:0006305,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:141,Alkylation of DNA leading to cancer 2,Event:97,DNA,Alkylation,Molecular,DNA alkylation,GO:0006305,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1240,Protein Production,Altered,Cellular,translation,GO:0006412,protein,PR:000000001,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:175,Thyroperoxidase inhibition leading to altered amphibian metamorphosis,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:176,Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:188,Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:192,Pendrin inhibition leading to altered amphibian metamorphosis,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:193,Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis,Event:277,Thyroid hormone synthesis,Decreased,Molecular,thyroid hormone generation,GO:0006590,thyroid hormone,CHEBI:60311,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:166,PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse,Event:1060,lipid metabolism,Alteration,Cellular,lipid metabolic process,GO:0006629,,,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:34,LXR activation leading to hepatic steatosis,Event:89,De Novo FA,Synthesis,Cellular,fatty acid biosynthetic process,GO:0006633,fatty acid,CHEBI:35366,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:458,De Novo FA synthesis,Increased,Cellular,fatty acid biosynthetic process,GO:0006633,fatty acid,CHEBI:35366,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:882,De Novo FA synthesis,Decreased,Cellular,fatty acid biosynthetic process,GO:0006633,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:859,Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids,Decreased,Molecular,fatty acid beta-oxidation,GO:0006635,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:860,Mitochondrial Fatty Acid Beta Oxidation,Decreased,Molecular,fatty acid beta-oxidation,GO:0006635,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:179,Mitochondrial fatty acid beta-oxidation,Decreased,Molecular,fatty acid beta-oxidation,GO:0006635,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:57,AhR activation leading to hepatic steatosis,Event:451,Mitochondrial fatty acid beta-oxidation,Inhibition,Molecular,fatty acid beta-oxidation,GO:0006635,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:451,Mitochondrial fatty acid beta-oxidation,Inhibition,Molecular,fatty acid beta-oxidation,GO:0006635,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:179,Mitochondrial fatty acid beta-oxidation,Decreased,Molecular,fatty acid beta-oxidation,GO:0006635,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:451,Mitochondrial fatty acid beta-oxidation,Inhibition,Molecular,fatty acid beta-oxidation,GO:0006635,fatty acid,CHEBI:35366,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1285,Unsaturated fatty acid,Up Regulation,Cellular,unsaturated fatty acid biosynthetic process,GO:0006636,unsaturated fatty acid,CHEBI:27208,increased process quality        ,PATO:0002304,hepatocyte,CL:0000182,,
Aop:70,Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell,Event:640,Proteomic alterations in the adult Leydig cell,Decreased steroidogenesis,Molecular,steroid biosynthetic process,GO:0006694,,,decreased process quality,PATO:0002302,Leydig cell,CL:0000178,,
Aop:69,Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell,Event:642,Decreased De Novo Biosynthesis of Choleseterol,Decreased Cholesterol,Molecular,cholesterol biosynthetic process,GO:0006695,cholesterol,CHEBI:16113,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:7,Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female,Event:3,17beta-estradiol synthesis by ovarian granulosa cells,Reduction,Cellular,estrogen biosynthetic process,GO:0006703,17beta-estradiol,CHEBI:16469,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:3,17beta-estradiol synthesis by ovarian granulosa cells,Reduction,Cellular,estrogen biosynthetic process,GO:0006703,17beta-estradiol,CHEBI:16469,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:3,17beta-estradiol synthesis by ovarian granulosa cells,Reduction,Cellular,estrogen biosynthetic process,GO:0006703,17beta-estradiol,CHEBI:16469,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:3,17beta-estradiol synthesis by ovarian granulosa cells,Reduction,Cellular,estrogen biosynthetic process,GO:0006703,17beta-estradiol,CHEBI:16469,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:3,17beta-estradiol synthesis by ovarian granulosa cells,Reduction,Cellular,estrogen biosynthetic process,GO:0006703,17beta-estradiol,CHEBI:16469,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:965,Reduced steroidogenic production of estradiol in granulosa cells,reduction in ovarian granulosa cells synthesis of estradiol,Cellular,estrogen biosynthetic process,GO:0006703,17beta-estradiol,CHEBI:16469,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:650,Increased Glucocorticoid,Stimulation of adult Leydig cells via the Adrenal Corticosterone,Molecular,glucocorticoid biosynthetic process,GO:0006704,glucocorticoid,CHEBI:24261,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1287,Glutathione synthesis,,Cellular,glutathione biosynthetic process,GO:0006750,glutathione,CHEBI:16856,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:40,ATP production,Decreased,Cellular,ATP biosynthetic process,GO:0006754,ATP,CHEBI:15422,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1138,Reduced ability to generate ATP,Uncoupling of oxidative phosphorylation,Molecular,ATP biosynthetic process,GO:0006754,ATP,CHEBI:15422,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:213,Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III),N/A,Molecular,heme oxidation,GO:0006788,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:933,Nitric Oxide,Depletion,Cellular,nitric oxide biosynthetic process,GO:0006809,nitric oxide,CHEBI:16480,decreased concentration,PATO:0001163,,,blood,UBERON:0000178
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:41,Bile Salt Export Pump (ABCB11),Inhibition,Molecular,transport,GO:0006810,bile salt export pump,PR:000003549,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:960,Uptake of thyroxine into tissue,Increased,Cellular,transport,GO:0006810,thyroxine,CHEBI:30660,increased process quality,PATO:0002304,,,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1132,"Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal",Blood loss and development of anemia,Cellular,transport,GO:0006810,nutrient ,CHEBI:33284,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:1158,Hepatic thyroid hormone uptake/transport,Increased,Tissue,transport,GO:0006810,thyroid hormone,CHEBI:60311,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:197,Sodium channel (Nav1.1) inhibition leading to population decline,Event:1176,sodium conductance,Decreased,Cellular,transport,GO:0006810,sodium ion,CHEBI:29101,decreased process quality,PATO:0002302,,,,
Aop:197,Sodium channel (Nav1.1) inhibition leading to population decline,Event:1179,GABA release,Decreased,Cellular,transport,GO:0006810,gamma-aminobutyric acid,CHEBI:16865,decreased process quality,PATO:0002302,,,,
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:52,Calcium influx,Decreased,Cellular,calcium ion transport,GO:0006816,calcium ion,CHEBI:39124,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:52,Calcium influx,Decreased,Cellular,calcium ion transport,GO:0006816,calcium ion,CHEBI:39124,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:49,Ca and HCO3 transport to shell gland,Reduction,Tissue,calcium ion transport,GO:0006816,calcium ion,CHEBI:39124,decreased process quality,PATO:0002302,,,oviduct shell gland,UBERON:0008975
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1218,Calcium influx,Opening of calcium channel,Cellular,calcium ion transport,GO:0006816,calcium ion,CHEBI:39124,increased process quality,PATO:0002304,calcium channel complex,GO:0034704,,
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,Event:447,Cholesterol transport in mitochondria,Reduction,Cellular,mitochondrial transport,GO:0006839,cholesterol,CHEBI:16113,decreased process quality,PATO:0002302,steroid hormone secreting cell,CL:0000174,,
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:447,Cholesterol transport in mitochondria,Reduction,Cellular,mitochondrial transport,GO:0006839,cholesterol,CHEBI:16113,decreased process quality,PATO:0002305,steroid hormone secreting cell,CL:0000174,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,receptor-mediated endocytosis,GO:0006898,vitellogenins,D014819,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,receptor-mediated endocytosis,GO:0006898,vitellogenins,D014819,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,receptor-mediated endocytosis,GO:0006898,vitellogenins,D014819,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:57,AhR activation leading to hepatic steatosis,Event:467,LDL uptake,Increased,Cellular,receptor-mediated endocytosis,GO:0006898,low density lipoprotein,CHEBI:39026,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,receptor-mediated endocytosis,GO:0006898,vitellogenins,D014819,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,receptor-mediated endocytosis,GO:0006898,vitellogenins,D014819,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:853,Cellular Homeostasis and Apoptosis,Changes/Inhibition,Cellular,apoptotic process,GO:0006915,,,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:496,decreased number of adult Leydig Cells,Increased apoptosis,Cellular,apoptotic process,GO:0006915,,,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:70,Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell,Event:648,Increased Apoptosis of Adult Leydig Cells,Decreased steroidogenesis,Tissue,apoptotic process,GO:0006915,Leydig cell,CL:0000178,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:525,Decreased testosterone by adult Leydig cells,Apoptosis of adult Leydig cells,Cellular,apoptotic process,GO:0006915,,,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1183,Apoptosis (Epithelial Cells),Decreased,Cellular,apoptotic process,GO:0006915,,,decreased process quality,PATO:0002302, epithelial cell,CL:0000066,,
AOP:205,AOP from chemical insult to cell death,Event:1262,Apoptosis,,Tissue,apoptotic process,GO:0006915,,,increased process quality        ,PATO:0002304,,,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1262,Apoptosis,,Tissue,apoptotic process,GO:0006915,,,increased process quality        ,PATO:0002304,,,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:993,Abdominal muscle contraction,Reduction,Organ,muscle contraction,GO:0006936,,,increased process quality,PATO:0002304,,,dermal skeleton,UBERON:0010364
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:601,muscle contraction,Overactivation,Tissue,muscle contraction,GO:0006936,,,increased process quality,PATO:0002304,,,muscle tissue,UBERON:0002385
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:149,Inflammation,Increase,Cellular,inflammatory response,GO:0006954,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:62,AKT2 activation leading to hepatic steatosis,Event:486,systemic inflammation leading to hepatic steatosis,,Organ,inflammatory response,GO:0006954,,,occurrence,PATO:0000057,,,,
Aop:114,HPPD inhibition leading to corneal papillomas and carcinomas (in rat),Event:777,Inflammation (corneal cells),Increase,Cellular,inflammatory response,GO:0006954,corneal epithelial cell,CL:0000575,increased process quality,PATO:0002304,corneal epithelial cell,CL:0000575,,
Aop:115,Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat),Event:149,Inflammation,Increase,Cellular,inflammatory response,GO:0006954,,,increased process quality,PATO:0002304,,,,
Aop:144,Lysosomal damage leading to liver inflammation,Event:901,Inflammatory cells,Infiltration,Tissue,inflammatory response,GO:0006954,,,increased process quality,PATO:0002304,,,liver,UBERON:0002107
Aop:171,Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.,Event:1087,inflammation,Increased,Cellular,inflammatory response,GO:0006954,,,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1225,Immune system response,Leukocyte recruitment,Tissue,inflammatory response,GO:0006954,,,increased process quality,PATO:0002304,,,immune system,UBERON:0002405
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1226,Respiratory irritability,Chronic Cough,Individual,inflammatory response,GO:0006954,respiratory system,UBERON:0001004,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1237,Immune system,Sensitization,Individual,immune response,GO:0006955,,,increased process quality,PATO:0002304,,,,
AOP:205,AOP from chemical insult to cell death,Event:1259,narcosis,,Cellular,plasma membrane organization,GO:0007009,,,abnormal,PATO:0000460,eukaryotic cell,CL:0000255,,
Aop:70,Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell,Event:649,Alterations in the Leydig Cell Cytoskeleton,Decreased steroidogenesis,Tissue,cytoskeleton organization,GO:0007010,Leydig cell,CL:0000178,deviation(from_normal),PATO:0000069,,,testis,UBERON:0000473
Aop:106,Chemical binding to tubulin in oocytes leading to aneuploid offspring,Event:720,Microtubule,Depolymerization,Molecular,microtubule depolymerisation,GO:0007019,microtubule,GO:0005874,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:106,Chemical binding to tubulin in oocytes leading to aneuploid offspring,Event:721,Spindle,Disorganization,Cellular,spindle organization,GO:0007051,spindle,GO:0005819,decreased process quality,PATO:0002302,female germ cell,CL:0000021,,
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:696,Chromosome misseggregation,Increased,Cellular,chromosome segregation,GO:0007059,,,deviation(from_normal),PATO:0000069,ooctye,CL:0000025,,
Aop:14,Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility,Event:202,Nuclear factor kappa B (NF-kB),Inhibition,Molecular,I-kappaB kinase/NF-kappaB signaling,GO:0007249,transcription factor NF-kappa-B subunit,PR:000001753,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:14,Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility,Event:145,IKB inhibitory protein,Induction,Cellular,I-kappaB phosphorylation,GO:0007252,NF-kappa-B inhibitor,PR:000003292,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:758,Hippocampal function,Decreased,Tissue,chemical synaptic transmission,GO:0007268,,,abnormal,PATO:0000460,,,brain,UBERON:0000955
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:669,Neuronal synaptic inhibition,Reduction,Cellular,synaptic transmission,GO:0007268,,,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:758,Hippocampal function,Decreased,Tissue,chemical synaptic transmission,GO:0007268,,,abnormal,PATO:0000460,,,brain,UBERON:0000955
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:758,Hippocampal function,Decreased,Tissue,chemical synaptic transmission,GO:0007268,,,abnormal,PATO:0000460,,,brain,UBERON:0000955
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:758,Hippocampal function,Decreased,Tissue,chemical synaptic transmission,GO:0007268,,,abnormal,PATO:0000460,,,brain,UBERON:0000955
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:600,Neuronotransmitter release,Overactivation,Molecular,neurotransmitter secretion,GO:0007269,,,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:968,Decreased hypothalamic estrogen reduces kisspeptinergic neuron response,Decreased Kisspeptin release from neurons in AVPV,Cellular,neurotransmitter secretion,GO:0007269,metastasis-suppressor KiSS-1 (rat),PR:Q7TSB7,decreased process quality,PATO:0002302,,,anteroventral periventricular nucleus,UBERON:0002690
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:385,Synaptogenesis,Decreased,Cellular,synapse assembly,GO:0007416,Synapse,GO:0045202,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:385,Synaptogenesis,Decreased,Cellular,synapse assembly,GO:0007416,Synapse,GO:0045202,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:175,Thyroperoxidase inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:176,Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:188,Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:189,Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:190,Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:191,Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:192,Pendrin inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:193,Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:1101,Amphibian metamorphosis,Altered,Organ,metamorphosis,GO:0007552,,,increased process quality,PATO:0002304,,,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:571,Aging,Accelerated,Individual,aging,GO:0007568,,,acceleration,PATO:0001028,,,,
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:401,Biliary excretion TH glucuronide,Increase,Organ,excretion,GO:0007588,Tetrahydroaldosterone-3-glucuronide,CHEBI:88728,increased process quality,PATO:0002304,,,biliary system,UBERON:0002294
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:401,Biliary excretion TH glucuronide,Increase,Organ,excretion,GO:0007588,Tetrahydroaldosterone-3-glucuronide,CHEBI:88728,increased process quality,PATO:0002304,,,biliary system,UBERON:0002294
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1122,Failure of secondary hemostasis,Under carboxylated clotting factors will not assemble on cell surfaces to form clot,Tissue,hemostasis,GO:0007599,,,deviation(from_normal),PATO:0000069,,,vascular system,UBERON:0007798
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1133,Depletion from blood of fully functional carboxylated clotting factors,Hemostasis,Tissue,hemostasis,GO:0007599,,,decreased process quality,PATO:0002302,,,blood,UBERON:0000178
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1008,Hearing,Reduced,Organ,sensory perception of sound ,GO:0007605,,,decreased process quality,PATO:0002302,,,,
Aop:156,Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1008,Hearing,Reduced,Organ,sensory perception of sound ,GO:0007605,,,decreased process quality,PATO:0002302,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1008,Hearing,Reduced,Organ,sensory perception of sound ,GO:0007605,,,decreased process quality,PATO:0002302,,,,
Aop:158,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1008,Hearing,Reduced,Organ,sensory perception of sound ,GO:0007605,,,decreased process quality,PATO:0002302,,,,
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1008,Hearing,Reduced,Organ,sensory perception of sound ,GO:0007605,,,decreased process quality,PATO:0002302,,,,
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:402,Cognitive Function,Decreased,Individual,learning or memory,GO:0007611,,,decreased process quality,PATO:0002302,,,,
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:402,Cognitive Function,Decreased,Individual,learning or memory,GO:0007611,,,decreased process quality,PATO:0002302,,,,
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:402,Cognitive Function,Decreased,Individual,learning or memory,GO:0007611,,,decreased process quality,PATO:0002302,,,,
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:402,Cognitive Function,Decreased,Individual,learning or memory,GO:0007611,,,decreased process quality,PATO:0002302,,,,
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:341,Learning and memory,impairment,Individual,learning,GO:0007612,,,decreased process quality,PATO:0002302,,,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:341,Learning and memory,Impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:341,Learning and memory,impairment,Individual,memory,GO:0007613,,,decreased process quality,PATO:0002302,,,,
Aop:39,Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins,Event:151,"Inflammatory cytokines, chemokines, cytoprotective gene pathways",Activation,Molecular,chemokine activity,GO:0008009,Chemokine,241981,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:43,Disruption of VEGFR Signaling Leading to Developmental Defects,Event:298,Vascular,Insufficiency,Organ,blood circulation,GO:0008015,blood,UBERON:0000178,decreased process quality,PATO:0002302,,,embryo,UBERON:0000922
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:887,NADH-ubiquinone oxidoreductase (complex I),Inhibition,Cellular,NADH dehydrogenase (ubiquinone) activity,GO:0008137,NADH-ubiquinone oxidoreductase chain 1,PR:000031316,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:32,"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",Event:77,Critical Metabolites (CGA 330050 and CGA 265307),Production,Cellular,metabolic process,GO:0008152,thiamethoxam,CHEBI:39185,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:32,"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",Event:77,Critical Metabolites (CGA 330050 and CGA 265307),Production,Cellular,metabolic process,GO:0008152,metabolite,CHEBI:25212,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:46,AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC),Event:409,Production of Reactive Electrophiles,Metabolism of AFB1,Molecular,metabolic process,GO:0008152,,,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:961,Clearance of thyroxine from tissues,Increased,Tissue,metabolic process,GO:0008152,thyroxine,CHEBI:30660,increased process quality,PATO:0002304,,,liver,UBERON:0002107
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:55,Cell injury/death,N/A,Cellular,cell death,GO:0008219,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:55,Cell injury/death,N/A,Cellular,cell death,GO:0008219,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:38,Protein Alkylation leading to Liver Fibrosis,Event:55,Cell injury/death,N/A,Cellular,cell death,GO:0008219,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:55,Cell injury/death,N/A,Cellular,cell death,GO:0008219,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:105,Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:709,Cytotoxicity (renal tubular cell),Increase,Cellular,cell death,GO:0008219,kidney tubule cell,CL:1000507,increased process quality,PATO:0002304,kidney tubule cell,CL:1000507,,
Aop:108,Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:768,Cytotoxicity,Increase,Cellular,cell death,GO:0008219,,,increased process quality,PATO:0002304,,,,
Aop:109,Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse),Event:770,Cytotoxicity (club cells),Increase,Cellular,cell death,GO:0008219,Clara cell,CL:0000158,increased process quality,PATO:0002304,Clara cell,CL:0000158,,
Aop:114,HPPD inhibition leading to corneal papillomas and carcinomas (in rat),Event:776,Cytotoxicity (corneal cells),Increase,Cellular,cell death,GO:0008219,corneal epithelial cell,CL:0000575,increased process quality,PATO:0002304,corneal epithelial cell,CL:0000575,,
Aop:115,Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat),Event:780,Cytotoxicity (epithelial cells),Increase,Cellular,cell death,GO:0008219,epithelial cell,CL:0000066,increased process quality,PATO:0002304,epithelial cell,CL:0000066,,
Aop:116,Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:783,Cytotoxicity (tubular epithelial cells),Increase,Cellular,cell death,GO:0008219,nephron tubule epithelial cell,CL:1000494,increased process quality,PATO:0002304,nephron tubule epithelial cell,CL:1000494,,
Aop:118,Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:786,Cytotoxicity (hepatocytes),Increase,Cellular,cell death,GO:0008219,hepatocyte,CL:0000182,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:121,Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat),Event:794,Cytotoxicity (urothelial cells),Increase,Cellular,cell death,GO:0008219,urothelial cell,CL:0000731,increased process quality,PATO:0002304,urothelial cell,CL:0000731,,
Aop:144,Lysosomal damage leading to liver inflammation,Event:55,Cell injury/death,N/A,Cellular,cell death,GO:0008219,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:171,Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.,Event:1086,cytotoxicity (pleura or peritoneum),persistent,Cellular,cell death,GO:0008219,pleura,UBERON:0000977,increased process quality,PATO:0002304,,,pleura,UBERON:0000977
Aop:109,Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse),Event:733,Necrosis (terminal bronchiolar cells),Increase,Cellular,cell death,GO:0008219 ,bronchial epithelial cell,CL:0002328,increased process quality,PATO:0002304,bronchial epithelial cell,CL:0002328,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:988,Secretion of ecdysis triggering hormone (ETH),Decreased,Cellular,ecdysis-triggering hormone activity,GO:0008255,,,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:1,Uncharacterized liver damage leading to hepatocellular carcinoma,Event:57,Cell proliferation in the absence of cytotoxicity,Proliferation,Cellular,cell proliferation,GO:0008283,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:272,T-cells,Activation/Proliferation,Organ,cell proliferation,GO:0008283,memory T cell,CL:0000813,increased process quality,PATO:0002304,,,lymph node,UBERON:0000029
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:854,Cellular proliferation / hyperplasia,Alterations,Tissue,cell proliferation,GO:0008283,Liver cell,63179,deviation(from_normal),PATO:0000069,,,liver,UBERON:0002107
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:416,Leydig cell,Increase proliferation,Cellular,cell proliferation,GO:0008283,,,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:107,Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:716,Mitogenic cell proliferation (hepatocytes),Increase,Cellular,cell proliferation,GO:0008283,mitogenic signaling cell,CL:0000422 ,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:739,Hypertrophy and proliferation (follicular cell),Increase,Cellular,cell proliferation,GO:0008283,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:114,HPPD inhibition leading to corneal papillomas and carcinomas (in rat),Event:778,Regenerative cell proliferation (corneal cells),Increase,Cellular,cell proliferation,GO:0008283,corneal epithelial cell,CL:0000575,increased process quality,PATO:0002304,corneal epithelial cell,CL:0000575,,
Aop:115,Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat),Event:781,Regenerative cell proliferation (forestomach epithelial cells),Increase,Cellular,cell proliferation,GO:0008283,epithelial cell,CL:0000066,increased process quality,PATO:0002304,,,murine forestomach,UBERON:0008827
Aop:118,Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:787,Regenerative cell proliferation (hepatocytes),Increase,Cellular,cell proliferation,GO:0008283,hepatocyte,CL:0000182,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:739,Hypertrophy and proliferation (follicular cell),Increase,Cellular,cell proliferation,GO:0008283,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:121,Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat),Event:795,Regenerative cell proliferation (urothelial cells),Increase,Cellular,cell proliferation,GO:0008283,urothelial cell,CL:0000731,increased object quality,PATO:0002305,urothelial cell,CL:0000731,,
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:870,Cell Proliferation,Increase,Cellular,cell proliferation,GO:0008283,,,increased process quality,PATO:0002304,olfactory epithelial cell,CL:0002167,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:923,Proliferation of goblet cells,Increase,Cellular,cell proliferation,GO:0008283,goblet cell ,CL:0000160,increased object quality,PATO:0002304,goblet cell ,CL:0000160,,
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1024,Hypertrophy and proliferation (follicular cell),Increased,Cellular,cell proliferation,GO:0008283,thyroid follicular cell,CL:0002258,increased process quality,PATO:0002304,thyroid follicular cell,CL:0002258,,
Aop:164,Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse,Event:1042,smooth muscle,Proliferation/Clonal Expansion,Cellular,cell proliferation,GO:0008283,smooth muscle cell,CL:0000192,increased process quality,PATO:0002304,smooth muscle cell,CL:0000192,,
Aop:166,PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse,Event:1062,Cellular proliferation / hyperplasia of acinar cells,Increased,Cellular,cell proliferation,GO:0008283,acinar cell,CL:0000622,increased process quality,PATO:0002304,acinar cell,CL:0000622,,
Aop:167,Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,Event:1067,aberrant basal cells,Proliferation/Clonal Expansion,Cellular,cell proliferation,GO:0008283,basal cell,CL:0000646,increased process quality,PATO:0002304,basal cell,CL:0000646,,
Aop:171,Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.,Event:1089,Cell Proliferation (mesothelium),Increased,Cellular,cell proliferation,GO:0008283,mesothelium,UBERON:0001136,increased process quality,PATO:0002304,,,mesothelium,UBERON:0001136
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1182,Cell Proliferation (Epithelial Cells),Increase,Cellular,cell proliferation,GO:0008283,,,increased process quality,PATO:0002304, epithelial cell,CL:0000066,,
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:694,"Meiotic prophase I/metaphase I transition, oocyte",Reduced,Cellular,meiotic G2/MI transition,GO:0008315,,,decreased process quality,PATO:0002302,ooctye,CL:0000024,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:424,Na+/I- symporter (NIS),Inhibition,Molecular,sodium:iodide symporter activity,GO:0008507,sodium/iodide cotransporter,PR:000015171,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:424,Na+/I- symporter (NIS),Inhibition,Molecular,sodium:iodide symporter activity,GO:0008507,sodium/iodide cotransporter,PR:000015171,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:424,Na+/I- symporter (NIS),Inhibition,Molecular,sodium:iodide symporter activity,GO:0008507,sodium/iodide cotransporter,PR:000015171,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:176,Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,Event:424,Na+/I- symporter (NIS),Inhibition,Molecular,sodium:iodide symporter activity,GO:0008507,sodium/iodide cotransporter,PR:000015171,decreased process quality,PATO:0002302,,,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:454,Triglyceride formation,Increased,Cellular,biosynthetic process,GO:0009058,trygliceride,CHEBI:17855,increased concentration,PATO:0001162,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:881,Triglyceride,Increased,Cellular,biosynthetic process,GO:0009058,triglyceride,CHEBI:17855,increased concentration,PATO:0001162,hepatocyte,CL:0000182,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:934,Tetrahydrobiopterin,Decrease,Cellular,biosynthetic process,GO:0009058,"5,6,7,8-tetrahydrobiopterin",CHEBI:15372,decreased object quality,PATO:0002303,vascular endothelial cell,CL:0002139,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1278,ROS formation,,Molecular,biosynthetic process,GO:0009058,reactive oxygen species,CHEBI:26523,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:570,Damaged mitochondrial DNA,Accumulation,Cellular,response to wounding,GO:0009611,Mitochondrial deoxyribonucleic acid,67199,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:43,Disruption of VEGFR Signaling Leading to Developmental Defects,Event:1001,Developmental Defects,Increased,Individual,anatomical structure morphogenesis,GO:0009653,,,malformed,PATO:0000646,,,,
Aop:210,Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building ,Event:1295,Defect of Embryogenesis,,Tissue,embryo development,GO:0009790,,,abnormal,PATO:0000460,,,embryo,UBERON:0000922
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1033,proliferation of mesenchymal cells,Increased,Cellular,mesenchymal cell proliferation,GO:0010463,mesenchymal cell,CL:0008019,increased process quality,PATO:0002304,mesenchymal cell,CL:0008019,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:1264,Nuclear receptor E75b gene,Induction,Molecular,gene expression,GO:0010467,"Eip75B protein, Drosophila",C061375,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:1265,Ftz-f1 gene,Suppression,Molecular,gene expression,GO:0010467,nuclear hormone receptor FTZ-F1 (fruit fly),PR:P33244,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:381,Release of BDNF,Reduced,Molecular,gene expression,GO:0010467,brain-derived neurotrophic factor,PR:000004716,decreased process quality,PATO:0002302,neural cell,CL:0002319,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:381,Release of BDNF,Reduced,Molecular,gene expression,GO:0010467,brain-derived neurotrophic factor,PR:000004716,decreased process quality,PATO:0002302,neural cell,CL:0002319,,
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,Event:266,Steroidogenic acute regulatory protein (STAR),Decrease,Cellular,gene expression,GO:0010467,STAR,PR:000015715,decreased process quality,PATO:0002302,steroid hormone secreting cell,CL:0000174,,
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,Event:289,Translocator protein (TSPO),Decrease,Cellular,gene expression,GO:0010467,translocator protein,PR:000016757,decreased process quality,PATO:0002302,steroid hormone secreting cell,CL:0000174,,
Aop:21,Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality,Event:1269,"Increase, COX-2 expression","Increase, COX-2 expression",Molecular,gene expression,GO:0010467,prostaglandin G/H synthase 2,PR:000013428,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:285,Vitellogenin synthesis in liver,Reduction,Tissue,gene expression,GO:0010467,vitellogenins,D014819,decreased process quality,PATO:0002302,,,liver,UBERON:0002107
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:285,Vitellogenin synthesis in liver,Reduction,Tissue,gene expression,GO:0010467,vitellogenins,D014819,decreased process quality,PATO:0002302,,,liver,UBERON:0002107
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:288,Transcriptional change,Activation of specific nuclear receptors,Cellular,gene expression,GO:0010467,bile acid receptor,PR:000011396,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:307,Vitellogenin synthesis in liver,Increase,Tissue,gene expression,GO:0010467,vitellogenins,D014819,increased process quality,PATO:0002304,,,liver,UBERON:0002107
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:285,Vitellogenin synthesis in liver,Reduction,Tissue,gene expression,GO:0010467,vitellogenins,D014819,decreased process quality,PATO:0002302,,,liver,UBERON:0002107
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:21,Alpha hemoglobin,Altered regulation,Cellular,gene expression,GO:0010467,hemoglobin subunit alpha (human),PR:P69905,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:131,Gulcose-6-phosphate dehydrogenase,Down Regulation,Cellular,gene expression,GO:0010467,glucose-6-phosphate 1-dehydrogenase,PR:000007749,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:34,LXR activation leading to hepatic steatosis,Event:54,CD36,Up Regulation,Molecular,gene expression,GO:0010467,platelet glycoprotein 4,PR:000001905,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:34,LXR activation leading to hepatic steatosis,Event:258,SCD-1,Activation,Molecular,gene expression,GO:0010467,acyl-CoA desaturase,PR:000014497,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:140,HSD17B10 expression,Decreased,Cellular,gene expression,GO:0010467,3-hydroxyacyl-CoA dehydrogenase type-2,PR:000008774,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:53,ER agonism leading to reduced survival due to renal failure,Event:418,Vitellogenin synthesis,Increased,Cellular,gene expression,GO:0010467,vitellogenins,D014819,increased process quality,PATO:0002304,kidney cell,CL:1000497,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:381,Release of BDNF,Reduced,Molecular,gene expression,GO:0010467,brain-derived neurotrophic factor,PR:000004716,decreased process quality,PATO:0002302,neural cell,CL:0002319,,
Aop:57,AhR activation leading to hepatic steatosis,Event:216,PCK1 expression (control point for glycolysis/gluconeogenesis pathway),Decreased,Cellular,gene expression,GO:0010467,"phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PR:000012416,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:57,AhR activation leading to hepatic steatosis,Event:54,CD36,Up Regulation,Molecular,gene expression,GO:0010467,platelet glycoprotein 4,PR:000001905,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:57,AhR activation leading to hepatic steatosis,Event:462,SCD-1,Increased,Molecular,gene expression,GO:0010467,acyl-CoA desaturase,PR:000014497,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:57,AhR activation leading to hepatic steatosis,Event:466,LDLR (low density lipoprotein receptor),Up Regulation,Molecular,gene expression,GO:0010467,low density lipoprotein receptor,PR:000009744,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:57,AhR activation leading to hepatic steatosis,Event:80,CYP1A1,Up Regulation,Molecular,gene expression,GO:0010467,cytochrome P450 1A1,PR:000006101,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:54,CD36,Up Regulation,Molecular,gene expression,GO:0010467,platelet glycoprotein 4,PR:000001905,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:462,SCD-1,Up Regulation,Molecular,gene expression,GO:0010467,acyl-CoA desaturase,PR:000014497,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:463,FAS,Up Regulation,Molecular,gene expression,GO:0010467,fatty acid synthase,PR:000007348,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:472,CPT1A,Down Regulation,Molecular,gene expression,GO:0010467,"carnitine O-palmitoyltransferase 1, liver isoform",PR:000005835,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:474,HMGCS2,Down Regulation,Molecular,gene expression,GO:0010467,"hydroxymethylglutaryl-CoA synthase, mitochondrial",PR:000008638,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:462,SCD-1,Up Regulation,Molecular,gene expression,GO:0010467,acyl-CoA desaturase,PR:000014497,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:54,CD36,Up Regulation,Molecular,gene expression,GO:0010467,platelet glycoprotein 4,PR:000001905,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:880,ApoB100,Increased,Tissue,gene expression,GO:0010467,apolipoprotein B-100,PR:000004145,increased concentration,PATO:0001162,,,blood,UBERON:0000178
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:799,HIF-1 heterodimer,Increased,Cellular,gene expression,GO:0010467,hypoxia-inducible factor 1 (Caenorhabditis elegans) ,PR:G5EGD2,increased process quality,PATO:0002304,,,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:285,Vitellogenin synthesis in liver,Reduction,Tissue,gene expression,GO:0010467,vitellogenins,D014819,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:799,HIF-1 heterodimer,Increased,Cellular,gene expression,GO:0010467,hypoxia-inducible factor 1-alpha,PR:000008555,increased process quality,PATO:0002304,,,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:802,HIF-1 alpha transcription,Increased,Cellular,gene expression,GO:0010467,hypoxia-inducible factor 1-alpha,PR:000008555,increased process quality,PATO:0002304,,,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:285,Vitellogenin synthesis in liver,Reduction,Tissue,gene expression,GO:0010467,vitellogenins,D014819,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:131,AhR activation leading to uroporphyria,Event:850,CYP1A2/CYP1A5,Induction,Molecular,gene expression,GO:0010467,cytochrome P450 1A2,PR:000006102,increased process quality,PATO:0002304,,,,
Aop:131,AhR activation leading to uroporphyria,Event:850,CYP1A2/CYP1A5,Induction,Molecular,gene expression,GO:0010467,cytochrome P450 1A5 (chicken),PR:P79761,increased process quality,PATO:0002304,,,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:962,Mucin production,Increase,Cellular,gene expression,GO:0010467,mucin-5AC,PR:000031343,increased process quality,PATO:0002304,goblet cell ,,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:948,VEGF,reduced production,Cellular,gene expression,GO:0010467,vascular endothelial growth factor A,PR:000017284,decreased process quality,PATO:0002302,angioblastic mesenchymal cell,CL:0000566 ,,
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1020,induction of UDPGT's in liver,Increased,Cellular,gene expression,GO:0010467,UDP-glucuronosyltransferase,PR:000024849,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1034,IGF-1 (mouse),Increased,Cellular,gene expression,GO:0010467,IGF-like family receptor 1 (mouse),PR:Q3U4N7,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:167,Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,Event:1066,SIX-1 postive basal-type progenitor cells,Promotion,Cellular,gene expression,GO:0010467,homeobox protein SIX1,PR:000014896,increased process quality,PATO:0002304,basal cell,CL:0000646,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1239,Gene Expression,Altered,Molecular,gene expression,GO:0010467,,,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:201,Juvenile hormone receptor agonism leading to male offspring induction associated population decline,Event:1206,Doublesex1 gene,Induction,Molecular,gene expression,GO:0010467,protein doublesex (fruit fly),PR:P23023,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:206,Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis,Event: 1274,Production of ?-smooth muscle actin,,Cellular,gene expression,GO:0010467,"actin, aortic smooth muscle",PR:000003675,increased process quality        ,PATO:0002304,myofibroblast cell,CL:0000186,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1284,SREBF2,Up Regulation,Cellular,gene expression,GO:0010467,sterol regulatory element-binding protein 2 proteolytic cleavage product,PR:000021564,increased process quality        ,PATO:0002304,hepatocyte,CL:0000182,,
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:756,Hippocampal gene expression,Altered,Tissue,regulation of gene expression,GO:0010468,hippocampal formation,UBERON:0002421,deviation(from_normal),PATO:0000069,,,brain,UBERON:0000955
Aop:19,Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),Event:286,Transcription of genes by AR,Decreased,Cellular,regulation of gene expression,GO:0010468,androgen receptor,PR:000004191,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:19,Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),Event:286,Transcription of genes by AR,Decreased,Cellular,regulation of gene expression,GO:0010468,androgen receptor,PR:000004191,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:756,Hippocampal gene expression,Altered,Tissue,regulation of gene expression,GO:0010468,hippocampal formation,UBERON:0002421,deviation(from_normal),PATO:0000069,,,brain,UBERON:0000955
Aop:107,Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:1214,"Altered gene expression specific to CAR activation, Hepatocytes","Altered gene expression specific to CAR activation, Hepatocytes",Cellular,regulation of gene expression,GO:0010468,,,abnormal,PATO:0000460,hepatocyte,CL:0000182,,
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:756,Hippocampal gene expression,Altered,Tissue,regulation of gene expression,GO:0010468,hippocampal formation,UBERON:0002421,deviation(from_normal),PATO:0000069,,,brain,UBERON:0000955
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:756,Hippocampal gene expression,Altered,Tissue,regulation of gene expression,GO:0010468,hippocampal formation,UBERON:0002421,deviation(from_normal),PATO:0000069,,,brain,UBERON:0000955
Aop:149,Oxidative Stress Leading to Hypertension,Event:927,eNOS,S-Glutathionylation,Molecular,protein glutathionylation ,GO:0010731,"nitric oxide synthase, endothelial",PR:000011328,increased process quality,PATO:0002304,vascular endothelial cell,CL:0002139,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:927,eNOS,S-Glutathionylation,Molecular,protein glutathionylation ,GO:0010731,cysteine residue,CHEBI:32460,increased process quality,PATO:0002304,vascular endothelial cell,CL:0002139,,
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:295,Upregulation of glucuronyltransferase activity,Induction,Molecular,glucuronosyltransferase activity,GO:0015020,"beta-1,3-glucuronyltransferase",PR:000001325,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:79,Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:178,Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure,Event:559,Nicotinic acetylcholine receptor,Activation,Molecular,acetylcholine receptor activity,GO:0015464,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:106,Chemical binding to tubulin in oocytes leading to aneuploid offspring,Event:718,Tubulin,Binding,Molecular,tubulin binding,GO:0015631,tubulin,PR:000028799,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:49,Ca and HCO3 transport to shell gland,Reduction,Tissue,bicarbonate transport,GO:0015701,hydrogencarbonate,CHEBI:17544,decreased process quality,PATO:0002302,,,oviduct shell gland,UBERON:0008975
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:425,Thyroidal iodide uptake,Decreased,Cellular,iodide transport,GO:0015705,iodide,CHEBI:16382,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:737,Uptake of inorganic iodide,Decreased,Cellular,iodide transport,GO:0015705,iodide,CHEBI:16382,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:425,Thyroidal iodide uptake,Decreased,Cellular,iodide transport,GO:0015705,iodide,CHEBI:16382,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:176,Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,Event:425,Thyroidal iodide uptake,Decreased,Cellular,iodide transport,GO:0015705,iodide,CHEBI:16382,decreased process quality,PATO:0002302,,,thyroid gland,UBERON:0002046
Aop:188,Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,Event:425,Thyroidal iodide uptake,Decreased,Cellular,iodide transport,GO:0015705,iodide,CHEBI:16382,decreased process quality,PATO:0002302,thyroid follicular cell,CL:0002258,,
Aop:57,AhR activation leading to hepatic steatosis,Event:465,FA Influx,Increased,Cellular,fatty acid transport,GO:0015908,fatty acid,CHEBI:35366,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:465,FA Influx,Increased,Cellular,fatty acid transport,GO:0015908,fatty acid,CHEBI:35366,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:465,FA Influx,Increased,Cellular,fatty acid transport,GO:0015908,fatty acid,CHEBI:35366,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
AOP:205,AOP from chemical insult to cell death,Event:1258,Decompartmentalization,,Molecular,cellular component organization,GO:0016043,,,abnormal,PATO:0000460,eukaryotic cell,CL:0000255,,
Aop:19,Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),Event:310,Wnt pathway,Alteration,Cellular,Wnt signaling pathway,GO:0016055,Wnt signalosome,GO:1990909,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:926,Glutathione,Oxidation,Molecular,antioxidant activity,GO:0016209,Glutathione,CHEBI:16856,deviation(from_normal),PATO:0000069,,,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:924,SP1,Activation,Molecular,phosphorylation,GO:0016310,transcription factor Sp1,PR:000000133,increased process quality,PATO:0002304,epithelial cell of lung,CL:0000082,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1138,Reduced ability to generate ATP,Uncoupling of oxidative phosphorylation,Molecular,oxidative phosphorylation uncoupler activity,GO:0017077,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:941,EGFR,Activation,,peptidyl-cysteine oxidation,GO:0018171,epidermal growth factor receptor,PR:000006933,occurrence,PATO:0000057,epithelial cell of lung,CL:0000082,,
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:363,Reproductive behaviour,Altered,Individual,reproductive behavior,GO:0019098,,,deviation(from_normal),PATO:0000069,,,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:565,Brood care,Reduced,Population,reproductive behavior,GO:0019098,,,decreased quality,PATO:0002301,,,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:1267,Ecdysis motoneuron bursts,Reduction,Tissue,transmission of nerve impulse,GO:0019226,motor neuron,CL:0000100,decreased process quality,PATO:0002302,,,nervous system,UBERON:0001016
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:454,Triglyceride formation,Increased,Cellular,triglyceride biosynthetic process,GO:0019432,triglyceride,CHEBI:17855,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:853,Cellular Homeostasis and Apoptosis,Changes/Inhibition,Cellular,cellular homeostasis,GO:0019725,,,deviation(from_normal),PATO:0000069,hepatocyte,CL:0000182,,
Aop:95,Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival,Event:593,Ether-a-go-go (ERG) voltage-gated potassium channel,Inhibition,Molecular,potassium channel inhibitor activity,GO:0019870,potassium voltage-gated channel subfamily H member 2 (human),PR:Q12809,decreased process quality,PATO:0002302,,,,
Aop:91,Sodium channel inhibition leading to reduced survival,Event:584,sodium channel,Inhibition,Molecular,sodium channel inhibitor activity,GO:0019871,sodium channel protein type 1 subunit alpha,PR:000002095,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:93,sodium channel inhibition leading to increased predation,Event:584,sodium channel,Inhibition,Molecular,sodium channel inhibitor activity,GO:0019871,sodium channel protein type 1 subunit alpha,PR:000002095,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:94,Sodium channel inhibition leading to congenital malformations,Event:584,sodium channel,Inhibition,Molecular,sodium channel inhibitor activity,GO:0019871,sodium channel protein type 1 subunit alpha,PR:000002095,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:598,sodium channel,modulation,Molecular,sodium channel inhibitor activity,GO:0019871,sodium channel protein type 1 subunit alpha,PR:000002095,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1236,Antigen presentation,Generation of novel epitopes,Cellular,antigen processing and presentation,GO:0019882,hapten,CHEBI:59174,increased process quality,PATO:0002304,,,,
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:158,Interferences with SH-/selen-proteins,N/A,Cellular,protein domain specific binding,GO:0019904,,,disrupted,PATO:0001507,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1242,Second Messenger Production,Increased,Cellular,second-messenger-mediated signaling,GO:0019932,,,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:63,Cyclooxygenase inhibition leading to reproductive dysfunction,Event:675,Reproductive Success,Reduced,Individual,reproductive process,GO:0022414,,,decreased process quality,PATO:0002304,,,,
Aop:195,5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,Event:1163,Reproductive Success,Increased,Individual,reproductive process,GO:0022414,,,increased process quality,PATO:0002304,,,,
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:64,Ionotropic GABA receptor chloride channel conductance,Reduction,Cellular,GABA-gated chloride ion channel activity,GO:0022851,Chloride ion,CHEBI:17996,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:160,Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,Event:762,ionotropic GABA Receptor chloride channel,Activation,Molecular,GABA-gated chloride ion channel activity,GO:0022851,Chloride ion,CHEBI:17996,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:239,"Pregnane-X receptor, NR1l2",Activation,Molecular,signaling,GO:0023052,nuclear receptor subfamily 1 group I member 2,PR:000011397,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:239,"Pregnane-X receptor, NR1l2",Activation,Molecular,signaling,GO:0023052,nuclear receptor subfamily 1 group I member 3,PR:000011398,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:195,NMDARs,Inhibition,Molecular,signaling,GO:0023052,NMDA selective glutamate receptor complex,GO:0017146 ??,arrested,PATO:0000297,neuron,CL:0000540,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:195,NMDARs,Inhibition,Molecular,signaling,GO:0023052,NMDA selective glutamate receptor complex,GO:0017146 ??,arrested,PATO:0000297,neuron,CL:0000540,,
Aop:33,Kidney toxicity induced by activation of 5HT2C,Event:9,5HT2c,Activation,Molecular,signaling,GO:0023052,5-hydroxytryptamine receptor 2C,PR:000001168,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:34,LXR activation leading to hepatic steatosis,Event:167,LXR,Activation,Molecular,signaling,GO:0023052,oxysterols receptor LXR-beta,PR:000011394,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:34,LXR activation leading to hepatic steatosis,Event:167,LXR,Activation,Molecular,signaling,GO:0023052,oxysterols receptor LXR-alpha,PR:000011395,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:34,LXR activation leading to hepatic steatosis,Event:66,ChREBP,Activation,Molecular,signaling,GO:0023052,carbohydrate-responsive element-binding protein,PR:000010460,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:165,Long term AHR receptor driven direct and indirect gene expression changes,Activation,Cellular,signaling,GO:0023052,aryl hydrocarbon receptor,PR:000003858,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:388,NMDARs,Overactivation,Molecular,signaling,GO:0023052,NMDA selective glutamate receptor complex,GO:0017146 ??,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:456,"Constitutive androstane receptor, NR1l3",Suppression,Molecular,signaling,GO:0023052,nuclear receptor subfamily 1 group I member 3,PR:000011398,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:167,LXR,Activation,Molecular,signaling,GO:0023052,oxysterols receptor LXR-beta,PR:000011394,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:167,LXR,Activation,Molecular,signaling,GO:0023052,oxysterols receptor LXR-alpha,PR:000011395,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:457,SREBF1,Activation,Molecular,signaling,GO:0023052,sterol regulatory element-binding protein 1,PR:000015611,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:66,ChREBP,Activation,Molecular,signaling,GO:0023052,carbohydrate-responsive element-binding protein,PR:000010460,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:59,HNF4alpha suppression leading to hepatic steatosis,Event:461,HNF4alpha,Suppression,Molecular,signaling,GO:0023052,hepatocyte nuclear factor 4-alpha,PR:000008654,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:245,PXR/SXR,Activation,Molecular,signaling,GO:0023052,nuclear receptor subfamily 1 group I member 2,PR:000011397,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:471,FoxA2,Inhibition,Molecular,signaling,GO:0023052,hepatocyte nuclear factor 3-beta,PR:000007603,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:478,NRF2,Activation,Molecular,signaling,GO:0023052,nuclear factor erythroid 2-related factor 2,PR:000011170,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:479,NR1H4,Activation,Molecular,signaling,GO:0023052,bile acid receptor,PR:000011396,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:480,SHP,Activation,Molecular,signaling,GO:0023052,nuclear receptor subfamily 0 group B member 2,PR:000011391,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:483,LXR alpha,Activation,Molecular,signaling,GO:0023052,oxysterols receptor LXR-alpha,PR:000011395,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:879,MTTP,Activation,Cellular,signaling,GO:0023052,microsomal triglyceride transfer protein large subunit MTTP,PR:000003392,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:62,AKT2 activation leading to hepatic steatosis,Event:484,AKT2,Activation,Molecular,signaling,GO:0023052,RAC-beta serine/threonine-protein kinase,PR:000003912,increased process quality,PATO: 0002304,hepatocyte,CL:0000182,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:529,GnRH cfos activity,Decreased,Molecular,signaling,GO:0023052,proto-oncogene c-Fos (mouse),PR:P01101,decreased process quality,PATO:0002302,gonadtroph,CL:0000437 ,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 1,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,signaling,GO:0023052,calmodulin,PR:000004978,deviation(from_normal),PATO:0000069,,,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,signaling,GO:0023052,calmodulin,PR:000004978,deviation(from_normal),PATO:0000069,,,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,signaling,GO:0023052,calmodulin,PR:000004978,deviation(from_normal),PATO:0000069,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:1243,"Altered, Ca2+-calmodulin activated signal transduction","Altered, Ca2+-calmodulin activated signal transduction",Cellular,signaling,GO:0023052,calmodulin,PR:000004978,deviation(from_normal),PATO:0000069,,,,
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:692,"Maturation inducing steroid receptor signalling, oocyte",Reduced,Tissue,signaling,GO:0023052,steroid hormone  ,CHEBI:26764,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:107,Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:715,Constitutive androstane receptor,Activation,Molecular,signaling,GO:0023052,nuclear receptor subfamily 1 group I member 3,PR:000011398,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:801,Unknown,modulation,Molecular,signaling,GO:0023052,hypoxia-inducible factor 1-alpha,PR:000008555 ,deviation(from_normal),PATO:0000069,,,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:529,GnRH cfos activity,Decreased,Molecular,signaling,GO:0023052,proto-oncogene c-Fos (mouse),PR:P01101,decreased process quality,PATO:0002302,gonadtroph,CL:0000437 ,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:849,Antgonism of NE receptor,Inhibition,Molecular,signaling,GO:0023052,alpha-2A adrenergic receptor ,PR:000001186,decreased process quality,PATO:0002302,,,,
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:877,p-amino hippuric acid channel,Inhibition,Molecular,signaling,GO:0023052,solute carrier family 22 member 6,PR:000014993,decreased process quality,PATO:0002302,,,proximal tubule,UBERON:0004134
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:964,Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol,Inhibition of Aromatase Enzyme,Molecular,signaling,GO:0023052,cytochrome P450 19A1,PR:000006100,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1134,Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone,Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139,Molecular,signaling,GO:0023052,androgen receptor,PR:000004191,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:192,Pendrin inhibition leading to altered amphibian metamorphosis,Event:1155,Pendrin,Inhibition,Molecular,signaling,GO:0023052,pendrin,PR:000015039,decreased process quality,PATO:0002302,,,,
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:1157,Hepatic nuclear receptor(s),Activation,Molecular,signaling,GO:0023052,protein,PR:000000001,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1215,TRPA1 Receptor,TRPA1 activation,Molecular,signaling,GO:0023052,transient receptor potential cation channel TRPV1,PR:000001065,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1230,TRPV1,TRPV1 activation,Molecular,signaling,GO:0023052,transient receptor potential cation channel TRPV1,PR:000001065,increased process quality,PATO:0002304,,,,
Aop:197,Sodium channel (Nav1.1) inhibition leading to population decline,Event:584,sodium channel,Inhibition,Molecular,signaling,GO:0023052,sodium channel protein type 1 subunit alpha,PR:000002095,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1181,Estrogen receptor,Activation,Molecular,signaling,GO:0023052,estrogen receptor,PR:000007204,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1191,Non-genomic signaling,Increased,Cellular,signaling,GO:0023052,,,increased process quality        ,PATO:0002304, epithelial cell,CL:0000066,,
Aop:201,Juvenile hormone receptor agonism leading to male offspring induction associated population decline,Event:1205,Juvenile hormone receptor,Activation,Molecular,signaling,GO:0023052,juvenile hormone,CHEBI:24943,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:206,Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis,Event: 1271,Activation of TGF-?? signaling,,Molecular,signaling,GO:0023052,TGF-beta ,PR:000000046,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1174,NADPH Oxidase,"Activation,",Molecular,signaling,GO:0023052,NADPH Oxidase,D019255,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1279,"Oxidative Stress / Activation, PMK-1 P38 MAPK",Increase,Cellular,signaling,GO:0023052,map kinase p38,PR:000003106,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1280,HIF-1,"Activation,",Cellular,signaling,GO:0023052,hypoxia-inducible factor 1 (Caenorhabditis elegans) ,PR:G5EGD2,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:208,Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure,Event:1282,JAK/STAT pathway,Activation,Cellular,signaling,GO:0023052,Janus kinase,PR:000025748,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:208,Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure,Event:1282,JAK/STAT pathway,Activation,Cellular,signaling,GO:0023052,signal transducer and transcription activator STAT,PR:000001933,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:208,Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure,Event:1283,TGF-beta pathway,Activation,Cellular,signaling,GO:0023052,TGF-beta,PR:000000046,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:210,Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building ,Event:1292,JNK,Activation,Cellular,signaling,GO:0023052,JNK Mitogen-Activated Protein Kinases,D048031,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:210,Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building ,Event:1293,FOXO,Activation,Cellular,signaling,GO:0023052,forkhead box protein O (Caenorhabditis elegans),PR:O16850,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:210,Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building ,Event:1294,Wnt pathway,Inhibition,Cellular,signaling,GO:0023052,Wnt signalosome,GO:1990909,abnormal,PATO:0000460,eukaryotic cell,CL:0000255,,
Aop:206,Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis,Event: 1272,Differentiation of Myofibroblast,,Cellular,cell differentiation,GO:0030154,myofibroblast cell,CL:0000186,increased process quality        ,PATO:0002304,myofibroblast cell,CL:0000186,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:863,Catabolism of Muscle Protein,Increased,Organ,protein catabolic process,GO:0030163,muscle protein,D009124,increased process quality,PATO:0002304,,,musculoskeletal system,UBERON:0002204
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:111,Estrogen receptor,Agonism,Molecular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:112,Estrogen receptor,Antagonism,Molecular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:52,ER agonism leading to skewed sex ratios due to altered sexual differentiation in males,Event:111,Estrogen receptor,Agonism,Molecular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:53,ER agonism leading to reduced survival due to renal failure,Event:111,Estrogen receptor,Agonism,Molecular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,increased process quality,PATO:0002304,kidney cell,CL:1000497,,
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:659,Activation by other estradiol agonists,Decreased testosterone by the fetal Leydig cells,Cellular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:112,Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat),Event:748,Estrogen receptor (ER) activity,Increased,Molecular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,increased process quality,PATO:0002304,,,,
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1046,Estrogen receptor (ER) activity,Suppression,Molecular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,decreased process quality,PATO:0002302,,,,
Aop:167,Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,Event:1064,Estrogen receptor (ER) activity,prepubertal increase,Molecular,estrogen receptor activity,GO:0030284,estrogen receptor,PR:000007204,increased process quality,PATO:0002304,,,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1187,ER binding to DNA (classical pathway),Increased,Molecular,estrogen receptor binding,GO:0030331,DNA,CHEBI:16991,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1188,ER binding to T.F. to DNA (non-classical pathway),Increased,Molecular,estrogen receptor binding,GO:0030331,TF (human),PR:000016261,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:118,Formation of hemoglobin adducts,Formation,Cellular,hemoglobin binding,GO:0030492,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:167,Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,Event:1065,estrogen receptor alpha,Activation,Molecular,intracellular estrogen receptor signaling pathway,GO:0030520,estrogen receptor alpha complex,PR:000027727 ,increased process quality,PATO:0002304,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:663,Nicotinic acetylcholine receptor,Desensitization,Molecular,receptor regulator activity,GO:0030545,,,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:663,Nicotinic acetylcholine receptor,Desensitization,Molecular,receptor regulator activity,GO:0030545,,,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:663,"Desensitization, Nicotinic acetylcholine receptor","Desensitization, Nicotinic acetylcholine receptor",Molecular,acetylcholine receptor activator activity,GO:0030549,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:663,Nicotinic acetylcholine receptor,Desensitization,Molecular,acetylcholine receptor activator activity,GO:0030549,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:663,Nicotinic acetylcholine receptor,Desensitization,Molecular,acetylcholine receptor activator activity,GO:0030549,Nicotinic acetylcholine receptor,61796,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:63,Cyclooxygenase inhibition leading to reproductive dysfunction,Event:488,Ovulation,Decrease,Tissue,ovulation,GO:0030728,,,decreased process quality,PATO:0002302,,,female gonad,UBERON:0000992
Aop:164,Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse,Event:1038,beta-2 adrenergic receptor,Activation,Molecular,beta-2 adrenergic receptor binding,GO:0031698,beta-2 adrenergic receptor,PR:000001193,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:970,Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs,Decreased LH release from Anterior Pituitary,Cellular,luteinizing hormone secretion,GO:0032275,luteinizing hormone,CHEBI:81568,decreased process quality,PATO:0002302,gonadtroph,CL:0000437 ,,
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1050,secretion of LH from anterior pituitary,Increased,Cellular,luteinizing hormone secretion,GO:0032275,leutinizing hormone,CHEBI:81568,decreased process quality,PATO:0002302,,,,
Aop:69,Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell,Event:644,Decreased Transport of Cholesterol to the Inner Mitochondrial Membrane,Decreased Cholesterol,Molecular,intracellular cholesterol transport,GO:0032367,cholesterol,CHEBI:16113,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:19,Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),Event:240,Primary and accessory male sex organs,Feminisation or incomplete development,Organ,developmental process,GO:0032502,male reproductive organ,UBERON:0003135,arrested,PATO:0000297,,,Male reproductive system,UBERON:0000079
Aop:21,Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality,Event:317,"Altered, Cardiovascular development/function","Altered, Cardiovascular development/function",Organ,developmental process,GO:0032502,cardiovascular system,UBERON:0004535,deformed,PATO:0001617,,,Heart,UBERON:0000948
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:364,Reproductive organs,Impaired development of,Individual,developmental process,GO:0032502,reproductive organ,UBERON:0003133,abnormal,PATO:0000460,,,,
Aop:84,Suppression of immune system contributes to impaired development and leads to colony loss/failure,Event:577,Development,impaired,Individual,developmental process,GO:0032502,,,deviation(from_normal),PATO:0000069,,,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:1202,IL-2 and IL-4 production,Suppression,Molecular,interleukin-2 production,GO:0032623,interleukin-2,PR:000001379,decreased process quality,PATO:0002302,,,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:1202,IL-2 and IL-4 production,Suppression,Molecular,interleukin-4 production,GO:0032633,interleukin-4,PR:000001391,decreased process quality,PATO:0002302,,,,
Aop:38,Protein Alkylation leading to Liver Fibrosis,Event:276,TGFbeta1 expression,Up Regulation,Cellular,transforming growth factor beta1 production,GO:0032905,TGF-beta 1,PR:000000182,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:34,LXR activation leading to hepatic steatosis,Event:264,SREBP-1c,Activation,Molecular,SREBP signaling pathway,GO:0032933,sterol regulatory element-binding protein 1,PR:000015611,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:878,SREBP1c,Inhibition,Molecular,SREBP signaling pathway,GO:0032933,sterol regulatory element-binding protein 1,PR:000015611,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:62,AKT2 activation leading to hepatic steatosis,Event:457,SREBF1,Activation,Molecular,SREBP signaling pathway,GO:0032933,sterol regulatory element-binding protein 1,PR:000015611,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:38,Protein Alkylation leading to Liver Fibrosis,Event:68,Collagen,Accumulation,Tissue,collagen biosynthetic process,GO:0032964,collagen,CHEBI:3815,increased process quality,PATO:0002304,,,connective tissue,UBERON:0002384
Aop:206,Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis,Event: 1273,Expression of Collagen,,Cellular,collagen biosynthetic process,GO:0032964,collagen,CHEBI:3815,increased process quality        ,PATO:0002304,myofibroblast cell,CL:0000186,,
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:826,Keratinocytes,Activation,Cellular,keratinocyte activation,GO:0032980,,,increased process quality,PATO:0002304,keratinocyte,CL:0000312,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:531,LH Surge,Decreased,Cellular,regulation of luteinizing hormone secretion,GO:0033684,Luteinizing hormone,CHEBI:81568,decreased concentration,PATO:0001163,gonadtroph,CL:0000437 ,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:535,Sperm penetration (polyspermy),Abnormal,Cellular,sperm entry,GO:0035037,,,deviation(from_normal),PATO:0000069,oocyte,CL:0000023,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:535,Sperm penetration (polyspermy),Abnormal,Cellular,sperm entry,GO:0035037,,,deviation(from_normal),PATO:0000069,,,,
Aop:4,Ecdysone receptor agonism leading to mortality,Event:103,Ecdysone receptor,Activation,Molecular,ecdysone receptor-mediated signaling pathway,GO:0035076,ecdysone receptor holocomplex,GO:0008230,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,Event:227,PPARalpha,Activation,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor alpha ,PR:000013056,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:34,LXR activation leading to hepatic steatosis,Event:228,PPARgamma,Activation,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor gamma,PR:000013058,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:231,PPAR-alpha activation,Decreased,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor alpha,PR:000013056,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:232,PPAR-beta activation,Decreased,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor delta,PR:000013057,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:233,PPAR-gamma activation,Decreased,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor gamma,PR:000013058,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:37,PPARalpha-dependent liver cancer,Event: 227,PPARalpha,Activation,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor alpha,PR:000013056,increased process quality,PATO:0002304,,,,
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:227,PPARalpha,Activation,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor alpha,PR:000013056,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:468,PPAR alpha,Inhibition,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor alpha,PR:000013056,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:228,PPARgamma,Activation,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor gamma,PR:000013058,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:227,PPARalpha,Activation,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor alpha ,PR:000013056,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1028,PPAR-gamma activation,Activation of specific nuclear receptors,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor gamma,PR:000013058,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:166,PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse,Event:1057,PPAR-alpha activation,Increased,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor alpha,PR:000013056,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:206,Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis,Event: 1270,Inactivation of PPAR??,,Molecular,peroxisome proliferator activated receptor signaling pathway,GO:0035357,peroxisome proliferator-activated receptor gamma,PR:000013058,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:858,PPARalpha transactivation of gene expression,Decreased,Molecular,receptor transactivation,GO:0035624,peroxisome proliferator-activated receptor alpha ,PR:000013056,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:655,Increased COUP-TFII in fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:656,Decreased COUP-TFII stem Leydig cells,Decreased number and function of adult Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,decreased process quality,PATO:0002302,Leydig cell ,CL:0000178,,
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:655,Increased COUP-TFII in fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:656,Decreased COUP-TFII stem Leydig cells,Decreased number and function of adult Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,decreased process quality,PATO:0002302,Leydig cell ,CL:0000178,,
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:655,Increased COUP-TFII in fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:656,Decreased COUP-TFII stem Leydig cells,Decreased number and function of adult Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,decreased process quality,PATO:0002302,Leydig cell ,CL:0000178,,
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:655,Increased COUP-TFII in fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:541,Decreased COUP-TFII stem Leydig cells,Decreased testosterone by the fetal Leydig cells,Cellular,receptor transactivation,GO:0035624,COUP transcription factor 2,PR:000011405,decreased process quality,PATO:0002302,Leydig cell ,CL:0000178,,
Aop:38,Protein Alkylation leading to Liver Fibrosis,Event:265,Stellate cells,Activation,Cellular,hepatic stellate cell activation,GO:0035733,hepatic stellate cell,CL:0000632,increased process quality,PATO:0002304,hepatic stellate cell,CL:0000632,,
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:191,Neuronal dysfunction,N/A,Cellular,neuron death in response to oxidative stress,GO:0036475,,,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation,Event:622,locomotion,Increased,Individual,locomotion,GO:0040011,,,increased process quality,PATO:0002304,,,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation,Event:625,muscular waves in foot,Increased,Organ,locomotion,GO:0040011,pedal ganglion,PDG,increased process quality,PATO:0002305,,,muscle of pes,UBERON:0001498
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:635,locomotion,Decreased,Individual,locomotion,GO:0040011,,,decreased process quality,PATO:0002302,,,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1130,Unresolved blood loss (hemorrhage),Failure in vascular repair mechanisms,Organ,wound healing,GO:0042060,,,deviation(from_normal),PATO:0000069,,,vascular system,UBERON:0007798
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:272,T-cells,Activation/Proliferation,Organ,T cell activation,GO:0042110,T-cell,CL:0000084,increased process quality,PATO:0002304,,,lymph node,UBERON:0000029
Aop:38,Protein Alkylation leading to Liver Fibrosis,Event:134,Activation and Recruitment of Hepatic macrophages (Kupffer Cells),Increased,Cellular,macrophage activation,GO:0042116,Kupffer cell,CL:0000091,increased process quality,PATO:0002304,Kupffer cell,CL:0000091,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1198,Macrophages,Activation,Cellular,macrophage activation,GO:0042116,,,decreased process quality,PATO:0002302,macrophage,CL:0000235,,
Aop:124,HMG-CoA reductase inhibition leading to decreased fertility,Event:804,HMG-CoA reductase,Inhibition,Cellular,hydroxymethylglutaryl-CoA reductase activity,GO:0042282,3-hydroxy-3-methylglutaryl-coenzyme A reductase,PR:000008636,decreased process quality,PATO:0002302,,,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:937,Vasodilation,impaired,Organ,Vasodilation,GO:0042311,blood vessel,UBERON:0001981,deviation(from_normal),PATO:0000069,,,circulatory system,UBERON:0001009
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1134,Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone,Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139,Molecular,vitamin K metabolic process,GO:0042373,vitamin K,CHEBI:28384,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:528,Synthesis of NE,Decreased,Cellular,norepinephrine biosynthetic process,GO:0042421,norepinephrine,CHEBI:18357,decreased process quality,PATO:0002302,noradrenergic cell,CL:0000459,,
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:414,Luteinizing hormone (LH),Increase,Cellular,hormone biosynthetic process,GO:0042446,luteinizing hormone,CHEBI:81568,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:495,Repressed expression of steroidogenic enzymes,N/A,Cellular,hormone biosynthetic process,GO:0042446,testosterone,CHEBI:17347,decreased process quality,PATO:0002302,Leydig cell,CL:0000178,,
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1021,T4/T3 catabolism,Increased,Cellular,hormone catabolic process,GO:0042447,thyroxine,CHEBI:30660,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:118,Formation of hemoglobin adducts,Formation,Cellular,hemoglobin biosynthetic process,GO:0042541,xenobiotic,CHEBI:35703,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:7,Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female,Event:405,ovarian cycle,irregularities,Individual,ovulation cycle,GO:0042698,,,disrupted,PATO:0001507,,,,
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:971,Decrease or delay in LH surge required for ovulation,"Ovulation of oocytes Reduced, Delayed, or Blocked",Individual,ovulation cycle,GO:0042698,,,deviation(from_normal),PATO:0000069,,,,
Aop:112,Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat),Event:749,Progesterone from corpus luteum,Decreased,Tissue,progesterone secretion,GO:0042701,Progesterone,CHEBI:17026,decreased concentration,PATO:0001163,,,corpus luteum,UBERON:0002512
Aop:69,Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell,Event:643,Decreased Uptake of Lipoproteins,Decreased Cholesterol,Molecular,lipoprotein transport,GO:0042953,lipoprotein,CHEBI:6495,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:633,histaminergic neuron excitation,Decrease,Cellular,rhythmic excitation,GO:0043179,histaminergic neuron,CL:0011110,decreased process quality,PATO:0002302,histaminergic neuron,CL:0011110,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1220,Bronchopulmonary vagul nerve excitation,Nerve excitation ,Cellular,rhythmic excitation,GO:0043179,vagus nerve,UBERON:0001759,decreased process quality,PATO:0002302,neuron,CL:0000540,respiratory tract,UBERON:0000065
Aop:43,Disruption of VEGFR Signaling Leading to Developmental Defects,Event:305,VegfR2,Inhibition,Molecular,vascular endothelial growth factor receptor 2 binding,GO:0043184,vascular endothelial growth factor receptor 2,PR:000002112,decreased process quality,PATO:0002302,somatic cell,CL:0002371,,
Aop:43,Disruption of VEGFR Signaling Leading to Developmental Defects,Event:305,VegfR2,Inhibition,Molecular,vascular endothelial growth factor receptor 2 binding,GO:0043184,vascular endothelial growth factor receptor 1,PR:000007563,decreased process quality,PATO:0002302,somatic cell,CL:0002371,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1190,Migration (Endothelial Cells),Increased,Cellular,endothelial cell migration,GO:0043542,,,increased process quality        ,PATO:0002304,endothelial cell,CL:0000115,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1169,Impairment of post-translational modification (carboxylation) of osteocalcin,Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone,Molecular,post-translational protein modification,GO:0043687,osteocalcin,PR:000030444,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:662,Hypermethylation in the fetal testis,Decreased testosterone by the fetal Leydig cells,Molecular,DNA hypermethylation,GO:0044026,,,increased process quality,PATO:0002304,male germ cell,CL:0000015,,
Aop:14,Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility,Event:403,Immune system,Suppression,Individual,suppression of host defenses,GO:0044414,Immune system,UBERON:0002405,increased process quality,PATO:0002304,,,,
Aop:84,Suppression of immune system contributes to impaired development and leads to colony loss/failure,Event:403,Immune system,Suppression,Individual,suppression of host defenses,GO:0044414,Immune system,UBERON:0002405,increased process quality,PATO:0002304,,,,
Aop:85,Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure,Event:403,Immune system,Suppression,Individual,suppression of host defenses,GO:0044414,Immune system,UBERON:0002405,increased process quality,PATO:0002304,,,,
Aop:164,Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse,Event:1040,smooth muscle,relaxation,Tissue,relaxation of smooth muscle,GO:0044557 ,,,increased process quality,PATO:0002304,,,,
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:253,Reproductive failure,N/A,Individual,multi-organism reproductive process,GO:0044703,,,deviation(from_normal),PATO:0000069,,,,
Aop:108,Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:769,Oxidative metabolism,Increase,Cellular,cellular respiration,GO:0045333,,,increased process quality,PATO:0002304,,,,
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1029,adipogenesis,Increased,Cellular,fat cell differentiation,GO:0045444,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:86,Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,Event:578,Glucose oxidase enzyme activity,Decreased,Molecular,glucose oxidase activity,GO:0046562,"D-glucono-1,5-lactone",CHEBI:16217,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:530,GnRH pulsatility/release,Decreased,Cellular,hormone secretion,GO:0046879,Gonadotropin Releasing Hormone,D007987,decreased process quality,PATO:0002302,gonadtroph,CL:0000437 ,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:530,GnRH pulsatility/release,Decreased,Cellular,hormone secretion,GO:0046879,Gonadotropin Releasing Hormone,D007987,decreased process quality,PATO:0002302,,,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:531,LH Surge,Decreased,Cellular,hormone secretion,GO:0046879,Luteinizing hormone,CHEBI:81568,decreased concentration,PATO:0001163,,,,
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:969,Decreased Kisspeptin stimulation of GnRH neurons,Decreased GnRH Release,Cellular,hormone secretion,GO:0046879,Gonadotropin Releasing Hormone,D007987,decreased process quality,PATO:0002302,gonadotropin releasing neuron,CL:0011111,,
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1047,secretion of GnRH from hypothalamus,Increased,Cellular,hormone secretion,GO:0046879,Gonadotropin Releasing Hormone,D007987,decreased process quality,PATO:0002302,gonadotropin releasing neuron,CL:0011111,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1071,GnRH pulsatility/release in hypothalamus,Decreased,Cellular,hormone secretion,GO:0046879,Gonadotropin Releasing Hormone,D007987,decreased process quality,PATO:0002302,gonadotropin releasing neuron,CL:0011111,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1072,LH Surge from anterior pituitary,Decreased,Cellular,hormone secretion,GO:0046879,leutinizing hormone,CHEBI:81568,decreased process quality,PATO:0002302,,,,
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1071,GnRH pulsatility/release in hypothalamus,Decreased,Cellular,hormone secretion,GO:0046879,Gonadotropin Releasing Hormone,D007987,decreased process quality,PATO:0002302,gonadotropin releasing neuron,CL:0011111,,
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1072,LH Surge from anterior pituitary,Decreased,Cellular,hormone secretion,GO:0046879,leutinizing hormone,CHEBI:81568,decreased process quality,PATO:0002302,,,,
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1049,secrection of FSH from anterior pituitary,Increased,Cellular,follicle-stimulating hormone secretion,GO:0046884,Follicle stimulating hormone,CHEBI:81569,decreased process quality,PATO:0002302,,,,
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:381,Release of BDNF,Reduced,Molecular,secretion,GO:0046903,brain-derived neurotrophic factor,PR:000004716,decreased process quality,PATO:0002302,neural cell,CL:0002319,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:381,Release of BDNF,Reduced,Molecular,secretion,GO:0046903,brain-derived neurotrophic factor,PR:000004716,decreased process quality,PATO:0002302,neural cell,CL:0002319,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:381,Release of BDNF,Reduced,Molecular,secretion,GO:0046903,brain-derived neurotrophic factor,PR:000004716,decreased process quality,PATO:0002302,neural cell,CL:0002319,,
Aop:57,AhR activation leading to hepatic steatosis,Event:450,VLDL secretion,Suppression,Cellular,secretion,GO:0046903,very-low-density lipoprotein,CHEBI:39027,decreased process quality,PATO:0002302,hepatocyte,CL:0000182,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:533,Cortical granule release/distribution upon fertilization,Decreased,Cellular,secretion,GO:0046903,cortical granule,GO:0060473,decreased process quality,PATO:0002302,oocyte,CL:0000023,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:533,Cortical granule release/distribution upon fertilization,Decreased,Cellular,secretion,GO:0046903,cortical granule,GO:0060473,decreased process quality,PATO:0002302,,,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:962,Mucin production,Increase,Cellular,secretion,GO:0046903,mucin-5AC,PR:000031343,increased process quality,PATO:0002304,goblet cell ,CL:0000160,,
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1032,secretion of local growth factors,Increased,Cellular,secretion,GO:0046903,eukaryotic protein,PR:000036194,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:171,Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.,Event:1032,secretion of local growth factors,Increased,Cellular,secretion,GO:0046903,eukaryotic protein,PR:000036194,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:21,Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality,Event:944,"dimerization, AHR/ARNT","dimerization, AHR/ARNT",Molecular,protein dimerization activity,GO:0046983,aryl hydrocarbon receptor,PR:000003858,disrupted,PATO:0001507,eukaryotic cell,CL:0000255,,
Aop:21,Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality,Event:944,"dimerization, AHR/ARNT","dimerization, AHR/ARNT",Molecular,protein dimerization activity,GO:0046983,ARNT,PR:000004303,disrupted,PATO:0001507,eukaryotic cell,CL:0000255,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:944,AHR/ARNT,dimerization,Molecular,protein dimerization activity,GO:0046983,AHR,PR:000003858,increased process quality,PATO:0002304,,,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:944,AHR/ARNT,dimerization,Molecular,protein dimerization activity,GO:0046983,ARNT,PR:000004303,increased process quality,PATO:0002304,,,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:945,ARNT/HIF1-alpha,reduced dimerization,Molecular,protein dimerization activity,GO:0046983,hypoxia-inducible factor 1-alpha,PR:000008555,decreased process quality,PATO:0002302,,,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:945,ARNT/HIF1-alpha,reduced dimerization,Molecular,protein dimerization activity,GO:0046983,ARNT,PR:000004303,decreased process quality,PATO:0002302,,,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:998,PPAR alpha,Binding of antagonist,Molecular,receptor antagonist activity,GO:0048019,peroxisome proliferator-activated receptor alpha ,PR:000013056,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:818,Cytoplasmic vacuolization (Renal tubule),Occurrence,Organ,autophagic cell death,GO:0048102,renal tubule,UBERON:0009773,occurrence,PATO:0000057,,,kidney,UBERON:0002113
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:833,Cytoplasmic vacuolization (hepatocyte),Occurrence,Cellular,autophagic cell death,GO:0048102,,,occurrence,PATO:0000057,hepatocyte,CL:0000182,,
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:835,Ballooning degeneration (hepatocyte),Occurrence,Cellular,autophagic cell death,GO:0048102,,,occurrence,PATO:0000057,hepatocyte,CL:0000182,,
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:836,Cytoplasmic vacuolization (Bile duct cell),Occurrence,Cellular,autophagic cell death,GO:0048102,,,occurrence,PATO:0000057,cholangiocyte,CL:1000488,,
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:837,Cytoplasmic vacuolization (kupffer cell),Occurrence,Cellular,autophagic cell death,GO:0048102,,,occurrence,PATO:0000057,Kupffer cell,CL:0000091,,
Aop:195,5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,Event:1161,gamete maturation,Increased,Organ,cell maturation,GO:0048469,gamete,CL:0000300,increased process quality,PATO:0002304,,,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte development,GO:0048599,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte development,GO:0048599,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte development,GO:0048599,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte development,GO:0048599,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:309,Vitellogenin accumulation into oocytes and oocyte growth/development,Reduction,Cellular,oocyte development,GO:0048599,,,decreased process quality,PATO:0002302,ooctye,CL:0000023,,
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1004,Posterior swim bladder inflation,Reduced,Organ,swim bladder inflation,GO:0048798,posterior chamber swim bladder,UBERON:2001278,decreased process quality,PATO:0002302,,,,
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1007,Anterior swim bladder inflation,Reduced,Organ,swim bladder inflation,GO:0048798,anterior chamber swim bladder,UBERON:2001277,decreased process quality,PATO:0002302,,,,
Aop:156,Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1007,Anterior swim bladder inflation,Reduced,Organ,swim bladder inflation,GO:0048798,anterior chamber swim bladder,UBERON:2001277,decreased process quality,PATO:0002302,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1004,Posterior swim bladder inflation,Reduced,Organ,swim bladder inflation,GO:0048798,posterior chamber swim bladder,UBERON:2001278,decreased process quality,PATO:0002302,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1007,Anterior swim bladder inflation,Reduced,Organ,swim bladder inflation,GO:0048798,anterior chamber swim bladder,UBERON:2001277,decreased process quality,PATO:0002302,,,,
Aop:158,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1007,Anterior swim bladder inflation,Reduced,Organ,swim bladder inflation,GO:0048798,anterior chamber swim bladder,UBERON:2001277,decreased process quality,PATO:0002302,,,,
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1007,Anterior swim bladder inflation,Reduced,Organ,swim bladder inflation,GO:0048798,anterior chamber swim bladder,UBERON:2001277,decreased process quality,PATO:0002302,,,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:382,Dendritic morphology,Aberrant,Cellular,dendrite morphogenesis,GO:0048813,dendrite,GO:0030425,abnormal,PATO:0000460,neuron,CL:0000540,,
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:186,Neuroanatomy,Altered,Organ,anatomical structure development,GO:0048856,nervous system,UBERON:0001016,deviation(from_normal),PATO:0000069,,,brain,UBERON:0000955
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1241,Motility,Increased,Cellular,cell motility,GO:0048870,,,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:87,Cytokine,Release,Cellular,cytokine secretion,GO:0050663,cytokine,84050,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:144,Lysosomal damage leading to liver inflammation,Event:87,Cytokine,Release,Cellular,cytokine secretion,GO:0050663,cytokine,84050,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:86,Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,Event:579,Hydrogen peroxide production,Decreased,Molecular,hydrogen peroxide biosynthetic process,GO:0050665,hydrogen peroxide,CHEBI:16240,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:105,Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:710,Regenerative cell proliferation (tubular epithelial cells),Increase,Cellular,epithelial cell proliferation,GO:0050673,nephron tubule epithelial cell,CL:1000494,increased process quality,PATO:0002304,nephron tubule epithelial cell,CL:1000494,,
Aop:109,Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse),Event:734,Regenerative cell proliferation (terminal bronchiolar epithelial cells),Increase,Cellular,epithelial cell proliferation,GO:0050673,bronchial epithelial cell,CL:0002328,increased process quality,PATO:0002304,bronchial epithelial cell,CL:0002328,,
Aop:116,Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:710,Regenerative cell proliferation (tubular epithelial cells),Increase,Cellular,epithelial cell proliferation,GO:0050673,nephron tubule epithelial cell,CL:1000494,increased process quality,PATO:0002304,nephron tubule epithelial cell,CL:1000494,,
Aop:160,Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,Event:1015,Neuronal synaptic inhibition,Increased,Cellular,negative regulation of synaptic transmission,GO:0050805,GABA receptor complex,GO:1902710,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:161,Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,Event:1015,Neuronal synaptic inhibition,Increased,Cellular,negative regulation of synaptic transmission,GO:0050805,GABA receptor complex,GO:1902710,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:70,Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell,Event:647,Decreased Activity of Steroidogenic Enzymes in Adult Leydig cells,Decreased steroidogenesis,Cellular,regulation of steroid biosynthetic process,GO:0050810,,,decreased process quality,PATO:0002302,Leydig cell,CL:0000178,,
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:652,Decreased testosterone by adult Leydig cells,Direct effects of Corticosterone on steroidogenesis,Cellular,regulation of steroid biosynthetic process,GO:0050810,,,deviation(from_normal),PATO:0000069,Leydig cell,CL:0000178,,
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:667,iGABAR chloride channel,Binding at picrotoxin site,Molecular,GABA receptor binding,GO:0050811,gamma-aminobutyric acid receptor subunit alpha-1,PR:000007766,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:667,iGABAR chloride channel,Binding at picrotoxin site,Molecular,GABA receptor binding,GO:0050811,gamma-aminobutyric acid receptor subunit alpha-5,PR:000007770,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:667,iGABAR chloride channel,Binding at picrotoxin site,Molecular,GABA receptor binding,GO:0050811,gamma-aminobutyric acid receptor subunit alpha-6,PR:000007771,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,Event:1142,"Increased, valve movement","Increased, valve movement",Tissue,muscoloskeletal movement,GO:0050881,valve,UBERON:0003978,increased process quality,PATO:0002304,,,,
Aop:195,5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,Event:1142,"Increased, valve movement","Increased, valve movement",Tissue,muscoloskeletal movement,GO:0050881,valve,UBERON:0003978,increased process quality,PATO:0002304,,,,
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:402,Cognitive Function,Decreased,Individual,cognition,GO:0050890,,,decreased process quality,PATO:0002302,,,,
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:402,Cognitive Function,Decreased,Individual,cognition,GO:0050890,,,decreased process quality,PATO:0002302,,,,
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:402,Cognitive Function,Decreased,Individual,cognition,GO:0050890,,,decreased process quality,PATO:0002302,,,,
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:402,Cognitive Function,Decreased,Individual,cognition,GO:0050890,,,decreased process quality,PATO:0002302,,,,
Aop:106,Chemical binding to tubulin in oocytes leading to aneuploid offspring,Event:752,Meiotic chromosome dynamics,Altered,Cellular,chromosome movement towards spindle pole,GO:0051305,chromosome,GO:0005694,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:848,Binding of NE to NE receptors on GnRH neurons,Decreased,Cellular,norepinephrine binding,GO:0051380,Norepinephrine,CHEBI:18357,decreased process quality,PATO:0002302,gonadotropin releasing neuron,CL:0011111,,
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:867,Intracellular pH,Decrease,Cellular,regulation of intracellular pH,GO:0051453,,,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:98,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation,Event:619,reuptake of 5-HT (5-hydroxytryptamine transporter; sodium-dependent serotonin transporter,Inhibition,Molecular,serotonin uptake,GO:0051610,sodium-dependent serotonin transporter,PR:000015189,decreased process quality,PATO:0002302,motor neuron,CL:0000100,,
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:616,A paroxysmal depolarizing shift,Occurrence,Tissue,membrane depolarization,GO:0051899,,,occurrence,PATO:0000057,,,brain,UBERON:0000955
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:599,Depolarization of neuronal membrane,prolonged,Cellular,membrane depolarization,GO:0051899,,,increased duration,PATO:0000498,neuron,CL:0000540,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1238,Oxidation of biomolecules,"Lipid membranes, proteins, DNA",Molecular,oxidation-reduction process,GO:0055114,plasma membrane,GO:0005886,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1238,Oxidation of biomolecules,"Lipid membranes, proteins, DNA",Molecular,oxidation-reduction process,GO:0055114,protein,PR:000000001,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1238,Oxidation of biomolecules,"Lipid membranes, proteins, DNA",Molecular,oxidation-reduction process,GO:0055114,DNA,CHEBI:16991,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1223,Trigeminal and/or vagal nerve excitation,"Airway Hyper-responsiveness,Cough, Dyspnea",Tissue,reflex,GO:0060004,trigeminal nerve,UBERON:0001645,increased process quality,PATO:0002304,,,respiratory tract,UBERON:0000065
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1434,Irritation of nasal mucosa inducing sneeze reflex,,Tissue,reflex,GO:0060004,sneezing,D012912,increased process quality,PATO:0002304,,,nasal cavity respiratory epithelium,UBERON:0005385
Aop:4,Ecdysone receptor agonism leading to mortality,Event:1268,Excitatory postsynaptic potential,Reduction,Tissue,excitatory postsynaptic potential,GO:0060079,,,decreased process quality,PATO:0002302,,,brain,UBERON:0000955
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:682,Amplified excitatory postsynaptic potential (EPSP),Generation,Tissue,excitatory postsynaptic potential,GO:0060079,,,occurrence,PATO:0000057,,,brain,UBERON:0000955
Aop:160,Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,Event:1012,Inhibitory postsynaptic potential,Increased,Cellular,inhibitory postsynaptic potential,GO:0060080,,,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:161,Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,Event:1012,Inhibitory postsynaptic potential,Increased,Cellular,inhibitory postsynaptic potential,GO:0060080,,,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:763,neuron,hyperpolarisation,Cellular,membrane hyperpolarization,GO:0060081,,,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1075,estrus,prolonged,Individual,estrus ,GO:0060209,,,delayed,PATO:0000502,,,,
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1075,estrus,prolonged,Individual,estrus ,GO:0060209,,,delayed,PATO:0000502,,,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:919,Transdifferentiation of ciliated epithelial cells,Increase,Cellular,transdifferentiation ,GO:0060290,ciliated epithelial cell,CL:0000067,occurrence,PATO:0000057,ciliated epithelial cell,CL:0000067,,
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:166,Long-term potentiation (LTP),Decreased,Organ,long-term synaptic potentiation,GO:0060291,,,decreased process quality,PATO:0002302,,,nervous system,UBERON:0001016
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:81,Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:85,Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:88,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:180,Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:182,Weather event contributes abnormal foraging leading to colony loss/failure,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:183,Nosema infection increases energetic demands leading to colony loss/failure,Event:560,Foraging activity and behavior,Abnormal,Individual,foraging behavior,GO:0060756,,,deviation(from_normal),PATO:0000069,,,,
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,Event:413,Testosterone synthesis in Leydig cells,Reduction,Cellular,testosterone biosynthetic process,GO:0061370,testosterone,CHEBI:17347,decreased process quality,PATO:0002302,testosterone secreting cell ,CL:0000177,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:274,Testosterone synthesis by ovarian theca cells,Reduction,Cellular,testosterone biosynthetic process,GO:0061370,testosterone,CHEBI:17347,decreased process quality,PATO:0002302,theca cell,CL:0000503,,
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:413,Testosterone synthesis in Leydig cells,Reduction,Cellular,testosterone biosynthetic process,GO:0061370,testosterone,CHEBI:17347,decreased process quality,PATO:0002305,testosterone secreting cell ,CL:0000177,,
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:413,Testosterone synthesis in Leydig cells,Reduction,Cellular,testosterone biosynthetic process,GO:0061370,testosterone,CHEBI:17347,decreased process quality,PATO:0002302,Leydig cell,CL:0000178,,
Aop:69,Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell,Event:645,Decreased Testosterone Production by Adult Leydig Cells,Decreased Cholesterol,Cellular,testosterone biosynthetic process,GO:0061370,testosterone,CHEBI:17347,decreased process quality,PATO:0002302,Leydig cell,CL:0000178,,
Aop:120,Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat),Event:792,Bioactivation of testosterone,Decrease,Tissue,testosterone biosynthetic process,GO:0061370,testosterone,CHEBI:17347,decreased concentration,PATO:0001163,,,blood,UBERON:0000178
Aop:202,In-utero DNA topoisomerase II poisons leading to infant leukaemia,Event:1252,In-utero DNA topoisomerase II ??poisons-,,Molecular,DNA topoisomerase II activity,GO:0061505,,,abnormal,PATO:0000460,eukaryotic cell,CL:0000255,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:383,Presynaptic release of glutamate,Reduced,Molecular,"glutamate secretion, neurotransmission",GO:0061535,Glutamate,CHEBI:14321,decreased process quality,PATO:0002302,neuron,CL:0000540,,
Aop:34,LXR activation leading to hepatic steatosis,Event:176,Mitochondria,Damaging,Cellular,mitochondrion disassembly,GO:0061726,mitochondrion,GO:0005739,damage,PATO:0001020,hepatocyte,CL:0000182,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:176,Mitochondria,Damaging,Cellular,mitochondrion disassembly,GO:0061726,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:148,EGFR Activation Leading to Decreased Lung Function,Event:1251,"Chronic, Mucus hypersecretion","Chronic, Mucus hypersecretion",Tissue,mucus secretion,GO:0070254,,,occurrence,PATO:0000057,,,lung,UBERON:0002048
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:868,"Tissue Degeneration, Necrosis & Atrophy",Increase,Tissue,necrotic cell death,GO:0070265,,,increased process quality,PATO:0002304,,,olfactory organ,UBERON:0002268
AOP:205,AOP from chemical insult to cell death,Event:1263,Necrosis,,Tissue,necrotic cell death,GO:0070265,,,increased process quality        ,PATO:0002304,,,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:821,Sodium reabsorption,Decreased,Organ,renal absorption,GO:0070293,sodium(1+),CHEBI:29101,decreased process quality,PATO:0002302,,,kidney,UBERON:0002113
Aop:7,Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female,Event:408,Aromatase (Cyp19a1),reduction in ovarian granulosa cells,Cellular,aromatase activity,GO:0070330,cytochrome P450 19A1,PR:000006100,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:36,Aromatase,Inhibition,Molecular,aromatase activity,GO:0070330,cytochrome P450 19A1,PR:000006100,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:800,Aromatase (Cyp19a1) mRNA,Decreased,Cellular,aromatase activity,GO:0070330,aromatase isoform 1,PR:000038849,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:800,Aromatase (Cyp19a1) mRNA,Decreased,Cellular,aromatase activity,GO:0070330,cytochrome P450 19A1,PR:000006100,decreased process quality,PATO:0002302,granulosa cell,CL:0000501,,
Aop:170,Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat,Event:1084,prolactin secretion,Increased,Tissue,prolactin secretion,GO:0070459,prolactin,PR:000013246,increased process quality,PATO:0002304,,,,
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:678,Pheromone release,Reduced,Individual,mating pheromone secretion,GO:0071834,pheromone,CHEBI:26013,decreased process quality,PATO:0002302,,,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:317,Cardiovascular development/function,Altered,Organ,cardiovascular system development,GO:0072358,cardiovascular system,UBERON:0004535,deviation(from_normal),PATO:0000069,,,Heart,UBERON:0000948
Aop:32,"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",Event:269,Sustained Cell Proliferation,Induction,Cellular,hepatocyte proliferation,GO:0072574,,,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:46,AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC),Event:491,to form Altered Hepatic Foci (AHF),Clonal Expansion/Cell Proliferation,Organ,hepatocyte proliferation,GO:0072574,Hepatocyte,CL:0000182,increased process quality,PATO:0002304,,,liver,UBERON:0002107
Aop:117,Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:716,Mitogenic cell proliferation (hepatocytes),Increase,Cellular,hepatocyte proliferation,GO:0072574,hepatocyte,CL:0000182,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation,Event:619,reuptake of 5-HT (5-hydroxytryptamine transporter; sodium-dependent serotonin transporter,Inhibition,Molecular,neurotransmitter reuptake,GO:0098810,sodium-dependent serotonin transporter,PR:000015189,decreased process quality,PATO:0002302,motor neuron,CL:0000100,,
Aop:195,5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,Event:619,reuptake of 5-HT (5-hydroxytryptamine transporter; sodium-dependent serotonin transporter,Inhibition,Molecular,neurotransmitter reuptake,GO:0098810,sodium-dependent serotonin transporter,PR:000015189,decreased process quality,PATO:0002302,motor neuron,CL:0000100,,
Aop:13,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,Event:386,Neuronal network function,Decreased,Organ,synaptic signaling,GO:0099536,,,decreased process quality,PATO:0002302,,,brain,UBERON:0000955
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:618,Neuronal network function in adult brain,Decreased,Organ,synaptic signaling,GO:0099536,,,decreased process quality,PATO:0002302,,,brain,UBERON:0000955
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:386,Neuronal network function,Decreased,Organ,synaptic signaling,GO:0099536,,,decreased process quality,PATO:0002302,,,brain,UBERON:0000955
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:386,Neuronal network function,Decreased,Organ,synaptic signaling,GO:0099536,,,decreased process quality,PATO:0002302,,,brain,UBERON:0000955
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:386,Neuronal network function,Decreased,Organ,synaptic signaling,GO:0099536,,,decreased process quality,PATO:0002302,,,brain,UBERON:0000955
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:695,Spindle assembly checkpoint protein Mad2-oocyte,Upregulated,Molecular,deactivation of mitotic spindle assembly checkpoint,GO:1902426,MAD2 like protein (fruit fly),PR:Q9VNE1,increased process quality,PATO:0002304,ooctye,CL:0000023,,
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:761,Chloride conductance,Increased,Cellular,chloride transmembrane transport,GO:1902476,Chloride ion,CHEBI:17996,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:160,Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,Event:761,Chloride conductance,Increased,Cellular,chloride transmembrane transport,GO:1902476,Chloride ion,CHEBI:17996,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:161,Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,Event:761,Chloride conductance,Increased,Cellular,chloride transmembrane transport,GO:1902476,Chloride ion,CHEBI:17996,increased process quality,PATO:0002304,neuron,CL:0000540,,
Aop:144,Lysosomal damage leading to liver inflammation,Event:898,Lysosome,Disruption,Cellular,organelle disassembly,GO:1903008,lysosome,GO:0005764,occurrence,PATO:0000057,eukaryotic cell,CL:0000255,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:935,GTPCH-1,Decrease,Cellular,proteasome complex disassembly,GO:1903009,GTP cyclohydrolase 1,PR:000007893,decreased object quality,PATO:0002303,vascular endothelial cell,CL:0002139,,
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:257,ROS production,Increased,Cellular,reactive oxygen species biosynthetic process,GO:1903409,reactive oxygen species,CHEBI:26523,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:249,Reactive oxygen species,Production,Tissue,reactive oxygen species biosynthetic process,GO:1903409,reactive oxygen species,CHEBI:26523,increased process quality,PATO:0002304,,,,
Aop:148,EGFR Activation Leading to Mucus Hypersecretion,Event:914,Apoptosis of ciliated epithelial cells,Decrease,Cellular,epithelial cell apoptotic process,GO:1904019,,,decreased process quality,PATO:0002302,ciliated epithelial cell,CL:0000067,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1132,"Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal",Blood loss and development of anemia,Cellular,cellular detoxification,GO:1990748,,,deviation(from_normal),PATO:0000069,eukaryotic cell,CL:0000255,,
Aop:34,LXR activation leading to hepatic steatosis,Event:115,FA Influx,Increase,Cellular,positive regulation of fatty acid transport,GO:2000193,fatty acid,CHEBI:35366,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1235,Epithelial irritation,Non-neuronal production of IL-8/CXCL1,Tissue,regulation of chemokine (C-X-C motif) ligand 1 production,GO:2000338,growth-regulated alpha protein,PR:000006063,increased process quality,PATO:0002304,,,,
Aop:53,ER agonism leading to reduced survival due to renal failure,Event:422,nephropathy,Increased,Individual,Nephropathy,HP:0000112,,,increased process quality,PATO:0002304,,,,
Aop:32,"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",Event:164,Liver ??Dysfunctional??Changes by CGA 330050,Induction,Organ,Decreased liver function,HP:0001410,,,decreased process quality,PATO:0002302,,,liver,UBERON:0002107
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:838,Microvesicular fat,Induction,Tissue,Microvesicular hepatic steatosis  ,HP:0001414,,,increased process quality,PATO:0002304,,,,
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1082,adenomas (pituitary),Increased,Tissue,Pituitary adenoma,HP:0002893,adenoma,D000236,increased object quality,PATO:0002305,,,pituitary gland,UBERON:0000007
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:657,Dysgenesis of fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Organ,Testicular dysgenesis,HP:0008715,,,increased object quality,PATO:0002305,,,testis,UBERON:0000473
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:660,Dysgenesis of fetal Leydig cells,decreased testosterone by fetal Leydig cells,Organ,Testicular dysgenesis,HP:0008715,,,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:660,Dysgenesis of fetal Leydig cells,decreased testosterone by fetal Leydig cells,Organ,Testicular dysgenesis,HP:0008715,,,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:540,Dysgensis of fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Organ,Testicular dysgenesis,HP:0008715,,,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:39,Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins,Event:75,"Covalent binding to protein, possibly lysine residue",N/A,Molecular,covalent binding,MI:0195,xenobiotic,CHEBI:35703,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:154,The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression,Event:979,Interference of NFAT complex formation at the site of nuclear cytokine promoters,Inhibition,Molecular,genetic interference,MI:0254,NFAT protein,PR:000003112,increased process quality,PATO:0002304,,,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:825,Renal ability to dilute urine,Decreased,Organ,function,MI:0613,kidney,UBERON:0002113,decreased process quality,PATO:0002302,,,,
AOP:205,AOP from chemical insult to cell death,Event:1260,Direct mitochondrial inhibition,,Molecular,function,MI:0613,mitochondrion,GO:0005739,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1131,"Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)","Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X",Molecular,carboxylation reaction,MI:1139,prothrombin,PR:000007299,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1131,"Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)","Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X",Molecular,carboxylation reaction,MI:1139,coagulation factor VII (mouse),PR:P70375,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1131,"Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)","Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X",Molecular,carboxylation reaction,MI:1139,coagulation factor IX (mouse),PR:P16294,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1131,"Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)","Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X",Molecular,carboxylation reaction,MI:1139,coagulation factor X (mouse),PR:O88947,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1169,Impairment of post-translational modification (carboxylation) of osteocalcin,Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone,Molecular,carboxylation reaction,MI:1139,matrix Gla protein (mouse),PR:P19788,decreased process quality,PATO:0002302,eukaryotic cell,CL:0000255,,
Aop:32,"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",Event:270,Sustained Hepatotoxicity,Induction,Individual,hepatotoxicity,MI:2141,,,increased process quality,PATO:0002304,,,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1291,Hepatotoxicity,,cellular,hepatotoxicity,MI:2141,,,increased process quality        ,PATO:0002304,,,,
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:319,Cochlear function,Loss,Organ,cochlear degeneration,MP:0000032,,,increased object quality,PATO:0002305,,,ear,UBERON:0001690
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1151,Bone deterioration,Osteoporosis and vascular calcification,Individual,osteoporosis,MP:0000066,,,increased object quality,PATO:0002305,,,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:952,Hypertension,N/A,Individual,hypertension,MP:0000231,,,increased object quality,PATO:0002305,,,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1078,Mammary gland,Hyperplasia,Tissue,mammary gland hyperplasia,MP:0000630,,,increased process quality,PATO:0002304,,,mammary gland,UBERON:0001911
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:39,"Ataxia, paralysis, or hyperactivity",Induction,Organ,paralysis,MP:0000753,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:602,"Ataxia, paralysis, or hyperactivity",Increased,Organ,paralysis,MP:0000753,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:764,"Ataxia, paralysis, or hyperactivity",N/A,Organ,paralysis,MP:0000753,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:160,Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,Event:1014,Somatic muscle paralysis,Induction,Tissue,paralysis,MP:0000753,,,increased object quality,PATO:0002305,,,somatic muscle,UBERON:0014895
Aop:161,Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,Event:1019,pharyngeal muscle paralysis,Induction,Tissue,paralysis,MP:0000753,,,increased object quality,PATO:0002305,,,pharyngeal muscle,UBERON:0000933
Aop:111,Decrease in androgen receptor activity leading to Leydig cell tumors (in rat),Event:744,Hyperplasia (Leydig cells),Increase,Cellular,Leydig cell hyperplasia,MP:0001152,Leydig cell,CL:0000178,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:120,Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat),Event:744,Hyperplasia (Leydig cells),Increase,Cellular,Leydig cell hyperplasia,MP:0001152,Leydig cell,CL:0000178,increased process quality,PATO:0002304,Leydig cell,CL:0000178,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1224,Epithelial irritation,Non-neuronal production of TNF,Individual,dermatitis,MP:0001194,,,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1234,Epithelial irritation,Production of nerve growth factor,Tissue,dermatitis,MP:0001194,,,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1235,Epithelial irritation,Non-neuronal production of IL-8/CXCL1,Tissue,dermatitis,MP:0001194,,,increased process quality,PATO:0002304,,,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:864,Body Weight,Decreased,Individual,weight loss,MP:0001263,,,decreased object quality ,PATO:0002303,,,,
Aop:82,Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure,Event:565,Brood care,Reduced,Population,abnormal maternal nurturing,MP:0001386,,,decreased quality,PATO:0002301,,,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:565,Brood care,Reduced,Population,abnormal maternal nurturing,MP:0001386,,,decreased quality,PATO:0002301,,,,
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:39,"Ataxia, paralysis, or hyperactivity",Induction,Organ,ataxia,MP:0001393,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:602,"Ataxia, paralysis, or hyperactivity",Increased,Organ,ataxia,MP:0001393,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:764,"Ataxia, paralysis, or hyperactivity",N/A,Organ,ataxia,MP:0001393,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:39,"Ataxia, paralysis, or hyperactivity",Induction,Organ,hyperactivity,MP:0001399,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:96,Axonal sodium channel modulation leading to acute mortality,Event:602,"Ataxia, paralysis, or hyperactivity",Increased,Organ,hyperactivity,MP:0001399,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:764,"Ataxia, paralysis, or hyperactivity",N/A,Organ,hyperactivity,MP:0001399,,,increased object quality,PATO:0002305,,,skeletal muscle tissue,UBERON:0001134
Aop:21,Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality,Event:317,"Altered, Cardiovascular development/function","Altered, Cardiovascular development/function",Organ,abnormal cardiovascular system physiology,MP:0001544,,,deformed,PATO:0001617,,,Heart,UBERON:0000948
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:317,Cardiovascular development/function,Altered,Organ,abnormal cardiovascular system physiology,MP:0001544,,,deformed,PATO:0001617,,,Heart,UBERON:0000948
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1132,"Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal",Blood loss and development of anemia,Cellular,anemia,MP:0001577,,,occurrence,PATO:0000057,erythrocyte,CL:0000232,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,Event:1139,"Increased, water retention in foot","Increased, water retention in foot",Organ,edema,MP:0001785,foot,FO,increased process quality,PATO:0002305,,,,
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:358,Pericardial edema,Increase,Organ,pericardial edema,MP:0001787,,,increased object quality,PATO:0002305,,,Heart,UBERON:0000948
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,microglial  cell,CL:0000129,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,astrocyte,CL:0000127,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,astrocyte,CL:0000127,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,microglial  cell,CL:0000129,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,astrocyte,CL:0000127,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,microglial  cell,CL:0000129,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,astrocyte,CL:0000127,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,microglial  cell,CL:0000129,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:188,Neuroinflammation,N/A,Tissue,brain inflammation,MP:0001847,astrocyte,CL:0000127,pathological,PATO:0001869,,,brain,UBERON:0000955
Aop:144,Lysosomal damage leading to liver inflammation,Event:902,Liver,Inflammation,Organ,liver inflammation,MP:0001860,,,occurrence,PATO:0000057,,,liver,UBERON:0002107
Aop:53,ER agonism leading to reduced survival due to renal failure,Event:421,glomerular rupture and renal hemorrhaging,Increased,Organ,hemorrhage,MP:0001914,,,increased process quality,PATO:0002304,,,kidney,UBERON:0002113
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1130,Unresolved blood loss (hemorrhage),Failure in vascular repair mechanisms,Organ,hemorrhage,MP:0001914,,,increased process quality,PATO:0002304,,,vascular system,UBERON:0007798
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:527,Decreased fecundity,Decreased,Individual,reduced fertility,MP:0001921,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:532,Ovulation,Delayed,Individual,abnormal ovulation,MP:0001928,,,delayed,PATO:0000502,,,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:532,Ovulation,Delayed,Individual,abnormal ovulation,MP:0001928,,,delayed,PATO:0000502,,,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1074,Ovulation,interruption,Individual,abnormal ovulation,MP:0001928,,,disrupted,PATO:0001507,,,,
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1074,Ovulation,interruption,Individual,abnormal ovulation,MP:0001928,,,disrupted,PATO:0001507,,,,
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:445,Respiratory distress/arrest,Increased,Organ,respiratory distress,MP:0001954,,,increased object quality,PATO:0002305,,,respiration organ,UBERON:0000171
Aop:94,Sodium channel inhibition leading to congenital malformations,Event:445,Respiratory distress/arrest,Increased,Organ,respiratory distress,MP:0001954,,,increased object quality,PATO:0002305,,,respiration organ,UBERON:0000171
Aop:111,Decrease in androgen receptor activity leading to Leydig cell tumors (in rat),Event:745,Leydig cell tumors,Increase,Cellular,neoplasm,MP:0002006,,,increased object quality,PATO:0002305,Leydig cell,CL:0000178,,
Aop:120,Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat),Event:745,Leydig cell tumors,Increase,Cellular,neoplasm,MP:0002006,,,increased object quality,PATO:0002305,Leydig cell,CL:0000178,,
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:872,Site of Contact Nasal Tumors,Increase,Organ,neoplasm,MP:0002006,olfactory segment of nasal mucosa,UBERON:0005386,increased object quality,PATO:0002305,,,olfactory organ,UBERON:0002268
Aop:107,Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:774,Preneoplastic foci (hepatocytes),Increase,Cellular,preneoplasia,MP:0002009,abnormal cell mass,MP:0003902,increased object quality,PATO:0002305,hepatocyte,CL:0000182,,
Aop:117,Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:774,Preneoplastic foci (hepatocytes),Increase,Cellular,preneoplasia,MP:0002009,abnormal cell mass,MP:0003902,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:118,Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:774,Preneoplastic foci (hepatocytes),Increase,Cellular,preneoplasia,MP:0002009,abnormal cell mass,MP:0003902,increased process quality,PATO:0002304,hepatocyte,CL:0000182,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:862,Circulating Ketone Bodies,Not Increased,Tissue,abnormal lipid homeostasis,MP:0002118,,,deviation(from_normal),PATO:0000069,,,blood,UBERON:0000178
Aop:12,Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging,Event:352,Neurodegeneration,N/A,Tissue,neurodegeneration,MP:0002229,,,increased process quality,PATO:0002304,,,brain,UBERON:0000955
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:352,Neurodegeneration,N/A,Tissue,neurodegeneration,MP:0002229,,,increased process quality,PATO:0002304,,,brain,UBERON:0000955
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:352,Neurodegeneration,N/A,Tissue,neurodegeneration,MP:0002229,,,increased process quality,PATO:0002304,,,brain,UBERON:0000955
Aop:84,Suppression of immune system contributes to impaired development and leads to colony loss/failure,Event:576,Viral susceptibility,Increased,Individual,increased susceptibility to viral infection,MP:0002418,,,increased process quality,PATO:0002304,,,,
Aop:85,Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure,Event:576,Viral susceptibility,Increased,Individual,increased susceptibility to viral infection,MP:0002418,,,increased process quality,PATO:0002304,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1225,Tissue irritation/inflammation,Leukocyte infiltration,Tissue,abnormal acute inflammation,MP:0002498,,,increased process quality,PATO:0002304,,,,
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:851,GABAergic interneurons morphology and function,Altered,Cellular,abnormal neuron morphology,MP:0002882,,,deviation(from_normal),PATO:0000069,GABAergic interneuron,CL:0011005,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1135,"Acidosis, hypovolemic shock and organ dysfunction",Reduced fitness or even mortality,Tissue,acidosis,MP:0003031,,,increased process quality,PATO:0002304,,,,
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:890,Degeneration of dopaminergic neurons of the nigrostriatal pathway,Increased,Organ,loss of dopaminergic neurons,MP:0003244,,,increased process quality,PATO:0002304,,,brain,UBERON:0000956
Aop:38,Protein Alkylation leading to Liver Fibrosis,Event:344,Liver fibrosis,N/A,Organ,liver fibrosis,MP:0003333,liver,UBERON:0002107,occurrence,PATO:0000057,,,liver,UBERON:0002107
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:840,Liver fibrosis,Formation,Tissue,liver fibrosis,MP:0003333,liver,UBERON:0002107,occurrence,PATO:0000057,,,liver,UBERON:0002107
Aop:33,Kidney toxicity induced by activation of 5HT2C,Event:759,Kidney Failure,Increased,Individual,kidney failure,MP:0003606,,,increased process quality,PATO:0002304,,,,
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:192,Neurophysiology,Altered,Organ,abnormal nervous system physiology,MP:0003633,,,deviation(from_normal),PATO:0000069,,,brain,UBERON:0000955
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:210,Oxidative stress,N/A,Cellular,oxidative stress,MP:0003674,,,occurrence,PATO:0000057,eukaryotic cell,CL:0000255,,
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:209,Oxidative Stress,Increase,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:211,Oxidative stress,Propagation,Molecular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:108,Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:209,Oxidative Stress,Increase,Cellular,oxidative stress,MP:0003674,,,increased object quality,PATO:0002305,,,,
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:1088,"Increased, Oxidative Stress","Increased, Oxidative Stress",Cellular,oxidative stress,MP:0003674,,,increased object quality,PATO:0002305,eukaryotic cell,CL:0000255,,
Aop:144,Lysosomal damage leading to liver inflammation,Event:209,Oxidative Stress,Increase,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:209,Oxidative Stress,Increase,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:171,Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.,Event:1088,Oxidative Stress,Increased,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,,,,
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1088,Oxidative Stress,Increased,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:186,unknown MIE leading to renal failure and mortality,Event:1088,Oxidative Stress,Increased,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1088,Oxidative Stress,Increased,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:207,NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans : Case study on silver nanoparticle,Event:1279,"Oxidative Stress / Activation, PMK-1 P38 MAPK",Increase,Cellular,oxidative stress,MP:0003674,,,increased process quality,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:210,Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building ,Event:209,Oxidative Stress,Increase,Cellular,oxidative stress,MP:0003674,,,increased process quality        ,PATO:0002304,eukaryotic cell,CL:0000255,,
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:356,Oxidative damage,Increased,Individual,oxidative stress,MP:0003674 ,,,increased process quality,PATO:0002304,,,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:536,Chromosome number (polyploid) zygote,Altered,Cellular,abnormal chromosome number,MP:0004023,,,increased object quality,PATO:0002305,zygote,CL:0000365,,
Aop:106,Chemical binding to tubulin in oocytes leading to aneuploid offspring,Event:723,Chromosome number,Altered,Cellular,abnormal chromosome number,MP:0004023,,,increased object quality,PATO:0002305,female germ cell,CL:0000021,,
Aop:106,Chemical binding to tubulin in oocytes leading to aneuploid offspring,Event:728,Aneuploid offspring,Increase,Individual,abnormal chromosome number,MP:0004023,,,increased object quality,PATO:0002305,,,,
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:536,Chromosome number (polyploid) zygote,Altered,Cellular,abnormal chromosome number,MP:0004023,,,increased object quality,PATO:0002305,zygote,CL:0000365,,
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:1097,"Occurrence, renal proximal tubular necrosis","Occurrence, renal proximal tubular necrosis",Tissue,renal tubular necrosis,MP:0004154,,,occurrence,PATO:0000057,,,proximal tubule,UBERON:0004134
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1097,renal proximal tubular necrosis,Occurrence,Tissue,renal tubular necrosis,MP:0004154,,,occurrence,PATO:0000057,,,proximal tubule,UBERON:0004134
Aop:186,unknown MIE leading to renal failure and mortality,Event:1097,renal proximal tubular necrosis,Occurrence,Tissue,renal tubular necrosis,MP:0004154,,,occurrence,PATO:0000057,,,proximal tubule,UBERON:0004134
Aop:149,Oxidative Stress Leading to Hypertension,Event:951,Vascular Resistance,Increase,Organ,increased systemic vascular resistance,MP:0004878,,,increased object quality,PATO:0002305,,,circulatory system,UBERON:0001009
Aop:81,Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure,Event:573,Energetic demands and therefore metabolic stress,Increase,Individual,increased energy expenditure,MP:0004889,,,increased process quality,PATO:0002304,,,,
Aop:183,Nosema infection increases energetic demands leading to colony loss/failure,Event:1110,Energetic demands and therefore metabolic stress,Increased,Individual,increased energy expenditure,MP:0004889,,,increased process quality,PATO:0002304,,,,
Aop:116,Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:784,Hyperplasia (tubular epithelial cells),Increase,Cellular,kidney epithelium hyperplasia,MP:0004968,nephron tubule epithelial cell,CL:1000494,increased process quality,PATO:0002304,nephron tubule epithelial cell,CL:1000494,,
Aop:94,Sodium channel inhibition leading to congenital malformations,Event:590,hypoxia,N/A,Tissue,hypoxia,MP:0005039,,,decreased process quality,PATO:0002302,,,,
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:753,Thyroid-stimulating hormone (TSH),Increase,Tissue,increased thyroid-stimulating hormone level,MP:0005135,thyroid stimulating hormone,CHEBI:81567 ,increased concentration,PATO:0001162,,,serum,UBERON:0001977
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:813,Serum creatinine,Increased,Organ,abnormal amino acid level,MP:0005332,,,increased process quality,PATO:0002304,,,serum,UBERON:0001977
Aop:115,Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat),Event:782,Hyperplasia (forestomach epithelial cells),Increase,Cellular,stomach epithelial hyperplasia,MP:0005493,epithelial cell,CL:0000066,increased process quality,PATO:0002304,,,murine forestomach,UBERON:0008827
Aop:131,AhR activation leading to uroporphyria,Event:369,Uroporphyria,N/A,Individual,porphyria,MP:0005654,,,increased object quality,PATO:0002305,,,,
Aop:206,Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis,Event: 1276,Lung fibrosis,,Organ,pulmonary fibrosis,MP:0006050,,,occurrence,PATO:0000057,,,lung,UBERON:0002048
Aop:150,Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty,Event:947,Embryolethality,Increase,Individual,embryonic lethality,MP:0008762,,,increased object quality,PATO:0002305,,,,
Aop:112,Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat),Event:772,Hyperplasia (glandular epithelial cells of endometrium),Increase,Cellular,endometrium hyperplasia,MP:0009092,glandular cell of endometrium,CL:0002656,increased process quality,PATO:0002304,glandular cell of endometrium,CL:0002656,,
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:246,RBC congestion in liver,Increase,Organ,liver vascular congestion,MP:0010019,,,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1135,"Acidosis, hypovolemic shock and organ dysfunction",Reduced fitness or even mortality,Tissue,hypovolemia ,MP:0010128,,,increased process quality,PATO:0002304,,,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1080,latency period,Increased,Individual,abnormal tumor latency,MP:0010307,,,increased process quality,PATO:0002304,,,,
Aop:170,Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat,Event:1080,latency period,Increased,Individual,abnormal tumor latency,MP:0010307,,,increased process quality,PATO:0002304,,,,
Aop:121,Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat),Event:793,Urinary bladder calculi,Increase,Organ,cystolithiasis,MP:0011625,Calculi,D002137,increased object quality,PATO:0002305,urinary bladder,UBERON:0001255,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:824,Cytoplasmic vacuolization (podocyte),Occurrence,Organ,podocyte vacuolization,MP:0011899,,,occurrence,PATO:0000057,,,kidney,UBERON:0002113
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:657,Dysgenesis of fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Organ,abnormal fetal Leydig cell differentiation,MP:0013603,,,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:660,Dysgenesis of fetal Leydig cells,decreased testosterone by fetal Leydig cells,Organ,abnormal fetal Leydig cell differentiation,MP:0013603,,,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:660,Dysgenesis of fetal Leydig cells,decreased testosterone by fetal Leydig cells,Organ,abnormal fetal Leydig cell differentiation,MP:0013603,,,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:540,Dysgensis of fetal Leydig cells,Decreased testosterone by the fetal Leydig cells,Organ,abnormal fetal Leydig cell differentiation,MP:0013603,,,increased process quality,PATO:0002304,,,testis,UBERON:0000473
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:656,Decreased COUP-TFII stem Leydig cells,Decreased number and function of adult Leydig cells,Cellular,abnormal adult Leydig cell differentiation,MP:0013604,,,increased process quality,PATO:0002304,Leydig cell ,CL:0000178,,
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:656,Decreased COUP-TFII stem Leydig cells,Decreased number and function of adult Leydig cells,Cellular,abnormal adult Leydig cell differentiation,MP:0013604,,,increased process quality,PATO:0002304,Leydig cell ,CL:0000178,,
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:656,Decreased COUP-TFII stem Leydig cells,Decreased number and function of adult Leydig cells,Cellular,abnormal adult Leydig cell differentiation,MP:0013604,,,increased process quality,PATO:0002304,Leydig cell ,CL:0000178,,
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:541,Decreased COUP-TFII stem Leydig cells,Decreased testosterone by the fetal Leydig cells,Cellular,abnormal adult Leydig cell differentiation,MP:0013604,,,increased process quality,PATO:0002304,Leydig cell ,CL:0000178,,
Aop:98,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation,Event:629,sheltering,Decreased,Individual,abnormal sheltering behavior,MP:0014039,,,decreased object quality,PATO:0002303,,,,
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:839,Mallory body,Formation,Cellular,Mallory bodies,MP:0014045,,,occurrence,PATO:0000057,,,,
Aop:98,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation,Event:627,anxiety,Decreased,Individual,fear/anxiety related behavior,NBO:0000018,,,decreased process quality,PATO:0002302,,,,
Aop:10,Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures,Event:613,Epileptic seizure,Occurrence,Individual,seizures,NBO:0000025,,,occurrence,PATO:0000057,,,,
Aop:79,Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure,Event:568,Hive thermoregulation,impaired,Population,thermoregulation behavior,NBO:0000051,,,deviation(from_normal),PATO:0000069,,,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:568,Hive thermoregulation,impaired,Population,thermoregulation behavior,NBO:0000051,,,deviation(from_normal),PATO:0000069,,,,
Aop:84,Suppression of immune system contributes to impaired development and leads to colony loss/failure,Event:568,Hive thermoregulation,impaired,Population,thermoregulation behavior,NBO:0000051,,,deviation(from_normal),PATO:0000069,,,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation,Event:624,burrowing,Increased,Individual,fossorial locomotion behavior,NBO:0000071,,,increased process quality,PATO:0002304,,,,
Aop:86,Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,Event:561,Food storage,Reduced,Population,feeding behavior,NBO:0000079,,,decreased process quality,PATO:0002302,,,,
Aop:91,Sodium channel inhibition leading to reduced survival,Event:587,feeding,Reduced,Individual,feeding behavior,NBO:0000079,,,decreased process quality,PATO:0002302,,,,
Aop:95,Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival,Event:587,feeding,Reduced,Individual,feeding behavior,NBO:0000079,,,decreased process quality,PATO:0002302,,,,
Aop:160,Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,Event:1016,Feeding,Inhibition,Individual,feeding behavior,NBO:0000079,,,decreased process quality,PATO:0002302,,,,
Aop:161,Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,Event:1016,Feeding,Inhibition,Individual,feeding behavior,NBO:0000079,,,decreased process quality,PATO:0002302,,,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:674,Ability to attract spawning mates,Reduced,Individual,attraction-related behavior,NBO:0000280,,,decreased process quality,PATO:0002302,,,,
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:674,Ability to attract spawning mates,Reduced,Individual,attraction-related behavior,NBO:0000280,,,decreased process quality,PATO:0002302,,,,
Aop:91,Sodium channel inhibition leading to reduced survival,Event:586,swimming speed,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased speed,PATO:0000304,,,,
Aop:93,sodium channel inhibition leading to increased predation,Event:586,swimming speed,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased process quality,PATO:0002302,,,,
Aop:95,Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival,Event:586,swimming speed,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased process quality,PATO:0002302,,,,
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1005,Swimming performance,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased process quality,PATO:0002302,,,,
Aop:156,Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1005,Swimming performance,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased process quality,PATO:0002302,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1005,Swimming performance,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased process quality,PATO:0002302,,,,
Aop:158,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1005,Swimming performance,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased process quality,PATO:0002302,,,,
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1005,Swimming performance,Reduced,Individual,aquatic locomotion,NBO:0000371,,,decreased process quality,PATO:0002302,,,,
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:442,Population trajectory,Decreased,Individual,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:63,Cyclooxygenase inhibition leading to reproductive dysfunction,Event:686,Population trajectory,Declining,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:97,5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,Event:361,"Decline, Population","Decline, Population",Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:360,Population trajectory,Decrease,Individual,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:679,Population trajectory,Decline,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:679,Population trajectory,Decline,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:686,Population trajectory,Declining,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:360,Population trajectory,Decrease,Individual,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:361,"Decline, Population","Decline, Population",Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:156,Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:158,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:360,Population trajectory,Decrease,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:361,Population,Decline,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1136,Population trajectory,Impaired recruitment,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:201,Juvenile hormone receptor agonism leading to male offspring induction associated population decline,Event:361,Population,Decline,Population,population growth rate,PCO:0000008,,,decreased rate,PATO:0000911,,,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:814,Kidney toxicity,Occurrence,Organ,toxicity,Q000633,kidney,UBERON:0002113,occurrence,PATO:0000057,,,kidney,UBERON:0002113
Aop:148,EGFR Activation Leading to Decreased Lung Function,Event:1250,"Decrease, Lung function","Decrease, Lung function",Individual,respiratory function,VT:0002327,,,decreased object quality,PATO:0002303,,,,
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:520,Decreased fertility,Decreased sperm quantity or quality in the adult,Individual,sperm quantity,VT:0002673,,,decreased object quality,PATO:0002303,,,,
Aop:91,Sodium channel inhibition leading to reduced survival,Event:592,survival,Reduced,Population,life span trait,VT:0005372,,,decreased object quality,PATO:0002303,,,,
Aop:95,Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival,Event:592,survival,Reduced,Population,life span trait,VT:0005372,,,decreased object quality,PATO:0002303,,,,
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:636,survival,Decreased,Population,life span trait,VT:0005372,,,decreased object quality,PATO:0002303,,,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:820,Renal plasma flow,Decreased,Tissue,kidney plasma flow trait,VT:0005524,,,decreased process quality,PATO:0002302,,,kidney,UBERON:0002113
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1135,"Acidosis, hypovolemic shock and organ dysfunction",Reduced fitness or even mortality,Tissue,wellness/fitness trait,VT:1000152,,,decreased object quality,PATO:0002303,,,,
Aop:201,Juvenile hormone receptor agonism leading to male offspring induction associated population decline,Event:1208,Male offspring,Increased,Population,offspring quantity,VT:1000189,,,increased object quality,PATO:0002305,,,,
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:78,Cumulative fecundity and spawning,Reduction,Individual,egg quantity,VT:1000294,,,decreased amount,PATO:0001997,,,,
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:78,Cumulative fecundity and spawning,Reduction,Individual,egg quantity,VT:1000294,,,decreased amount,PATO:0001997,,,,
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:78,Cumulative fecundity and spawning,Reduction,Individual,egg quantity,VT:1000294,,,decreased amount,PATO:0001997,,,,
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:78,Cumulative fecundity and spawning,Reduction,Individual,egg quantity,VT:1000294,,,decreased amount,PATO:0001997,,,,
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:78,Cumulative fecundity and spawning,Reduction,Individual,egg quantity,VT:1000294,,,decreased amount,PATO:0001997,,,,
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:78,Cumulative fecundity and spawning,Reduction,Individual,egg quantity,VT:1000294,,,decreased amount,PATO:0001997,,,,
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:972,Reduced number of oocytes ovulated,Decreased fertility,Individual,egg quantity,VT:1000294,,,decreased amount,PATO:0001997,,,,
Aop:1,Uncharacterized liver damage leading to hepatocellular carcinoma,Event:294,Unknown,N/A,Molecular,,,,,,,eukaryotic cell,CL:0000255,,
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:3,Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits,Event:896,Parkinsonian motor deficits,Increased,Individual,,,Parkinsonian disorders,D020734,occurrence,PATO:0000057,,,,
Aop:6,Antagonist binding to PPARalpha leading to starvation-like body-weight loss,Event:862,Circulating Ketone Bodies,Not Increased,Tissue,,,ketone body,CHEBI:73693,deviation(from_normal),PATO:0000069,,,blood,UBERON:0000178
Aop:7,Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female,Event:219,Plasma 17beta-estradiol concentrations,Reduction,Organ,,,17beta-estradiol,CHEBI:16469,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:280,Thyroxin (T4) in neuronal tissue,Decreased,Organ,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,brain,UBERON:0000955
Aop:8,"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",Event:757,Hippocampal anatomy,Altered,Organ,,,hippocampal formation,UBERON:0002421,malformed,PATO:0000646,,,brain,UBERON:0000955
Aop:14,Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility,Event:168,Lymphocytes,Decreased,Individual,,,lymphocyte,CL:0000542,decreased amount,PATO:0001997,,,,
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:10,Acetylcholine in synapses,Accumulation,Cellular,,,acetylcholine,CHEBI:15355,increased amount,PATO:0000470,eukaryotic cell,CL:0000255,,
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:444,Atrioventricular block and bradycardia,Increased,Organ,,,atrioventricular block,D054537,increased object quality,PATO:0002305,,,heart,UBERON:0000948
Aop:16,Acetylcholinesterase inhibition leading to acute mortality,Event:444,Atrioventricular block and bradycardia,Increased,Organ,,,decreased heart rate,D001919,increased object quality,PATO:0002305,,,heart,UBERON:0000948
Aop:17,Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration,Event:130,GSH,Depletion,Cellular,,,glutathione,CHEBI:16856,decreased concentration,PATO:0001163,eukaryotic cell,CL:0000255,,
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,Event:446,testosterone level,Reduction,Tissue,,,testosterone,CHEBI:17347,decreased concentration,PATO:0001163,,,blood,UBERON:0000178
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,Event:348,Male reproductive tract,Malformation,Organ,,,male reproductive organ,UBERON:0003135,malformed,PATO:0000646,,,Male reproductive system,UBERON:0000079
Aop:18,PPARalpha activation in utero leading to impaired fertility in males,`,Fertility,impaired,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:19,Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),Event:337,Impairment of reproductive capacity,N/A,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:23,Aromatase inhibition leading to reproductive dysfunction,Event:219,Plasma 17beta-estradiol concentrations,Reduction,Organ,,,17beta-estradiol,CHEBI:16469,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:221,Plasma vitellogenin concentrations,Reduction,Organ,,,vitellogenins,D014819,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:129,"Gonadotropins, circulating concentrations",Reduction,Organ,,,Luteinizing hormone,CHEBI:81568,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:23,Androgen receptor agonism leading to reproductive dysfunction,Event:129,"Gonadotropins, circulating concentrations",Reduction,Organ,,,Follicle stimulating hormone,CHEBI:81569,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:219,Plasma 17beta-estradiol concentrations,Reduction,Organ,,,17beta-estradiol,CHEBI:16469,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:25,Aromatase inhibition leading to reproductive dysfunction,Event:221,Plasma vitellogenin concentrations,Reduction,Organ,,,vitellogenins,D014819,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:50,Ca++ (intracellular),Increase,Cellular,,,calcium ion,CHEBI:39124,increased amount,PATO:0000470,eukaryotic cell,CL:0000255,,
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:178,Mitochondrial electron transport chain,Disruption,Cellular,,,mitochondrial respiratory chain,GO:0005746,disrupted,PATO:0001507,eukaryotic cell,CL:0000255,,
Aop:26,Calcium-mediated neuronal ROS production and energy imbalance,Event:193,Nitric Oxide,Decreased,Cellular,,,nitric oxide,CHEBI:16480,decreased amount,PATO:0001997,eukaryotic cell,CL:0000255,,
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:214,Pathological condition,Bile accumulation,Cellular,,,bile,UBERON:0001970,increased amount,PATO:0000470,eukaryotic cell,CL:0000255,,
Aop:27,Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),Event:357,Pathology,Cholestasis,Individual,,,cholestasis,D002779,occurrence,PATO:0000057,,,,
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:243,Prostaglandin E2 concentration,Reduction,Tissue,,,prostaglandin E2,CHEBI:15551,decreased concentration,PATO:0002303,,,blood,UBERON:0000178
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:106,Eggshell thickness,Reduction,Tissue,,,eggshell,UBERON:0005079,decreased thickness,PATO:0000592,,,eggshell,UBERON:0005079
Aop:28,Cyclooxygenase inhibition leading reproductive failure,Event:119,Gap,N/A,Tissue,,,eggshell,UBERON:0005079,damage,PATO:0001020,,,eggshell,UBERON:0005079
Aop:29,Estrogen receptor agonism leading to reproductive dysfunction,Event:220,Plasma vitellogenin concentrations,Increase,Organ,,,vitellogenins,D014819,increased concentration,PATO:0001162,,,blood plasma,UBERON:0001969
Aop:30,Estrogen receptor antagonism leading to reproductive dysfunction,Event:221,Plasma vitellogenin concentrations,Reduction,Organ,,,vitellogenins,D014819,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:250,Red blood cells; hemolysis,Damaging,Cellular,,,hemolysis,D006461,increased object quality,PATO:0002305,erythrocyte,CL:0000232,,
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:246,RBC congestion in liver,Increase,Organ,,,erythrocyte,CL:0000232,increased amount,PATO:0000470,,,liver,UBERON:0002107
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:161,Liver and splenic hemosiderosis,Increase,Organ,,,hemosiderosis,D006486,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:161,Liver and splenic hemosiderosis,Increase,Organ,,,hemosiderosis,D006486,increased object quality,PATO:0002305,,,spleen,UBERON:0002106
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:173,"Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",N/A,Organ,,,Methemoglobinemia,D008708,increased object quality,PATO:0002305,,,blood,UBERON:0000178
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:173,"Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",N/A,Organ,,, hemoglobin ,CHEBI:35143,decreased amount,PATO:0001997,,,blood,UBERON:0000178
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:173,"Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",N/A,Organ,,,erythrocyte,CL:0000232,increased amount,PATO:0000470,,,blood,UBERON:0000178
Aop:31,Oxidation of iron in hemoglobin leading to hematotoxicity,Event:321,Cyanosis occurs,N/A,Individual,,,Cyanosis,D003490,occurrence,PATO:0000057,,,,
Aop:32,"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",Event:347,Liver tumor,Formation,Individual,,,hepatocellular carcinoma,D006528,increased object quality,PATO:0002305,,,,
Aop:33,Kidney toxicity induced by activation of 5HT2C,Event:294,Unknown,N/A,Cellular,,,,,,,,,,
Aop:34,LXR activation leading to hepatic steatosis,Event:291,Triglyceride,Accumulation,Cellular,,,triglyceride,CHEBI:17855,increased concentration,PATO:0001162,hepatocyte,CL:0000182,,
Aop:34,LXR activation leading to hepatic steatosis,Event:345,Liver Steatosis,N/A,Organ,,,fatty liver,D005234,occurrence,PATO:0000057,,,liver,UBERON:0002107
Aop:35,Narcosis leading to respiratory failure,Event:46,Biological membranes,Accumulation,Cellular,,,membrane,GO:0016020,increased object quality,PATO:002305,eukaryotic cell,CL:0000255,,
Aop:35,Narcosis leading to respiratory failure,Event:169,Membrane integrity,Disruption,Cellular,,,plasma membrane,GO:0005886,abnormal,PATO:0000460,eukaryotic cell,CL:0000255,,
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:327,Fatty acid,Accumulation,Organ,,,fatty acid,CHEBI:35366,increased concentration,PATO:0001162,,,liver,UBERON:0002107
Aop:36,Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,Event:459,Liver Steatosis,Increased,Organ,,,Fatty liver,D005234,increased process quality,PATO:0002304,,,liver,UBERON:0002107
Aop:40,Covalent Protein binding leading to Skin Sensitisation,Event:827,skin,sensitisation,Organ,,,,,,,,,,
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:139,"Hepatotoxicity, Hepatopathy, including a constellation of observable effects",N/A,Tissue,,,Liver Diseases,D008107,occurrence,PATO:0000057,,,liver,UBERON:0002107
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:856,Hepatocellular and Bile duct tumors,Formation,Organ,,,hepatocellular carcinoma,D006528,increased object quality,PATO:0002305,,,hepatobiliary system,UBERON:0002423
Aop:41,Sustained AhR Activation leading to Rodent Liver Tumours,Event:856,Hepatocellular and Bile duct tumors,Formation,Organ,,,Bile Duct Neoplasms,D001650,increased object quality,PATO:0002305,,,hepatobiliary system,UBERON:0002423
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:280,Thyroxin (T4) in neuronal tissue,Decreased,Organ,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,brain,UBERON:0000955
Aop:42,Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:757,Hippocampal anatomy,Altered,Organ,,,hippocampal formation,UBERON:0002421,malformed,PATO:0000646,,,brain,UBERON:0000955
Aop:43,Disruption of VEGFR Signaling Leading to Developmental Defects,Event:298,Vascular,Insufficiency,Organ,,,capillary plexus,UBERON:0035753,abnormal,PATO:0000460,,,embryo,UBERON:0000922
Aop:46,AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC),Event:378,Hepatocellular carcinoma,Tumorigenesis,Individual,,,hepatocellular carcinoma,D006528,increased object quality,PATO:0002305,,,,
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:389,Intracellular Calcium overload,Increased,Cellular,,,calcium ion,CHEBI:39124,increased concentration,PATO:0001162,eukaryotic cell,CL:0000255,,
Aop:48,"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:51,PPARalpha activation leading to impaired fertility in adult male rodents,Event:446,testosterone level,Reduction,Tissue,,,testosterone,CHEBI:17347,decreased concentration,PATO:0001163,,,blood,UBERON:0000178
Aop:53,ER agonism leading to reduced survival due to renal failure,Event:220,Plasma vitellogenin concentrations,Increase,Organ,,,vitellogenins,D014819,increased concentration,PATO:0001162,,,blood plasma,UBERON:0001969
Aop:53,ER agonism leading to reduced survival due to renal failure,Event:419,renal vitellogenin deposition,Increased,Organ,,,vitellogenins,D014819,increased concentration,PATO:0001162,,,kidney,UBERON:0002113
Aop:53,ER agonism leading to reduced survival due to renal failure,Event:421,glomerular rupture and renal hemorrhaging,Increased,Organ,,,glomerular basement membrane,UBERON:0005777,damage,PATO:0001020,,,kidney,UBERON:0002113
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:54,Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children,Event:280,Thyroxin (T4) in neuronal tissue,Decreased,Organ,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,brain,UBERON:0000955
Aop:57,AhR activation leading to hepatic steatosis,Event:327,Fatty acid,Accumulation,Organ,,,fatty acid,CHEBI:35366,increased concentration,PATO:0001162,,,liver,UBERON:0002107
Aop:57,AhR activation leading to hepatic steatosis,Event:291,Triglyceride,Accumulation,Cellular,,,triglyceride,CHEBI:17855,increased concentration,PATO:0001162,hepatocyte,CL:0000182,,
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:327,Fatty acid,Accumulation,Organ,,,fatty acid,CHEBI:35366,increased concentration,PATO:0001162,,,liver,UBERON:0002107
Aop:58,NR1I3 (CAR) suppression leading to hepatic steatosis,Event:459,Liver Steatosis,Increased,Organ,,,Fatty liver,D005234,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:327,Fatty acid,Accumulation,Organ,,,fatty acid,CHEBI:35366,increased concentration,PATO:0001162,,,liver,UBERON:0002107
Aop:60,"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis",Event:459,Liver Steatosis,Increased,Organ,,,Fatty liver,D005234,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:61,NFE2L2/FXR activation leading to hepatic steatosis,Event:459,Liver Steatosis,Increased,Organ,,,Fatty liver,D005234,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:62,AKT2 activation leading to hepatic steatosis,Event:459,Liver Steatosis,Increased,Organ,,,Fatty liver,D005234,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:63,Cyclooxygenase inhibition leading to reproductive dysfunction,Event:685,"Prostaglandins, ovary",Reduced,Organ,,,prostaglandin,CHEBI:26333,decreased concentration,PATO:0001163,,,female gonad,UBERON:0000992
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:446,testosterone level,Reduction,Tissue,,,testosterone,CHEBI:17347,decreased object quality,PATO:0002303,,,serum ,UBERON:0001977
Aop:64,Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility,Event:520,Decreased fertility,Decreased sperm quantity or quality in the adult,Individual,,,sperm cell,CL:0000019,malformed,PATO:0000646,,,,
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:65,XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:280,Thyroxin (T4) in neuronal tissue,Decreased,Organ,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,brain,UBERON:0000955
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:653,Increased corticosterone,Decreased testosterone by the fetal Leydig cells,Cellular,,,corticosterone,CHEBI:16827,increased concentration,PATO:0001162,Leydig cell,CL:0000178,,
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:505,Decreased fertility,Decreased sperm quantity / quality in the adult,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:66,Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,Event:505,Decreased fertility,Decreased sperm quantity / quality in the adult,Individual,,,sperm,CL:0000019,decreased amount,PATO:0001997,,,,
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:658,Increased estradiol,Decreased testosterone by the fetal Leydig cells,Cellular,,,estradiol,PR:000007204,increased concentration,PATO:0001162,Leydig cell,CL:0000178,,
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:505,Decreased fertility,Decreased sperm quantity / quality in the adult,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:67,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:505,Decreased fertility,Decreased sperm quantity / quality in the adult,Individual,,,sperm,CL:0000019,decreased amount,PATO:0001997,,,,
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome,Event:661,Alterations in the fetal testis proteome,Decreased testosterone by the fetal Leydig cells,Molecular,,,fetal proteins,D005326,deviation(from_normal),PATO:0000069,male gonocyte,CL:0002238,,
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:505,Decreased fertility,Decreased sperm quantity / quality in the adult,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:68,Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,Event:505,Decreased fertility,Decreased sperm quantity / quality in the adult,Individual,,,sperm,CL:0000019,decreased amount,PATO:0001997,,,,
Aop:69,Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell,Event:646,Decreased sperm quantity and/or quality in the adult testis,Decreased Cholesterol,Organ,,,sperm,CL:0000019,decreased amount,PATO:0001997,,,testis,UBERON:0000473
Aop:70,Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell,Event:520,Decreased fertility,Decreased sperm quantity or quality in the adult,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:70,Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell,Event:520,Decreased fertility,Decreased sperm quantity or quality in the adult,Individual,,,sperm,CL:0000019,decreased amount,PATO:0001997,,,,
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:525,Decreased testosterone by adult Leydig cells,Apoptosis of adult Leydig cells,Cellular,,,testosterone,CHEBI:17347,decreased concentration,PATO:0001163,Leydig cell,CL:0000178,,
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:520,Decreased fertility,Decreased sperm quantity or quality in the adult,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:71,Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,Event:520,Decreased fertility,Decreased sperm quantity or quality in the adult,Individual,,,sperm,CL:0000019,decreased amount,PATO:0001997,,,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:534,Formation of cortical envelope,Altered,Cellular,,,fertilization envelope,GO:0060387,deviation(from_normal),PATO:0000069,oocyte,CL:0000023,,
Aop:73,Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,Event:527,Decreased fecundity,Decreased,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:543,Decreased sperm quantity and/or quality in the adult testis,Decreased fertility in the adult,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:74,Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis,Event:543,Decreased sperm quantity and/or quality in the adult testis,Decreased fertility in the adult,Individual,,,sperm,CL:0000019,decreased amount,PATO:0001997,,,,
Aop:77,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:78,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:564,Roll change within caste,Abnormal,Population,,,,,,,,,,
Aop:79,Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:80,Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,Event:572,Number of worker bees,Decrease,Population,,,population of organisms,PCO:0000001,decreased object quality,PATO:0002303,,,,
Aop:81,Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure,Event:572,Number of worker bees,Decrease,Population,,,population of organisms,PCO:0000001,decreased object quality,PATO:0002303,,,,
Aop:82,Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure,Event:564,Roll change within caste,Abnormal,Population,,,,,,,,,,
Aop:84,Suppression of immune system contributes to impaired development and leads to colony loss/failure,Event:572,Number of worker bees,Decrease,Population,,,population of organisms,PCO:0000001,decreased object quality,PATO:0002303,,,,
Aop:85,Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure,Event:572,Number of worker bees,Decrease,Population,,,population of organisms,PCO:0000001,decreased object quality,PATO:0002303,,,,
Aop:86,Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,Event:564,Roll change within caste,Abnormal,Population,,,,,,,,,,
Aop:86,Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,Event:580,Antiseptic incorporated in food,Reduced,Population,,,,,,,,,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:87,Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2,Event:1108,"Abnormal, Role change within caste","Abnormal, Role change within caste",Population,,,,,,,,,,
Aop:89,Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure                         ,Event:1108,"Abnormal, Role change within caste","Abnormal, Role change within caste",Population,,,,,,,,,,
Aop:90,Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure,Event:564,Roll change within caste,Abnormal,Population,,,,,,,,,,
Aop:94,Sodium channel inhibition leading to congenital malformations,Event:444,Atrioventricular block and bradycardia,Increased,Organ,,,atrioventricular block,D054537,increased object quality,PATO:0002305,,,heart,UBERON:0000948
Aop:94,Sodium channel inhibition leading to congenital malformations,Event:444,Atrioventricular block and bradycardia,Increased,Organ,,,decreased heart rate,D001919,increased object quality,PATO:0002305,,,heart,UBERON:0000948
Aop:94,Sodium channel inhibition leading to congenital malformations,Event:591,amputations,Increased,Individual,,,"Amputation, Congenital",C565682,increased object quality,PATO:0002305,,,,
Aop:99,Histamine (H2) receptor antagonism leading to reduced survival,Event:634,sedation,N/A,Individual,,,anesthesia,D000758,increased object quality,PATO:0002305,,,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:671,"Prostaglandin F2alpha concentration, plasma",Reduced,Individual,,,prostaglandin F2alpha,CHEBI:15553,decreased concentration,PATO:0001163,,,,
Aop:100,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior,Event:673,Spawning behavior,Reduced,Individual,,,fertility,D005298,abnormal,PATO:0000460,,,,
Aop:101,Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release,Event:671,"Prostaglandin F2alpha concentration, plasma",Reduced,Individual,,,prostaglandin F2alpha,CHEBI:15553,decreased concentration,PATO:0001163,,,,
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:693,cyclic adenosine monophosphate,Increased,Tissue,,,"3',5'-cyclic AMP(1-)",CHEBI:58165,increased concentration,PATO:0001162,,,,
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:687,"Prostaglandin E2 concentration, hypothalamus",Reduced,Tissue,,,prostaglandin E2,CHEBI:15551,decreased concentration,PATO:0001163,,,hypothalamus,UBERON:0001898
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:689,"Gonadotropin releasing hormone, hypothalamus",Reduced,Tissue,,,         Gonadotropin-Releasing Hormone,D007987,decreased concentration,PATO:0001163,,,hypothalamus,UBERON:0001898
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:690,"Luteinizing hormone (LH), plasma",Reduced,Tissue,,,Luteinizing hormone,CHEBI:81568,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:102,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition,Event:691,"Maturation inducing steroid, plasma",Reduced,Tissue,,,steroid hormone  ,CHEBI:26764,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:687,"Prostaglandin E2 concentration, hypothalamus",Reduced,Tissue,,,prostaglandin E2,CHEBI:15551,decreased concentration,PATO:0001163,,,hypothalamus,UBERON:0001898
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:689,"Gonadotropin releasing hormone, hypothalamus",Reduced,Tissue,,,         Gonadotropin-Releasing Hormone,D007987,decreased concentration,PATO:0001163,,,hypothalamus,UBERON:0001898
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:690,"Luteinizing hormone (LH), plasma",Reduced,Tissue,,,Luteinizing hormone,CHEBI:81568,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:103,Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint,Event:691,"Maturation inducing steroid, plasma",Reduced,Tissue,,,steroid hormone  ,CHEBI:26764,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:105,Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:713,Adenomas/carcinomas (renal tubular),Increase,Tissue,,,Adenoma,D000236,increased object quality,PATO:0002305,,,renal tubule,UBERON:0009773
Aop:105,Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:713,Adenomas/carcinomas (renal tubular),Increase,Tissue,,,Carcinoma,D002277,increased object quality,PATO:0002305,,,renal tubule,UBERON:0009773
Aop:105,Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:708,Accumulation of alpha2u microglobulin (proximal tubular epithelium),Increased,Tissue,,,major urinary protein (rat),PR:P02761,increased concentration,PATO:0001162,,,proximale tubular epithelium,UBERON:0008404
Aop:107,Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,,,Adenoma,D000236,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:107,Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,,,Carcinoma,D002277,increased object quality,PATO:0002305,,,liver,
Aop:108,Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,,,Adenoma,D000236,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:108,Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,,,Carcinoma,D002277,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:109,Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse),Event:736,Adenomas/carcinomas (bronchioloalveolar),Increase,Tissue,,,Adenoma,D000236,increased object quality,PATO:0002305,,,lung,UBERON:0002048
Aop:109,Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse),Event:736,Adenomas/carcinomas (bronchioloalveolar),Increase,Tissue,,,Carcinoma,D002277,increased object quality,PATO:0002305,,,lung,UBERON:0002048
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:771,Serum thyroid hormone (T4/T3),Decrease,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:741,Adenomas/carcinomas (follicular cell),Increase,Tissue,,,Adenoma,D000236,increased object quality,PATO:0002305,,,thyroid gland,UBERON:0002046
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:741,Adenomas/carcinomas (follicular cell),Increase,Tissue,,,Carcinoma,D002277,increased object quality,PATO:0002305,,,thyroid gland,UBERON:0002046
Aop:110,Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:753,Thyroid-stimulating hormone (TSH),Increase,Tissue,,,thyroid stimulating hormone,CHEBI:81567 ,increased concentration,PATO:0001162,,,serum,UBERON:0001977
Aop:111,Decrease in androgen receptor activity leading to Leydig cell tumors (in rat),Event:754,Luteinizing hormone (LH),Increased,Tissue,,,Luteinizing hormone,CHEBI:81568,increased concentration,PATO:0001162,,,blood,UBERON:0000178
Aop:112,Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat),Event:747,Prolactin,Decreased,Tissue,,,Prolactin,CHEBI:81580,decreased concentration,PATO:0001163,,,blood,UBERON:0000178
Aop:112,Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat),Event:773,Endometrial adenocarcinomas,Increase,Tissue,,,adenoma,D000236,increased object quality,PATO:0002305,,,endometrium,UBERON:0001295
Aop:112,Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat),Event:773,Endometrial adenocarcinomas,Increase,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,endometrium,UBERON:0001295
Aop:113,Glutamate-gated chloride channel activation leading to acute mortality,Event:765,population,Decreased,Population,,,population quality,PCO:0000003,decreased quality,PATO:0002301,,,,
Aop:114,HPPD inhibition leading to corneal papillomas and carcinomas (in rat),Event:779,Papillomas/carcinomas (squamous cells),Increase,Cellular,,,papilloma ,D010212,increased object quality,PATO:0002305,squamous epithelial cell,CL:0000076,,
Aop:114,HPPD inhibition leading to corneal papillomas and carcinomas (in rat),Event:779,Papillomas/carcinomas (squamous cells),Increase,Cellular,,,carcinoma,D002277,increased object quality,PATO:0002305,squamous epithelial cell,CL:0000076,,
Aop:114,HPPD inhibition leading to corneal papillomas and carcinomas (in rat),Event:775,Plasma tyrosine,Increased,Tissue,,,tyrosine,CHEBI:18186,increased process quality,PATO:0002304,,,blood plasma,UBERON:0001969
Aop:115,Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat),Event:779,Papillomas/carcinomas (squamous cells),Increase,Cellular,,,papilloma,D010212,increased object quality,PATO:0002305,squamous epithelial cell,CL:0000076,,
Aop:115,Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat),Event:779,Papillomas/carcinomas (squamous cells),Increase,Cellular,,,carcinoma,D002277,increased object quality,PATO:0002305,squamous epithelial cell,CL:0000076,,
Aop:116,Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat),Event:713,Adenomas/carcinomas (renal tubular),Increase,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,renal tubule,UBERON:0009773
Aop:117,Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:118,Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat),Event:719,Adenomas/carcinomas (hepatocellular),Increase,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,liver,UBERON:0002107
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:771,Serum thyroid hormone (T4/T3),Decrease,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:741,Adenomas/carcinomas (follicular cell),Increase,Tissue,,,adenoma,D000236,increased object quality,PATO:0002305,,,thyroid gland,UBERON:0002046 
Aop:119,Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse),Event:741,Adenomas/carcinomas (follicular cell),Increase,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,thyroid gland,UBERON:0002046 
Aop:120,Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat),Event:791,Leutinizing hormone (LH),Increased,Tissue,,,leutinizing hormone,CHEBI:81568,increased concentration,PATO:0001162,,,serum,UBERON:0001977
Aop:121,Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat),Event:797,Adenomas/carcinomas (urothelial),Increase,Tissue,,,adenoma,D000236,increased object quality,PATO:0002305,,,urothelium,UBERON:0000365
Aop:121,Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat),Event:797,Adenomas/carcinomas (urothelial),Increase,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,urothelium,UBERON:0000365
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:219,Plasma 17beta-estradiol concentrations,Reduction,Organ,,,17beta-estradiol,CHEBI:16469,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:122,Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,Event:221,Plasma vitellogenin concentrations,Reduction,Organ,,,vitellogenins,D014819,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:219,Plasma 17beta-estradiol concentrations,Reduction,Organ,,,17beta-estradiol,CHEBI:16469,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:123,Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription,Event:221,Plasma vitellogenin concentrations,Reduction,Organ,,,vitellogenins,D014819,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:124,HMG-CoA reductase inhibition leading to decreased fertility,Event:330,Fertility,Decreased,Individual,,,fertility,D005298,decreased object quality,PATO:0002303,,,,
Aop:124,HMG-CoA reductase inhibition leading to decreased fertility,Event:805,mevalonate,Decreased,Cellular,,,mevalonate ,CHEBI:25350,decreased object quality,PATO:0002303,,,,
Aop:124,HMG-CoA reductase inhibition leading to decreased fertility,Event:807,cholesterol,Decreased,Cellular,,,cholesterol,CHEBI:16113,decreased object quality,PATO:0002303,,,,
Aop:124,HMG-CoA reductase inhibition leading to decreased fertility,Event:808,Testosterone,Decreased,Individual,,,testosterone,CHEBI:17347,decreased concentration,PATO:0001163,,,,
Aop:124,HMG-CoA reductase inhibition leading to decreased fertility,Event:809,Male reproductive tract,malformed,Individual,,,Male reproductive system,UBERON:0000079,malformed,PATO:0000646,,,Male reproductive system,UBERON:0000079
Aop:126,Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation,Event:534,Formation of cortical envelope,Altered,Cellular,,,fertilization envelope,GO:0060387,deviation(from_normal),PATO:0000069,oocyte,CL:0000023,,
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:426,Thyroxine (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:128,Kidney dysfunction by decreased thyroid hormone,Event:813,Serum creatinine,Increased,Organ,,,creatinine,CHEBI:16737,increased object quality,PATO:0002305,,,serum,UBERON:0001977
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:829,Lipid bilayer,Damage,Cellular,,,Lipid bilayer of wall of lysosome,67514,damage,PATO:0001020,,,,
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:831,Lysosomal function,Disturbance,Cellular,,,lysosome,GO:0005764,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:130,Phospholipase A inhibitors lead to hepatotoxicity,Event:832,Mitochondria,Injury,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:131,AhR activation leading to uroporphyria,Event:846,Highly carboxylated porphyrins,Accumulation,Organ,,,porphyrins,CHEBI:26214,increased object quality,PATO:0002305,,,,
Aop:131,AhR activation leading to uroporphyria,Event:844,Uroporphyrinogen,Oxidation,Cellular,,,uroporphyrinogen,CHEBI:27258,increased process quality,PATO:0002304,hepatoctye,CL:0000182,,
Aop:131,AhR activation leading to uroporphyria,Event:844,Uroporphyrinogen,Oxidation,Cellular,,,uroporphyrinogen,CHEBI:27258,increased process quality,PATO:0002304,cardiac muscle cell,CL:0000746,,
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:757,Hippocampal anatomy,Altered,Organ,,,hippocampal formation,UBERON:0002421,malformed,PATO:0000646,,,brain,UBERON:0000955
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:280,Thyroxin (T4) in neuronal tissue,Decreased,Organ,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,brain,UBERON:0000955
Aop:134,Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:869,Respiratory or Squamous Metaplasia,Increase,Tissue,,,Metaplasia,D008679,increased object quality,PATO:0002305,,,respiratory system epithelium,UBERON:0004807
Aop:136,Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors,Event:869,Respiratory or Squamous Metaplasia,Increase,Tissue,,,Metaplasia,D008679,increased object quality,PATO:0002305,,,squamous epithelium,UBERON:0006914
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:1096,"Increased, blood uric acid concentration","Increased, blood uric acid concentration",Tissue,,,uric acid,CHEBI:27226,increased object quality,PATO:0002305,,,blood,UBERON:0000178
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:1098,"Increased, blood potassium concentration","Increased, blood potassium concentration",Tissue,,,Potassium,CHEBI:26216,increased object quality,PATO:0002305,,,blood,UBERON:0000178
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:1102,"Occurrence, tophi (urate) deposition","Occurrence, tophi (urate) deposition",Tissue,,,uric acid,CHEBI:27226,increased object quality,PATO:0002305,,,,
Aop:138,Organic anion transporter (OAT1) inhibition leading to renal failure and mortality,Event:1106,"Occurrence, cardiac arrhythmia","Occurrence, cardiac arrhythmia",Organ,,,"Arrhythmias, Cardiac",D001145,increased object quality,PATO:0002305,,,,
Aop:139,Alkylation of DNA leading to cancer 3,Event:885,Cancer,Increase,Tissue,,,         Neoplasms,D009369,increased object quality,PATO:0002305,,,,
Aop:141,Alkylation of DNA leading to cancer 4,Event:885,Cancer,Increase,Tissue,,,         Neoplasms,D009369,increased object quality,PATO:0002305,,,,
Aop:144,Lysosomal damage leading to liver inflammation,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:149,Oxidative Stress Leading to Hypertension,Event:932,eNOS,Uncoupling,Cellular,,,"nitric oxide synthase, endothelial",PR:000011328,insufficient,PATO:0001628,endothelial cell,CL:0000115,,
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:757,Hippocampal anatomy,Altered,Organ,,,hippocampal formation,UBERON:0002421,malformed,PATO:0000646,,,brain,UBERON:0000955
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:280,Thyroxin (T4) in neuronal tissue,Decreased,Organ,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,brain,UBERON:0000955
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:959,Free serum thyroxine (T4),Increased,Tissue,,,thyroxine,CHEBI:30660,increased concentration,PATO:0001162,,,blood,UBERON:0000178
Aop:152,Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,Event:958,Serum thyroxine (T4) from transthyretin,Displacement,Molecular,,,thyroxine,CHEBI:30660,increased concentration,PATO:0001162,,,,
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:966,Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation,Reduced Estradiol in Circulation,Tissue,,,17beta-estradiol,CHEBI:16469,decreased concentration,PATO:0001163,,,blood,UBERON:0000178
Aop:153,Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats,Event:967,Reduced estradiol in circulation decreases estrogen concentration at hypothalamus,Decreased positive estrogenic feedback on hypothalamus,Organ,,,estrogen,CHEBI:50114,decreased concentration,PATO:0001163,,,hypothalamus,UBERON:0001898
Aop:155,Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1003,Triiodothyronine (T3) in serum,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:156,Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1003,Triiodothyronine (T3) in serum,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:157,Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation,Event:1003,Triiodothyronine (T3) in serum,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:158,Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:1003,Triiodothyronine (T3) in serum,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:159,Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1022,serum T4/T3,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1023,Thyroid-stimulating hormone (TSH),Increased,Tissue,,,thyroid stimulating hormone,CHEBI:81567 ,increased concentration,PATO:0001162,,,serum,UBERON:0001977
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1026,Adenomas/carcinomas (follicular cell),Increased Apoptosis,Tissue,,,adenoma,D000236,increased object quality,PATO:0002305,,,thyroid gland,UBERON:0002046 
Aop:162,Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse),Event:1026,Adenomas/carcinomas (follicular cell),Increased Apoptosis,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,thyroid gland,UBERON:0002046 
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1035,Firbrosarcoma,Increased,Tissue,,,Fibrosarcoma,D005354,increased object quality,PATO:0002305,,,fibrous connective tissue,UBERON:0011824
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1036,liposarcoma,Increased,Tissue,,,liposarcoma,D008080,increased object quality,PATO:0002305,,,adipose tissue,UBERON:0001013
Aop:163,"PPARgamma activation leading to sarcomas in rats, mice, and hamsters",Event:1037,hemagiosarcoma,Increased,Tissue,,,hemangiosarcoma,         D006394,increased object quality,PATO:0002305,,,blood vessel endothelium, UBERON:0004638
Aop:164,Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse,Event:1044,mesovarian leiomyomas,Promotion,Tissue,,,leiomyoma,D007889,increased object quality,PATO:0002305,,,uterus,UBERON:0000995
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1045,Ovarian E2,Decreased,Tissue,,,estradiol,CHEBI:23965,decreased concentration,PATO:0001163,,,female gonad,UBERON:0000992
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1053,ovarian adenomas,Promotion,Tissue,,,adenoma,D000236,increased object quality,PATO:0002305,,, female gonad        UBERON:0000992 ,
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1054,ovarian granular cell tumors,Promotion,Cellular,,,Granular Cell Tumor,D016586,increased object quality,PATO:0002305,,, female gonad        UBERON:0000992 ,
Aop:165,Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,Event:1056,E2 blood concentrations at hypothalamus,Decrease,Tissue,,,17beta-estradiol,CHEBI:16469,decreased concentration,PATO:0001163,,,blood,UBERON:0000178
Aop:166,PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse,Event:1058,bile flow,Decreased,Organ,,,bile,UBERON:0001970,decreased amount,PATO:0001997,,,bile canaliculi,UBERON:0001283
Aop:166,PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse,Event:1059,cholestasis,Increased,Organ,,,cholestasis,D002779,occurrence,PATO:0000057,,,bile duct,UBERON:0002394
Aop:166,PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse,Event:1061,elevation of serum CCK,prolonged,Tissue,,,cholecystokinin,PR:000005110,increased object quality,PATO:0002305,,,serum ,UBERON:0001977
Aop:166,PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse,Event:1063,Pancreatic acinar tumors,Increased,Organ,,,carcinoma,D002277,increased object quality,PATO:0002305,,,pancreas,UBERON:0001264
Aop:167,Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,Event:1068,aberrant basal cells,squamous metaplasia,Tissue,,,metaplasia,D008679,deformed,PATO:0001617,,,,
Aop:167,Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,Event:1070,adenosquamous carcinomas of endometrium,Increased,Tissue,,,adenosquamous carcinoma,D018196,increased object quality,PATO:0002305,,,endometrium,UBERON:0001295
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1076,circulating estrogen levels,Increased,Organ,,,estrogen,CHEBI:50114,increased concentration,PATO:0001162,,,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1077,prolactin exposure,Increased,Tissue,,,prolactin,PR:000013246,increased concentration,PATO:0001162,,,,
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1079,Adenomas/carcinomas (mammary),Increased,Tissue,,,adenoma,D000236,increased object quality,PATO:0002305,,,mammary gland,UBERON:0001911
Aop:168,GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.,Event:1079,Adenomas/carcinomas (mammary),Increased,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,mammary gland,UBERON:0001911
Aop:169,GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.,Event:1076,circulating estrogen levels,Increased,Organ,,,estrogen,CHEBI:50114,increased concentration,PATO:0001162,,,,
Aop:170,Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat,Event:1079,Adenomas/carcinomas (mammary),Increased,Tissue,,,adenoma,D000236,increased object quality,PATO:0002305,,,mammary gland,UBERON:0001911
Aop:170,Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat,Event:1079,Adenomas/carcinomas (mammary),Increased,Tissue,,,carcinoma,D002277,increased object quality,PATO:0002305,,,mammary gland,UBERON:0001911
Aop:171,Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.,Event:1090,mesotheliomas,Increased,Tissue,,,mesothelioma,D008654,increased object quality,PATO:0002305,,,,
Aop:175,Thyroperoxidase inhibition leading to altered amphibian metamorphosis,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:175,Thyroperoxidase inhibition leading to altered amphibian metamorphosis,Event:1093,Thyroxine (T4) in tissues,Decreased,Tissue,,,thyroxine,CHEBI:30660,increased object quality,PATO:0002305,,,,
Aop:175,Thyroperoxidase inhibition leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,increased object quality,PATO:0002305,,,,
Aop:176,Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:176,Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,Event:1093,Thyroxine (T4) in tissues,Decreased,Tissue,,,thyroxine,CHEBI:30660,increased object quality,PATO:0002305,,,,
Aop:176,Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,increased object quality,PATO:0002305,,,,
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1104,"Prostaglandin F2alpha concentration, plasma",Decreased,Tissue,,,prostaglandin F2alpha,CHEBI:15553,decreased concentration,PATO:0001163,,,blood plasma,UBERON:0001969
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1098,blood potassium concentration,Increased,Tissue,,,Potassium,CHEBI:26216,increased object quality,PATO:0002305,,,blood,UBERON:0000178
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1106,cardiac arrhythmia,Occurrence,Organ,,,"Arrhythmias, Cardiac",D001145,increased object quality,PATO:0002305,,,,
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1096,blood uric acid concentration,Increased,Tissue,,,uric acid,CHEBI:27226,increased object quality,PATO:0002305,,,blood,UBERON:0000178
Aop:177,Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality,Event:1102,tophi (urate) deposition,Occurrence,Tissue,,,uric acid,CHEBI:27226,increased object quality,PATO:0002305,,,,
Aop:178,Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:179,Varroa mite infestation increases virus levels leading to colony loss/failure,Event:1109,Deformed Wing Virus levels,Increased,Individual,,,Viral load,D019562,increased process quality,PATO:0002304,,,,
Aop:186,unknown MIE leading to renal failure and mortality,Event:1114,MIE,Unknown,Molecular,,,,,,,,,,
Aop:186,unknown MIE leading to renal failure and mortality,Event:1115,Reactive oxygen species,Increased,Cellular,,,reactive oxygen species,CHEBI:26523,increased object quality,PATO:0002305,eukaryotic cell,CL:0000255,,
Aop:186,unknown MIE leading to renal failure and mortality,Event:1098,blood potassium concentration,Increased,Tissue,,,Potassium,CHEBI:26216,increased object quality,PATO:0002305,,,blood,UBERON:0000178
Aop:186,unknown MIE leading to renal failure and mortality,Event:1106,cardiac arrhythmia,Occurrence,Organ,,,"Arrhythmias, Cardiac",D001145,increased object quality,PATO:0002305,,,heart,UBERON:0000948
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1133,Depletion from blood of fully functional carboxylated clotting factors,Hemostasis,Tissue,,,blood coagulation factors,D001779,decreased object quality,PATO:0002303,,,blood,UBERON:0000178
Aop:187,Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,Event:1135,"Acidosis, hypovolemic shock and organ dysfunction",Reduced fitness or even mortality,Tissue,,,organ,UBERON:0000062,non-functional,PATO:0001511,,,,
Aop:188,Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,Event:426,Thyroxine (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:188,Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,Event:1093,Thyroxine (T4) in tissues,Decreased,Tissue,,,thyroxine,CHEBI:30660,increased object quality,PATO:0002305,,,,
Aop:188,Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,increased object quality,PATO:0002305,,,,
Aop:189,Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,,
Aop:189,Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,Event:1003,Triiodothyronine (T3) in serum,Decreased,Cellular,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,serum ,UBERON:0001977
Aop:190,Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased object quality,PATO:0002303,,,,
Aop:191,Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,Event:1154,Triiodothyronine (T3) in tissues,Increased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased object quality,PATO:0002303,,,,
Aop:192,Pendrin inhibition leading to altered amphibian metamorphosis,Event:426,Thyroxine (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:192,Pendrin inhibition leading to altered amphibian metamorphosis,Event:1093,Thyroxine (T4) in tissues,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,,
Aop:192,Pendrin inhibition leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,,
Aop:193,Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis,Event:426,Thyroxine (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:193,Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis,Event:1093,Thyroxine (T4) in tissues,Decreased,Tissue,,,thyroxine,CHEBI:30660,increased object quality,PATO:0002305,,,,
Aop:193,Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased object quality,PATO:0002303,,,,
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:281,Thyroxin (T4) in serum,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased concentration,PATO:0001163,,,serum,UBERON:0001977
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:1093,Thyroxine (T4) in tissues,Decreased,Tissue,,,thyroxine,CHEBI:30660,decreased object quality,PATO:0002303,,,,
Aop:194,Hepatic nuclear receptor activation leading to altered amphibian metamorphosis,Event:1116,Triiodothyronine (T3) in tissues,Decreased,Tissue,,,Triiodothyronine,CHEBI:18258,decreased concentration,PATO:0001163,,,,
Aop:195,5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,Event:1164,Population,Increased,Population,,,population,PCO:0000001,increased object quality,PATO:0002305,,,,
Aop:195,5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,Event:1255,induced spawning,induced spawning,Individual,,,spawning,C82476,acceleration,PATO:0001028,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1223,Trigeminal and/or vagal nerve excitation,"Airway Hyper-responsiveness,Cough, Dyspnea",Tissue,,,cough,D003371,increased process quality,PATO:0002304,,,respiratory tract,UBERON:0000065
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1223,Trigeminal and/or vagal nerve excitation,"Airway Hyper-responsiveness,Cough, Dyspnea",Tissue,,,Respiratory Hypersensitivity,D012130,increased object quality,PATO:0002305,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1223,Trigeminal and/or vagal nerve excitation,"Airway Hyper-responsiveness,Cough, Dyspnea",Tissue,,,Cough,D003371,increased object quality,PATO:0002305,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1223,Trigeminal and/or vagal nerve excitation,"Airway Hyper-responsiveness,Cough, Dyspnea",Tissue,,,Dyspnea,D004417,increased object quality,PATO:0002305,,,,
Aop:196,Adverse outcome pathway for airway irritation and chemical sensitization,Event:1226,Respiratory irritability,Chronic Cough,Individual,,,Cough,D003371,increased object quality,PATO:0002305,,,,
Aop:199,ER mediated breast cancer AOP,,,,,,,,,,,,,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:177,Mitochondrial dysfunction,N/A,Cellular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1193,Breast Cancer,N/A,Individual,,, Breast Neoplasms,D001943,pathological,PATO:0001869,,,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1194,DNA Damage,Increased,Molecular,,,DNA,CHEBI:16991,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1195,Extracellular Matrix Composition,modulation,Cellular,,,extracellular matrix,GO:0031012,deformed,PATO:0001617,eukaryotic cell,CL:0000255,,
Aop:200,Estrogen receptor activation leading to breast cancer,Event:1196,Invasion,Increased,Cellular,,, epithelial cell,CL:0000066,increased object quality,PATO:0002305,,,mammary duct,UBERON:0001765
Aop:201,Juvenile hormone receptor agonism leading to male offspring induction associated population decline,Event:1208,Male offspring,Increased,Population,,,male organism,UBERON:0003101,increased object quality,PATO:0002305,,,,
Aop:201,Juvenile hormone receptor agonism leading to male offspring induction associated population decline,Event:1209,Male reproductive tract,Induction,Organ,,,male reproductive organ,UBERON:0003135,increased fecundity,PATO:0001695,,,Male reproductive system,UBERON:0000079
Aop:201,Juvenile hormone receptor agonism leading to male offspring induction associated population decline,Event:1210,Food-web structures,Alteration,Population,,,Food Chain,D020387,deviation(from_normal),PATO:0000069,,,,
Aop:202,In-utero DNA topoisomerase II poisons leading to infant leukaemia,Event:1254,Infant leukaemia,,Individual,,,,,,,,,,
AOP:205,AOP from chemical insult to cell death,Event:1261,Mitochondrial impairment,,Molecular,,,mitochondrion,GO:0005739,damage,PATO:0001020,eukaryotic cell,CL:0000255,,
Aop:206,Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis,Event: 1275,Collagen Deposition,,Tissue,,,collagen,CHEBI:3815,increased object quality,PATO:0002305,,,lung,UBERON:0002048
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1289,Perturbation of cholesterol,,Cellular,,,cholesterol,CHEBI:16113,abnormal,PATO:0000460,hepatocyte,CL:0000182,,
Aop:209,Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ,Event:1290,Glutathione homeostasis,,Cellular,,,glutathione,CHEBI:16856,abnormal,PATO:0000460,hepatocyte,CL:0000182,,